drug_1_name,drug_2_name,drug_1_SMILES,drug_2_SMILES,molecular_interaction,mechanism,evidence,severity
alendronic acid,Indapamide,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,Hydrogen Bonding,"Hydrogen bonds may form between a hydrogen donor (such as -NH or -OH groups) and an acceptor (such as -NH, -OH, or carbonyl oxygen groups) under physiological conditions. This is due to the attractive forces between the partially positive hydrogen and the electronegative atoms with lone pairs.","- SMILES 1 contains a hydroxyl group (-OH) in `CC(O)(P(=O)(O)O)P(=O)(O)O` which can act as a hydrogen bond donor.
- SMILES 2 contains a carbonyl group (C=O) in `NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N` which can act as a hydrogen bond acceptor.","Moderate - The hydrogen bonding could potentially influence solubility or the interaction of these molecules when in close proximity, which might have implications for pharmacokinetic or pharmacodynamic properties."
Methylphenidate,Terazosin,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors (e.g., -NH) and acceptors (e.g., C=O) in polar functional groups.","SMILES 1 contains an oxygen in the ester group (COC(=O)C), which can act as a hydrogen bond acceptor. SMILES 2 possesses an amine group (N) within a triazine derivative, potentially acting as a donor or acceptor depending on the tautomer/ionization state.","Moderate - Hydrogen bonding is a common interaction that can influence pharmacokinetics or binding affinities significantly, but is not typically high-impact unless it dramatically alters drug binding or distribution."
mitomycin C,vincristine,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors such as -NH or -OH groups and acceptors like carbonyl oxygen (=O) due to the presence of partial positive (δ+) and negative (δ−) charges, respectively.","In SMILES 1, the string includes several carbonyl groups (C=O) and an amide (C(=O)N), which can act as hydrogen bond acceptors. In SMILES 2, there is an -OH group attached to a quaternary carbon adjacent to the -CCC sequence, which can act as a hydrogen bond donor.","Low - While these hydrogen bonds may slightly influence binding interactions or solubility, they are likely to have a minor direct pharmacological impact when considered alone."
Diazepam,Perindopril,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bond Donor-Acceptor,"A carbonyl oxygen in the first molecule can act as a hydrogen bond acceptor, while an amide NH in the second molecule can act as a hydrogen bond donor. This interaction is possible under physiological conditions where hydrogen bonds can stabilize molecular associations.","The carbonyl group in SMILES 1 is represented as C(=O), and the amide NH in SMILES 2 is part of NC(C).",Moderate - Hydrogen bonding can influence drug solubility and receptor binding but may not profoundly affect interactions without specific contexts.
Cetirizine,Pyridostigmine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,Pi-Pi Stacking,Pi-pi stacking interactions can occur between the aromatic rings of two molecules. These interactions are stabilized by the overlap of the pi-orbitals in conjugated systems like benzene rings.,"SMILES 1 contains aromatic phenyl rings at C2=CC=CC=C2 and C3=CC=C(C=C3)Cl. SMILES 2 contains an aromatic pyridinium ring, denoted as C[N+]1=CC=CC(=C1).","Moderate - Pi-pi stacking can influence the binding and stability of drug molecules within biological systems, potentially affecting pharmacokinetics and drug interactions."
Methylphenidate,Ziprasidone,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Potential Hydrogen Bond,The secondary amine group in SMILES 1 (N1 in the piperidine ring) could potentially form a hydrogen bond with the carbonyl oxygen in SMILES 2 (C=O in the cyclic lactam).,"SMILES 1 contains a secondary amine (N1 in C1CCCCN1), which can act as a hydrogen bond donor. SMILES 2 contains a carbonyl group (C(=O)N3), providing a potential hydrogen bond acceptor site.",Low - This interaction might not significantly alter the pharmacological profile but could somewhat influence binding affinity or metabolic stability.
Celecoxib,chlortalidone,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,Hydrogen Bonding,"The sulfonamide group (S(=O)(=O)N) in SMILES 1 can form a hydrogen bond with the hydroxyl group (C2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O) in SMILES 2. The presence of the polarized S=O bond provides potential hydrogen bond acceptors in SMILES 1, which can interact with the hydrogen bond donor in the hydroxyl group of SMILES 2.","SMILES 1 contains the group S(=O)(=O)N, where the oxygens are potential hydrogen bond acceptors. SMILES 2 contains the group C2(...)O, where the hydroxyl group can serve as a hydrogen bond donor.","Moderate - Hydrogen bonding could affect the drugs' solubility, stability, or binding properties in a biological context, potentially impacting pharmacological activity."
Aciclovir,Ganciclovir,C1=NC2=C(N1COCCO)NC(=NC2=O)N,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N,Hydrogen Bonding,"Hydrogen bonding can occur between donor and acceptor groups present in both molecules. There are potential hydrogen bond donors (NH groups) and acceptors (carbonyl oxygen, nitrogen atoms in heterocycles) in both structures.","- Both SMILES have NH groups (imidazole-like nitrogens and exocyclic NH) that can act as hydrogen bond donors. 
- Each molecule also contains carbonyl groups (C=O) that are capable of accepting hydrogen bonds. 
- Additionally, the ether linkages (-O-) can potentially participate in hydrogen bonding with available hydrogen donors.","Moderate - Given the presence of multiple donor and acceptor groups, there is a moderate likelihood that hydrogen bonding can occur, potentially influencing their binding affinities or solubility characteristics in physiological environments."
Ketoprofen,Lamivudine,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen atom attached to an electronegative atom (such as oxygen or nitrogen) and another electronegative atom possessing a lone pair of electrons (typically, oxygen or nitrogen).","- SMILES 1 contains a carboxylic acid group (C(=O)O) that has an oxygen atom with lone pairs, possibly acting as a hydrogen bond acceptor.
- SMILES 2 includes a hydroxyl group (O), which can act as a hydrogen bond donor because it has an OH group.","Low - While hydrogen bonding can affect drug solubility and interaction, it is a relatively weak interaction in a pharmacological context and would likely have a moderate impact if it does influence activity."
Risedronic acid,Zolpidem,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor (usually an –OH or –NH group) and a hydrogen acceptor (commonly N, O, or F atoms) in close proximity.","In SMILES 1, there is a –OH group (indicated by the ""O"" in ""CC(O)(P(=O)(O)O)"") that can act as a hydrogen donor. In SMILES 2, there are nitrogen atoms in the pyridine and pyrimidine rings (indicated by the ""N"" in ""N3C=C(C=CC3=N2)"" and ""C2=C(N3C=..."") which can serve as potential hydrogen bond acceptors.",Moderate – Hydrogen bonds are common in drug interactions and can influence binding affinity and selectivity.
Famotidine,Pirbuterol,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen bond donors and acceptors. In physiological conditions, the amine (-NH2) groups and hydroxyl (-OH) groups are common sites for such interactions.","From SMILES 1, there is a thiol group in 'N=C(S1)'. From SMILES 2, there is a hydroxyl group 'O' from 'C1=NC(=C(C=C1)O)CO'. The hydrogen atoms from the thiol or amine group in SMILES 1 can potentially interact with the oxygen in the hydroxyl group in SMILES 2, forming hydrogen bonds.","Moderate - Based on the structural potential for hydrogen bonding, such interactions could influence pharmacodynamics or pharmacokinetics."
Duloxetine,Acamprosate,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,CC(=O)NCCCS(=O)(=O)O,Hydrogen Bonding,"The SMILES strings indicate the presence of potential hydrogen bond donors and acceptors. Specifically, the sulfonic acid group (SO3H) in SMILES 2 can act as a hydrogen bond donor or acceptor, interacting with the ether oxygen in SMILES 1.","SMILES 1 contains an ether linkage (OC), which includes an oxygen that can serve as a hydrogen bond acceptor. SMILES 2 contains a sulfonic acid group (S(=O)(=O)O), where the hydrogen of the -OH group can serve as a hydrogen bond donor, and the oxygens as acceptors.","Moderate - The interaction could affect the drugs' respective solubility and distribution when co-administered, due to potential aggregation or altered binding affinities in biological systems."
Temazepam,Megestrol,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Steric Clashes,"Steric clashes can occur when bulky groups from different molecules are in close proximity, potentially leading to unfavorable overlap of their electron clouds.","SMILES 1 contains a phenyl group with a chlorine substituent and a bulky benzimidazole structure. SMILES 2 represents a steroid backbone with multiple cyclic structures, including several quaternary carbon centers, which contribute to its bulkiness. The combination of these features can lead to steric interference if both molecules attempt to occupy the same space.","Moderate - The presence of bulky groups can hinder the proper binding or activity of either molecule in a complex, potentially impacting their pharmacological behavior. However, without dynamic or spatial context, the exact extent of interference cannot be precisely determined."
Candesartan,Duloxetine,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,π-π Stacking Interaction,"Aromatic rings can engage in π-π stacking interactions, where the electron clouds of the aromatic systems overlap favorably, providing stabilization. This usually happens in a hydrophobic environment where there is accessibility for the rings to approach each other closely.","In SMILES 1, there is a biphenyl moiety, represented by ""C4=CC=CC=C4C5=NNN=N5"", and in SMILES 2, there is a biphenyl group formed by ""OC2=CC=CC3=CC=CC=C32"". These phenyl rings from both molecules can potentially engage in stacking interactions.","Moderate - π-π stacking can influence the binding affinity and selectivity of small molecules towards biological targets, potentially affecting their pharmacological activity."
Sildenafil,Zaleplon,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,Hydrogen Bonding,"Hydrogen bonding may occur between a hydrogen bond donor group, such as a secondary amine or hydroxyl group, and a hydrogen bond acceptor group such as carbonyl oxygen or cyano nitrogen.","In SMILES 1, there is a sulfonamide oxygen (S(=O)(=O)) which can act as a hydrogen bond acceptor. In SMILES 2, there is a secondary amine group (CCN) which can potentially serve as a hydrogen bond donor.","Moderate - Hydrogen bonding can influence drug solubility and receptor binding, impacting the pharmacological activity and metabolism."
Risedronic acid,Imatinib,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor (such as an -OH or -NH group) and an acceptor (such as a carbonyl oxygen or a nitrogen atom in an aromatic ring). Here, one molecule contains multiple -OH groups on phosphate groups, and the other contains carbonyl groups and aromatic nitrogen atoms.","- From SMILES 1: The molecule possesses phosphoryl groups (P(=O)(O)O) with hydroxyl groups (-OH), which can act as hydrogen bond donors.
- From SMILES 2: The presence of carbonyl oxygen atoms (C=O) and aromatic nitrogen atoms (such as in NC=O and in pyridine rings) can act as hydrogen bond acceptors.","Moderate - This interaction might influence the positioning or orientation of the molecules relative to each other, which could impact drug efficacy or bioavailability."
Furosemide,Telithromycin,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Hydrogen Bonding,"This interaction is likely because drug structures exhibit both hydrogen bond donors (e.g., hydroxyl groups) and acceptors (e.g., carbonyl groups, sulfonamide groups) that can form hydrogen bonds under physiological conditions.","In SMILES 1, the carboxylic acid group (COOH, represented by ""C(=O)O"") and the sulfonamide group (S(=O)(=O)N) are present, which can act as hydrogen bond acceptors. SMILES 2 contains several hydroxyl groups (e.g., ""O3"") that can act as hydrogen bond donors.",Moderate - The indicated groups are common in drug molecules and might contribute to binding specificity in physiological settings but typically result in moderate pharmacological interactions in terms of efficacy or side effects unless specifically designed for such interactions.
Citalopram,nevirapine,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Aromatic π-π stacking,"This type of non-covalent interaction can occur between aromatic rings, where the π-orbitals overlap allow the aromatic systems to transiently interact.",SMILES 1 contains a substituted phenyl ring (C3=CC=C(C=C3)F) and SMILES 2 contains a pyridine ring (C3=C(C=CC=N3)). The presence of these aromatic rings in a relatively similar context (planar structure with potential face-to-face or edge-to-face alignment under suitable conditions) can facilitate π-π interactions.,Moderate - Aromatic π-π stacking may stabilize transient complex formations but generally does not lead to strong or irreversible interactions under typical pharmacological conditions.
Bumetanide,Fenofibrate,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Pi-Pi stacking interaction,"Pi-Pi stacking interactions occur between aromatic rings when the electron clouds of these rings overlap, stabilizing the interaction. This often happens in chemical structures with planar, aromatic rings in proximity.","In SMILES 1, there is an aromatic benzene ring [represented by C1=CC=CC=C1 as part of the methoxybenzene (OC2=CC=CC=C2) structure]. In SMILES 2, there are also phenyl rings (C1=CC=C(C=C1) and C2=CC=C(C=C2)Cl), allowing for the possibility of pi-pi interactions between these two extended aromatic systems.","Moderate - While pi-pi stacking can stabilize drug interactions, the pharmacological impact can vary based on the context, such as concentration and the presence of other interacting molecules or structures, but it is generally not as strong as ionic or covalent interactions."
folinic acid,Thalidomide,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor (e.g., -NH group) and a hydrogen acceptor (e.g., C=O group) present within the structures.","In SMILES 1, there are multiple C=O groups and NH groups within the cyclic and acyclic amide functionalities that could serve as acceptors and donors, respectively. Similarly, SMILES 2 contains C=O groups in the imide and amide functionalities and an NH group in the cyclic structure as hydrogen bond acceptors and donors, respectively.","Moderate - The presence of multiple potential hydrogen bond donors and acceptors in vicinity increases the potential for interaction, which could influence their pharmacological dynamics."
Diazepam,Ibuprofen,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,π-π Stacking,"The benzene rings in both molecules can align parallel to each other, allowing for π-π interactions through stacking. These interactions occur because the delocalized π electrons in the aromatic rings can stabilize each other when the rings are positioned face-to-face.","SMILES 1 contains a benzene ring in the ""C3=CC=CC=C3"" portion, while SMILES 2 contains a benzene ring in the ""C1=CC=C(C=C1)"" portion. These structural features suggest the potential for π-π stacking between the two aromatic rings.","Moderate - Depending on the orientation and proximity, this interaction could modestly affect pharmacological outcomes, especially if aromatic interactions are crucial in binding or transport mechanisms."
Naproxen,Palonosetron,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,Pi-Pi Stacking,"Pi-pi stacking occurs between the aromatic rings of the two different molecules. Both SMILES contain aromatic systems that could align parallel to each other, allowing their electron clouds to interact, which is a stabilizing non-covalent interaction.","The first SMILES has a naphthalene moiety (two fused benzene rings). The second SMILES contains a bicyclic structure with an aromatic ring (isoquinoline), which can participate in pi-pi stacking with the naphthalene rings in the first SMILES structure.","Moderate - Pi-pi interactions can significantly influence the drug’s pharmacodynamics and pharmacokinetics, altering binding to targets or other biomolecules."
Alprazolam,Formoterol,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Hydrogen Bonding,"A hydrogen bond could form between a hydrogen donor in one molecule and an acceptor in the other. The hydroxyl (-OH) group, which is a hydrogen bonding donor, in SMILES 2 can interact with nitrogen atoms, which are potential hydrogen bond acceptors, in the triazole ring of SMILES 1.","In SMILES 1, the nitrogen atoms (N) in the triazole ring (NN=C) can act as hydrogen bond acceptors. In SMILES 2, the hydroxyl group (-OH) at the end of the main carbon chain can donate a hydrogen in hydrogen bonding.","Moderate - Hydrogen bonds can impact binding affinity and pharmacokinetics, possibly altering efficacy or solubility."
Fentanyl,Trimethoprim,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Hydrogen bonding,Hydrogen bonding can occur between a hydrogen atom attached to a nitrogen or oxygen in SMILES 2 (which contains multiple nitrogen atoms within the pyrazine ring) and a carbonyl oxygen atom from the amide group in SMILES 1.,"In SMILES 1, the carbonyl oxygen in the acetamide group (C=O) can serve as a hydrogen bond acceptor. In SMILES 2, the amino group (N) in the pyrazine ring can potentially act as a hydrogen bond donor.",Moderate - This interaction may affect the binding affinity or solubility profiles under physiological conditions.
Citalopram,Midodrine,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,Hydrogen Bonding,"A hydrogen bond could form between a hydrogen bond donor in SMILES 2 and a hydrogen bond acceptor in SMILES 1. Specifically, the hydroxyl group (O-H) in SMILES 2 can donate a hydrogen bond to the nitrogen atom in the cyano group (C#N) from SMILES 1, which acts as a hydrogen bond acceptor.","In SMILES 2, the group ""C(CNC(=O)CN)O"" contains a hydroxyl (-OH) where oxygen can serve as a hydrogen bond donor. In SMILES 1, ""C#N"" specifies the presence of a nitrogen which can act as a hydrogen bond acceptor.",Moderate - This interaction can influence solubility and binding but its overall impact depends on the drug's context and target.
Duloxetine,solifenacin,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,Pi-Pi Stacking,"Pi-Pi stacking is a non-covalent interaction between aromatic rings, where the electron clouds of the rings interact with each other. This can stabilize the interaction between molecules.","SMILES 1 contains two aromatic rings (thiophene S1 and a benzene), and SMILES 2 contains multiple benzene rings. Specifically, SMILES 1 includes `C1=CC=CS1` and `C2=CC=CC3=CC=CC=C32`, and SMILES 2 includes `C4=CC=CC=C4` and `C5=CC=CC=C5`. These aromatic components can engage in pi-pi stacking interactions.","Moderate - Pi-pi stacking can affect binding affinity and specificity, but impact depends on the overall molecular environment."
Rofecoxib,Imatinib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,π-π Stacking,"π-π stacking occurs when aromatic rings interact with each other through their π-electron clouds, aligning in a parallel orientation due to quadrupole interactions.","Both SMILES strings contain aromatic structures. In SMILES 1, there are benzene rings (C1=CC=C(C=C1) and C3=CC=CC=C3). In SMILES 2, multiple aromatic rings are present, specifically those within the phenyl groups (C1=C(C=C(C=C1)) and C2=CC=C(C=C2)) along with additional heteroaromatic structures. These aromatic rings are conducive to forming π-π interactions.","Moderate - π-π stacking can stabilize the interaction between drug molecules and may affect binding or solubility, though it may not be the most dominant interaction."
Diazepam,Ketoprofen,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Hydrogen Bonding,"This interaction can occur due to the presence of a hydrogen bond donor and acceptor in each molecule. In SMILES 1, there is a carbonyl group (C=O), which can act as a hydrogen bond acceptor, and in SMILES 2, there is a carboxylic acid group (C(=O)O), where the hydroxyl (OH) group can serve as a hydrogen bond donor.","In SMILES 1, the C(=O) group positioned on the lactam ring nitrogen can accept hydrogen bonds. In SMILES 2, the C(=O)O group provides a hydroxyl group (O-H) capable of forming hydrogen bonds with the acceptor of SMILES 1.","Moderate - While hydrogen bonding can influence drug interaction, the strength of this interaction will depend on the three-dimensional conformation of the drugs in solution, the specific physiological environment, and other competing interactions or bonds."
Diazepam,Temozolomide,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,Hydrogen Bonding,The presence of a carbonyl oxygen in SMILES 1 can potentially form a hydrogen bond with hydrogen donors in SMILES 2 under physiological conditions.,"In SMILES 1, the carbonyl group within the urea-based moiety (C=O) can act as a hydrogen bond acceptor. In SMILES 2, the NH group (within the C(=O)N) can act as a hydrogen bond donor.",Moderate - This interaction might influence how the molecules align with biological targets or with each other but needs to be confirmed by further structural context from actual binding studies.
Naproxen,Pyridostigmine,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,Ionic Interaction,"Ionic interactions can occur between oppositely charged groups. In this case, there is an ammonium ion (a positively charged nitrogen center) in SMILES 2 that could potentially interact with the carboxylate group (a negatively charged oxygen center) in SMILES 1.","SMILES 1 contains a carboxylate group ""C(=O)O,"" which is likely to deprotonate under physiological conditions, forming a negative charge. SMILES 2 contains a quaternary ammonium indicated by ""C[N+],"" which has a permanent positive charge.","Moderate - This type of interaction can significantly affect the pharmacokinetic properties or binding affinity in a biological context, depending on the concentration and localization of these drugs."
Temozolomide,Trimethoprim,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Hydrogen Bonding,The hydrogen bonding interaction can occur when a hydrogen atom attached to an electronegative atom such as nitrogen (N-H) is in proximity to a lone pair on another electronegative atom (such as oxygen or nitrogen) from a different molecule.,"- In SMILES 1, the presence of an amide group with a nitrogen atom that can donate a hydrogen for hydrogen bonding. Notably, `C(=O)N` indicates a carbonyl group adjacent to a nitrogen.
- In SMILES 2, there is a 2-amino purine moiety `N=C(N)N` which could potentially serve as an acceptor for the hydrogen bond due to the presence of lone pair electrons on nitrogen atoms.","Moderate - Hydrogen bonding is a common, but significant type of interaction in drug binding and can influence drug solubility and target affinity."
Oxaprozin,Sildenafil,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,π-π Stacking,"The interaction arises from the overlapping of aromatic rings, allowing for favorable electronic interactions between them.","SMILES 1 contains two separate phenyl rings (`C1=CC=CC=C1` and `C3=CC=CC=C3`), and SMILES 2 contains a phenyl ring as part of the quinazoline structure (`C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC`). The presence of these aromatic systems suggests the potential for π-π stacking.","Moderate - π-π stacking can affect the binding and conformational stability of molecular complexes in physiological environments, potentially impacting drug activity."
Citalopram,Darunavir,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Hydrogen Bond Donor-Acceptor Interaction,"A hydrogen bond can form between a hydrogen bond donor and an acceptor where lone pair electrons participate in bonding. The second SMILES contains a secondary amine, which could act as a hydrogen donor, and the first SMILES contains a nitrile group which can act as an acceptor.","The group ""C#N"" in the first SMILES (nitrile group) can act as a hydrogen bond acceptor, and the group ""NC(=O)"" in the second SMILES includes a nitrogen that can act as a hydrogen bond donor when protonated at physiological pH.","Low - While this interaction can occur, its pharmacological impact is likely minimal due to the general stability and relatively high energy required for significant hydrogen bonding between these groups under physiological conditions."
Famotidine,melphalan,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,Hydrogen Bonding,Hydrogen bonds may form between the hydrogen donor groups and the hydrogen acceptor sites present on the two molecules.,"In SMILES 1, there are amino groups (`-NH2` or `-NH-`) which can serve as hydrogen bond donors. SMILES 2 contains carboxyl group (=O) that can act as a hydrogen bond acceptor.",Moderate - Hydrogen bonding interactions can influence the pharmacokinetics or binding affinities in drug interactions.
Rofecoxib,Balsalazide,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O,π-π Stacking,"π-π stacking interactions occur between aromatic rings in the structures, which can align and attract each other due to overlapping electron clouds.","Both SMILES strings contain aromatic rings. SMILES 1 has two phenyl rings (C1 and C3), while SMILES 2 contains multiple aromatic systems, including a phenyl ring (C1) and a heteroaromatic ring (containing nitrogen) (NN=C2).",Moderate - π-π stacking can influence drug-receptor interactions or alter pharmacokinetics but typically does not result in severe pharmacological consequences on its own.
Tramadol,Almotriptan,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,Hydrogen Bonding,"A hydrogen bond can occur between a hydrogen donor and an acceptor. In SMILES 1, the phenol group (-O) can act as a hydrogen bond donor. In SMILES 2, the sulfonamide oxygen atoms (S(=O)(=O)) can act as hydrogen bond acceptors.","SMILES 1 contains the group (C2=CC(=CC=C2)OC)O, where the -O at the end is a potential hydrogen donor. SMILES 2 contains CS(=O)(=O)N, where the =O are potential hydrogen acceptors.",Moderate - Hydrogen bonds can significantly influence drug binding affinity and specificity.
Rofecoxib,Telmisartan,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Hydrogen Bond Donor-Acceptor Interaction,Hydrogen bonds occur when there is a partial positive charge on a hydrogen atom bonded to an electronegative atom (such as nitrogen or oxygen) that can interact with a lone pair of electrons on another electronegative atom.,"In SMILES 1, the sulfone group (S(=O)(=O)) contains oxygen atoms that can act as hydrogen bond acceptors. In SMILES 2, the carboxyl group (C(=O)O) contains an oxygen that can potentially be a hydrogen bond donor under physiological conditions.","Moderate - This interaction could influence drug binding or conformation, possibly affecting pharmacokinetics or pharmacodynamics."
Triazolam,Rosiglitazone,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,π-π Stacking,"π-π stacking occurs when aromatic rings from the two molecules align in such a way that their π-electron clouds overlap, creating a stabilizing interaction.","Both molecules have aromatic rings. SMILES 1 contains two chlorophenyl groups and a triazole ring, while SMILES 2 has a pyridine ring and a phenyl group. The presence of multiple aromatic rings in close proximity can facilitate π-π stacking interactions when aligned appropriately under physiological conditions.","Moderate - π-π stacking can influence binding affinity and specificity between molecules, potentially affecting pharmacological activity."
Naproxen,Dapsone,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Hydrogen bonding,"The hydrogen bond can occur between the hydroxyl group in the carboxylic acid of SMILES 1 and the amine group in SMILES 2. In physiological conditions, these groups can donate and accept hydrogen bonds due to their polar nature.","- SMILES 1 contains a carboxylic acid group (-C(=O)O).
- SMILES 2 has an amine group (-C1=CC(=CC=C1N)).",Moderate - Hydrogen bonding can significantly impact pharmacodynamics and pharmacokinetics but tends to be less impactful than covalent interactions.
Metronidazole,Terazosin,CC1=NC=C(N1CCO)[N+](=O)[O-],COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen bonding,"The presence of a nitro group in the first compound (SMILES 1) can act as a hydrogen bond acceptor. The second compound (SMILES 2) contains several hydrogen bond donors, such as the NH groups in the triazole ring. This structural combination could facilitate hydrogen bonding.","- SMILES 1: The [N+](=O)[O-] group indicates a nitro group that can participate as a hydrogen bond acceptor due to the electron-withdrawing nature of the nitro group contributing to partial charges.
- SMILES 2: The triazole ring contains NH groups that could act as hydrogen bond donors.","Moderate - Hydrogen bonds can significantly influence drug-receptor interactions and therefore have a potential, though moderate, impact in pharmacological contexts."
Diazepam,Moexipril,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,Hydrogen Bonding,"The second SMILES string contains a carboxylic acid group (C(=O)O), which can act as a hydrogen bond donor or acceptor. The first SMILES string has an amide group (C=O) in the lactam ring that can potentially act as a hydrogen bond acceptor.","In SMILES 1, the C(=O) within the lactam ring can act as a hydrogen bond acceptor, while in SMILES 2, the carboxylic acid's -OH group is a hydrogen bond donor.",Moderate - Hydrogen bonds can significantly impact solubility and binding interactions but alone may not cause major pharmacological changes without additional supportive interactions.
Methylphenidate,Megestrol,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,Steric Clash,"The two SMILES represent relatively bulky organic molecules with cyclic structures. When present in the same binding pocket or region, they could experience steric clashes due to their substantial and complex carbon frameworks.","SMILES 1 contains a piperidine ring (C1CCCCN1) adjacent to an aromatic ring (C2=CC=CC=C2), whereas SMILES 2 has fused polycyclic structures with multiple substituents (e.g., C1=CC2C(CCC3...)). Their large, rigid frameworks occupy significant spatial volume, potentially leading to steric conflict when near each other.",Moderate - This interaction can alter pharmacokinetics by impacting the binding or docking of these molecules in active sites within biomolecular environments.
Citalopram,Gemfibrozil,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors (e.g., O-H groups) and acceptors (e.g., nitrogen or oxygen atoms with lone pairs) present in the structures.","SMILES 1 contains a nitrile group (C#N), where the nitrogen can act as a hydrogen bond acceptor. SMILES 2 contains a hydroxyl group (O-H) capable of acting as a hydrogen bond donor.",Moderate - This interaction could influence the solubility or binding dynamics of the drugs depending on the context within a biological environment.
Lamotrigine,Oxaprozin,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,Hydrogen Bond,"A hydrogen bond may form between the NH group in the triazole ring (in SMILES 1) and the carbonyl oxygen in the carboxylic acid group (in SMILES 2). The NH group can act as a hydrogen bond donor, while the carbonyl oxygen can act as a hydrogen bond acceptor.","In SMILES 1, the ""N=N2)N"" part indicates the presence of an NH group on the triazole, and in SMILES 2, the ""CCC(=O)O"" part indicates a carbonyl oxygen in a carboxylic acid group.","Moderate - Hydrogen bonds can contribute to potential interactions between drugs, affecting solubility or receptor binding under physiological conditions."
Citalopram,Palonosetron,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,Pi-Pi Stacking,"Pi-pi stacking occurs due to the interaction between aromatic ring systems present in both molecules. This type of interaction is facilitated by the overlap of the electron clouds (pi orbitals) of the aromatic rings, stabilizing the interaction.","SMILES 1 contains an aromatic benzene ring, as observed from ""C3=CC=C(C=C3)F"", and SMILES 2 contains an aromatic isoquinoline ring, noted from ""C3=CC=CC(=C23)C1"". These features suggest potential pi-pi stacking between these aromatic systems.","Moderate - Pi-pi interactions are a common type of non-covalent interaction that can influence molecular recognition and binding in pharmacology, potentially affecting the drug's binding affinity and efficacy."
Metronidazole,Zolpidem,CC1=NC=C(N1CCO)[N+](=O)[O-],CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,π-π Stacking,"π-π stacking occurs between aromatic rings when they align parallel to each other, allowing for overlapping electron clouds and stabilization through van der Waals forces.","SMILES 1 contains an aromatic pyridine ring (C1=NC=C(N1CCO)), and SMILES 2 contains two connected aromatic rings in the quinoline structure (C1=CC=CC=C1C2=C3C=CC=CC3=NC2).",Moderate - This interaction can potentially impact the binding of these molecules to aromatic-rich active sites or pockets in a biological context.
Tramadol,Telmisartan,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,π-π Stacking Interaction,"The presence of multiple aromatic rings in both molecular structures can allow for π-π stacking interactions, which occur when π systems (aromatic rings) align parallel to each other and stabilize the interaction via overlap of their π orbitals.","The SMILES for both molecules contain aromatic rings: SMILES 1 has a phenyl group (C2=CC(=CC=C2)), and SMILES 2 has multiple aromatic systems, including a naphthalene-type structure (C3=CC=C(C=C3)C4=CC=CC=C4C(=O)O).","Moderate - π-π interactions are common stabilizing interactions, but their pharmacological impact depends on the spatial orientation and environment within a biological system."
Cetirizine,Dipyridamole,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,Electrostatic Interaction (Potential π-cation interaction),"The aromatic rings in SMILES 1 can participate in π-cation interactions due to delocalized π-electrons, and SMILES 2 has tertiary amines that can be protonated under physiological conditions, providing positive charge.","SMILES 1 contains aromatic phenyl rings ""C2=CC=CC=C2"" and ""C3=CC=C(C=C3)Cl"". SMILES 2 contains tertiary amine centers within the piperazine and alkyl chain sections ""N(CCO)CCO"", which can be protonated in a physiological environment, interacting with the π-electrons of the aromatic rings.","Moderate - Such an interaction could influence binding affinity and bioavailability, with a potential to affect pharmacodynamics and/or pharmacokinetics under specific conditions."
Methylphenidate,Trazodone,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Hydrogen Bonding,"The carbonyl oxygen in SMILES 1 could act as a hydrogen bond acceptor interacting with a hydrogen bond donor, such as a protonated amine group present within physiological conditions.","SMILES 1 contains an ester group 'COC(=O)' with a carbonyl oxygen that could serve as an acceptor. In SMILES 2, there is a secondary amine within the piperazine ring (C1CN(CCN1)), which under physiological pH, could be protonated and act as a hydrogen bond donor.",Moderate - This interaction could influence the pharmacokinetics or binding properties if both drugs are administered together.
Duloxetine,Darunavir,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Hydrogen Bonding,"Hydrogen bonding can occur between potential hydrogen bond donors and acceptors, such as oxygen or nitrogen atoms in close proximity.","- SMILES 1 contains an ether oxygen in the ""OC2=CC=CC3=CC=CC=C32"" moiety.
- SMILES 2 has a hydroxyl group, ""O"" next to the secondary amine, that can act as a hydrogen bond donor.",Moderate - This interaction might influence molecular binding or solubility profiles when both compounds are present.
Aciclovir,Trimethoprim,C1=NC2=C(N1COCCO)NC(=NC2=O)N,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Hydrogen Bonding,"Hydrogen bonding can occur between donor and acceptor groups present in close proximity when drugs interact in a physiological environment. In these SMILES, both drugs have hydrogen bond donors (amines) and acceptors (carbonyl and nitrogen groups) that can potentially interact.","- SMILES 1 has a primary amine group (-NH2) and a carbonyl group (=O) which can act as a hydrogen bond donor and acceptor, respectively.
- SMILES 2 contains a similar primary amine group (-NH2) on the imidazole ring, which can form hydrogen bonds with the acceptor groups in SMILES 1.","Moderate - Hydrogen bonding can affect drug solubility, bioavailability, and binding affinity, potentially altering efficacy or toxicity."
Ondansetron,Salmeterol,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor and an acceptor. In SMILES 2, the hydroxyl groups (-OH) on the phenol and alcohol moieties can act as hydrogen bond donors, and the nitrogen in the pyrimidine ring in SMILES 1 can act as a hydrogen bond acceptor.","In SMILES 1, the nitrogen atom in the pyrimidine ring (N1) can accept hydrogen bonds. In SMILES 2, the hydroxyl groups (-OH) (alcohol on the aliphatic chain and phenol group) can donate hydrogen bonds.","Moderate - While hydrogen bonding is a common interaction with moderate strength, it could potentially influence binding affinity if these molecules were to interact in a biological system."
Fentanyl,Trazodone,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Hydrogen Bonding,Both SMILES feature carbonyl groups (C=O) which can serve as hydrogen bond acceptors. The secondary amines in each molecule may act as hydrogen bond donors.,"- SMILES 1 contains a carbonyl group at 'CCC(=O)N' and secondary amine in the morpholine-like structure 'N(C1CCN(CC1)'.
- SMILES 2 contains a carbonyl group in the portion 'C(=O)N' and secondary amines in the piperazine-like structure 'C1CN(CCN1'.","Moderate - Hydrogen bonds, while individually weak, can significantly influence molecular interaction and drug binding."
Metolazone,Pamidronic acid,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,"The sulfonamide group (-S(=O)(=O)N-) in SMILES 1 can act as a hydrogen bond acceptor due to its oxygen atoms, which can interact with the hydroxyl group in SMILES 2 that has a hydrogen to donate.","In SMILES 1, the sulfonamide group (S(=O)(=O)N) contains oxygens capable of accepting hydrogen bonds. In SMILES 2, the hydroxyl group (-C(O)P(=O)(O)P(=O)(O)O) has hydrogen in the hydroxyl (-OH) that can donate to these oxygens.","Moderate - While hydrogen bonds can affect molecular interactions and drug binding, the overall impact depends on additional context not provided."
Cetirizine,Salmeterol,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Hydrogen bonding,"Hydrogen bonds can occur between hydrogen donors and acceptors. The first molecule has ester groups (O=C-O) that could act as hydrogen bond acceptors, while the second molecule includes phenol (hydroxyl group, -OH) which is a potential hydrogen bond donor.","In SMILES 1, the ester group is represented as ""C(=O)O"". In SMILES 2, the phenol is represented as ""O"" (linked to a benzene ring). Together, these functional groups suggest the potential for hydrogen bonding.","Moderate - This interaction could influence pharmacokinetic properties or receptor binding, though it may not directly cause significant pharmacological effect unless the contexts of these bonds facilitate changes in drug conformation or solubility that influence absorption or site-specific delivery."
Ticlopidine,Tirofiban,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,Hydrogen bonding,Hydrogen bonds can form between hydrogen donors (such as -OH or -NH groups) and hydrogen acceptors (such as carbonyl -C=O or -NH groups).,"- SMILES 1 contains an amine group (C1CN) that can act as a hydrogen donor.
- SMILES 2 contains a sulfonamide group (S(=O)(=O)N) and a carboxyl group (C(=O)O) that can act as hydrogen acceptors.","Moderate - Hydrogen bonding could potentially influence the binding affinity of these molecules to proteins or enzymes, thereby affecting their pharmacological activity."
Gabapentin,Telithromycin,C1CCC(CC1)(CC(=O)O)CN,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Hydrogen Bonding,A hydrogen bonding interaction can occur between the carboxylic acid group present in SMILES 1 and the tertiary amine nitrogen in SMILES 2. Hydrogen bonds are formed when a hydrogen atom covalently bonded to an electronegative atom (such as oxygen or nitrogen in a carboxylic acid) interacts with a lone pair on another electronegative atom (such as a nitrogen in an amine).,"- In SMILES 1, the carboxylic acid group: CC(=O)O provides both a hydrogen donor (OH) and a hydrogen acceptor (O=C).
- In SMILES 2, there are tertiary amine groups which can provide lone pair electrons for hydrogen bonding, particularly the nitrogen atom in the secondary amine `CCCCN` segment.","Moderate - This hydrogen bonding can influence drug binding or disposition, which can affect the pharmacological profile under certain conditions."
Alprazolam,Fluorouracil,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,C1=C(C(=O)NC(=O)N1)F,Hydrogen Bonding,The interaction is possible between a hydrogen bond donor from the second molecule and a hydrogen bond acceptor from the first molecule.,"The second SMILES contains an amide group (NC(=O)N) which can act as both a hydrogen bond donor (NH) and a hydrogen bond acceptor (C=O). In the first SMILES, the nitrogen atoms in the pyrazole ring (CC1=NN=C2N1C) could serve as hydrogen bond acceptors.",Moderate - The presence of possible hydrogen bond interactions can impact binding affinity and solubility but may not drastically alter pharmacological activity without other present interactions.
folinic acid,Pamidronic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors present in the molecular structures. The second SMILES has multiple phosphate groups, which contain oxygen atoms capable of acting as hydrogen bond acceptors. The first SMILES string contains several amide -NH groups and a carboxylic acid -OH that can act as hydrogen bond donors.","- From SMILES 1: Amide NH groups (e.g., NC(=O) and NC)
- From SMILES 2: Phosphate oxygens (P(=O)(O)O)","Moderate - Depending on the spatial configuration, these interactions can significantly affect molecular recognition and binding within biological systems."
Fentanyl,Ketamine,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,pi-pi stacking,Pi-pi stacking occurs when aromatic rings interact with each other through delocalized pi-electron systems. This type of interaction is common between aromatic rings and can influence the binding affinity and orientation of molecules.,"SMILES 1 contains the aromatic ring C3=CC=CC=C3. Similarly, SMILES 2 contains an aromatic ring C2=CC=CC=C2. The presence of these aromatic rings in both molecules suggests the potential for pi-pi stacking interactions between them.","Moderate - Such interactions can affect the physical properties and orientation of drugs within biological environments, potentially influencing their pharmacodynamics and pharmacokinetics."
Risedronic acid,Telmisartan,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Hydrogen Bonding,Hydrogen bonding can occur between the hydroxyl group (OH) in the first molecule and the carbonyl oxygen (C=O) in the second molecule.,"The first SMILES string contains an '-OH' group (alcohol) indicative of hydrogen bond donors, while the second SMILES contains a 'C=O' group (carbonyl) known to be a hydrogen bond acceptor.","Moderate - This hydrogen bonding interaction can influence the binding affinity and solubility under physiological conditions, potentially affecting the activity or availability of the compounds in a biological system."
Amlodipine,Dapsone,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Hydrogen bonding,"The hydrogen bonding interaction occurs when there is an acceptor-donor pair, which can arise between a hydrogen donor group like NH or OH and an acceptor such as a carbonyl oxygen (C=O) or sulfonamide oxygen (SO2).","- SMILES 1 has the carbonyl group C(=O)OC, which can act as a hydrogen bond acceptor.
- SMILES 2 contains an amine group N, which can donate a hydrogen for bonding.",Moderate - This type of interaction can influence binding affinity and solubility under physiological conditions.
Famotidine,Propofol,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CC(C)C1=C(C(=CC=C1)C(C)C)O,Hydrogen Bonding,"The presence of hydrogen bond donors and acceptors in the two molecules may facilitate hydrogen bonding. Specifically, the first SMILES contains several nitrogen atoms in amine groups that can act as hydrogen bond donors or acceptors, and the hydroxyl group in the second SMILES can act as a hydrogen bond donor.","In SMILES 1, the NH groups in the thiosemicarbazone moiety (N=C(N)N) and the sulfonamide group (NS(=O)(=O)N) are potential hydrogen bond donors/acceptors. In SMILES 2, the C1=C(C(=CC=C1)C(C)C)O structure indicates a hydroxyl group (-OH) that readily participates in hydrogen bonding.","Moderate - Such interactions could potentially alter the solubility or binding characteristics of the drug molecules, depending on the context of their formulation or administration."
alendronic acid,Imatinib,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,"The first SMILES string contains a primary amine group (CN), which can act as a hydrogen bond donor, while the second SMILES string includes several nitrogen-containing groups (e.g., pyridine rings, amide) that can act as hydrogen bond acceptors.","- SMILES 1: The 'CN' group in the structure represents an amine, which is NH2 after hydrogen saturation, providing N-H for potential hydrogen bonding.
- SMILES 2: Multiple nitrogen atoms, such as those in 'NC(=O)' and the pyridine rings 'NC4=NC=CC(=N4)', can accept hydrogen bonds due to their lone pairs.",Moderate - Such interactions are common under physiological conditions and can influence the binding affinity or solubility of the molecules when they interact.
Citalopram,hydralazine,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,C1=CC=C2C(=C1)C=NN=C2NN,π-π Stacking,"Aromatic rings from both molecules may align parallel to one another, allowing π electron clouds to interact. This can stabilize close association between the two structures.","SMILES 1 contains an aromatic phenyl ring (CC3=CC=C(C=C3)F), and SMILES 2 contains an aromatic phenyl ring as part of a 5-membered heteroaromatic system (C1=CC=C2C(=C1)C=NN=C2).","Moderate - While π-π stacking can significantly influence the positioning and stabilization of drugs if they bind to the same biomolecule or chemical environment, its pharmacological impact largely depends on the context of their administration and target sites."
Aciclovir,Dipyridamole,C1=NC2=C(N1COCCO)NC(=NC2=O)N,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,Hydrogen Bonding,Hydrogen bonds could potentially form between the nitrogen and oxygen atoms with available lone pairs or hydrogens capable of participating in hydrogen bonds.,"- SMILES 1 contains a primary amide group (C=O) that can act as a hydrogen bond acceptor and two NH groups that can act as hydrogen bond donors.
- SMILES 2 includes multiple nitrogen atoms in the aromatic ring structures and tertiary amines with potential lone pair acceptor capabilities.","Moderate - Given the presence of these functional groups in multiple locations on the molecules, it is likely these could form hydrogen bonds under appropriate conditions, potentially affecting binding affinity or change in conformation when these molecules coexist."
Rosiglitazone,Bimatoprost,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors. In SMILES 1, the sulfonamide group (S=O) contains oxygen atoms that can act as hydrogen bond acceptors. In SMILES 2, there are hydroxyl groups (O-H) that can donate hydrogen for bonding.","- SMILES 1 contains the O=S double-bond structure, where oxygen can act as a hydrogen bond acceptor.
- SMILES 2 contains multiple hydroxyl groups (e.g., -CC(C1C=CC(CCC2=CC=CC=C2)O)O) that can serve as hydrogen donors.","Moderate - Hydrogen bonds are common and can be significant in drug interactions or protein binding, but alone, they are not usually highly disruptive."
Metronidazole,Thalidomide,CC1=NC=C(N1CCO)[N+](=O)[O-],C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Hydrogen bonding,"The presence of an amine group in SMILES 1 has the potential to act as a hydrogen bond donor, while the carbonyl groups in SMILES 2 can act as hydrogen bond acceptors.","SMILES 1 contains an amine functional group within the structure ""N1CCO"", which can donate a hydrogen for bonding. SMILES 2 contains multiple carbonyl groups ""C(=O)"", which are known hydrogen bond acceptors.",Moderate - Such interactions could influence molecular binding affinity and pharmacodynamics but would not necessarily imply a large-scale pharmacological change without more context.
acetazolamide,Propofol,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,CC(C)C1=C(C(=CC=C1)C(C)C)O,Hydrogen bonding,"Hydrogen bonding can occur between a hydrogen donor and a hydrogen acceptor group. In SMILES 1, the sulfonamide group (S(=O)(=O)N) contains sulfone oxygens which can act as hydrogen bond acceptors. In SMILES 2, the hydroxyl group (O) linked to the benzene ring acts as a potential hydrogen bond donor.","In SMILES 1, the sulfonamide moiety includes O atoms capable of accepting hydrogen bonds. In SMILES 2, the hydroxyl (-OH) group can donate a hydrogen bond.",Moderate - This interaction can potentially affect solubility or binding in a physiological environment.
Metoprolol,Fulvestrant,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,Hydrogen Bonding,"This interaction can occur when a hydrogen atom covalently bonded to an electronegative atom (such as O, N, or F) interacts with another electronegative atom possessing lone pairs of electrons.","- From SMILES 1: The presence of the hydroxyl group (-O) on the aliphatic chain (CC(C)NCC(COC1=CC=C(C=C1)CCOC)O) suggests potential hydrogen bond donating capability.
- From SMILES 2: The presence of multiple hydroxyl groups and a sulfoxide group (S(=O)) in CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F provides potential hydrogen bond accepting sites.","Moderate - Hydrogen bonds can significantly affect solubility and binding properties, impacting pharmacokinetics and pharmacodynamics, but the strength of individual hydrogen bonds can be limited."
Celecoxib,Fulvestrant,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,Hydrogen Bonding,"A potential hydrogen bond could form between the hydrogen donor hydroxyl group (-OH) of SMILES 2 and a potential acceptor, the sulfonamide group (S(=O)(=O)N) of SMILES 1.",The hydroxyl group (-OH) in SMILES 2 provides a hydrogen donor. The sulfonamide group (S(=O)(=O)N) in SMILES 1 includes oxygen atoms which can act as hydrogen bond acceptors.,Moderate - Hydrogen bonding could alter binding dynamics and pharmacokinetics under physiological conditions.
Aciclovir,Ibuprofen,C1=NC2=C(N1COCCO)NC(=NC2=O)N,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor and an acceptor due to their complementary polar characteristics. In the provided SMILES strings, such an interaction is feasible between the hydrogen bond donor group (an amine or hydroxyl) and an acceptor group (a carbonyl oxygen or aromatic nitrogen).","- SMILES 1 contains an amine group, represented by ""N"", which can act as a hydrogen bond donor. 
- SMILES 2 contains a carboxylic acid group, represented by ""C(=O)O"", where the carbonyl oxygen can serve as a hydrogen bond acceptor.","Moderate - While hydrogen bonds are relatively weak on their own, they can significantly contribute to the interaction's stability depending on the context, such as the potential for drug interactions or alteration of drug efficacy."
Metronidazole,vincristine,CC1=NC=C(N1CCO)[N+](=O)[O-],CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen bonding,A potential hydrogen bond interaction can occur between the nitro group oxygen of SMILES 1 and a proton donor in the bulky macrocyclic structure of SMILES 2.,"In SMILES 1, the nitro group [N+](=O)[O-] contains negatively charged oxygen atoms that can accept hydrogen bonds. In SMILES 2, multiple hydroxyl (O) and amide (C=O) groups are potential proton donors, particularly the ester and carbonyl oxygens.","Moderate - while potential hydrogen bond acceptors and donors are present, the bulky structure may limit approachability, affecting the interaction strength."
Megestrol,Sorafenib,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Hydrogen bonding,"The potential interaction involves a hydrogen bond between an oxygen atom and a hydrogen donor. In SMILES 1, the -OH group can act as a hydrogen donor, while the carbonyl groups (=O) in SMILES 2 could serve as hydrogen bond acceptors.","- From SMILES 1: The presence of -OH (hydroxyl group) identified as ""O"" in the SMILES string, which is capable of acting as a hydrogen bond donor.
- From SMILES 2: The carbonyl groups present as ""C(=O)"" can function as hydrogen bond acceptors.","Moderate - While hydrogen bonds can influence the pharmacokinetics and dynamics by affecting binding efficiency and molecular stability, the overall pharmacological impact depends on the context within the biological system."
indometacin,Pamidronic acid,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,"Hydrogen bonding interactions can occur between hydrogen bond donors (typically, hydrogens attached to electronegative atoms like oxygen or nitrogen) and acceptors (electronegative atoms with lone pairs, such as oxygen or nitrogen).","In SMILES 1, the carboxylic acid group (CC(=O)O) contains a hydrogen bond donor (the OH group) and a hydrogen bond acceptor (the carbonyl oxygen). In SMILES 2, there are several phosphate groups (P(=O)(O)O), each with oxygens capable of accepting hydrogen bonds. This structural configuration supports potential hydrogen bonding between the two molecules.",Moderate - Hydrogen bonding can influence drug solubility and transport but isn't typically disruptive to overall drug action unless it significantly alters distribution or binding to targets.
Bumetanide,vincristine,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen bonding,"Hydrogen bonding occurs when a hydrogen atom, covalently bonded to an electronegative atom (such as nitrogen or oxygen), interacts with another electronegative atom. In SMILES 1, the presence of the carboxylic acid group (C(=O)O) and the sulfonamide group (S(=O)(=O)N) indicate potential hydrogen bond acceptors. In SMILES 2, the multiple nitrogen-containing groups suggest potential hydrogen bond donors due to lone pair electrons on nitrogen.","- SMILES 1 contains a carboxylic acid group (C(=O)O) and sulfonamide (S(=O)(=O)N) group capable of forming hydrogen bonds.
- SMILES 2 has multiple tertiary amine groups (e.g., N(C)C) that can act as hydrogen bond donors.","Moderate - Given the presence of several potential donor and acceptor groups capable of forming a network of hydrogen bonds, this interaction could moderate pharmacological behavior by altering the binding characteristics of each molecule."
Doxazosin,Pamidronic acid,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors. In these structures, the hydrogen atoms of the phosphate groups (linked to oxygen in SMILES 2) can potentially interact with the nitrogen atoms in the heterocyclic structure of SMILES 1, primarily in the ring containing N atoms.","SMILES 1 includes heterocyclic nitrogen atoms which can act as hydrogen bond acceptors, and SMILES 2 features phosphate groups P(=O)(O)O with hydrogen atoms that can serve as donors.","Moderate - Hydrogen bonding may stabilize interactions under physiological conditions, potentially affecting pharmacokinetics or binding properties."
Methylphenidate,Erlotinib,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,π-π Stacking Interactions,Aromatic rings can engage in π-π stacking interactions due to overlap of their electron clouds.,"SMILES 1 contains an aromatic phenyl ring (C2=CC=CC=C2), and SMILES 2 contains an aromatic ring within the quinazoline structure (C1=C(C=C2...) and NC3=CC=CC(=C3)...).",Moderate - π-π stacking can influence binding affinity and drug stability but requires spatial proximity and correct orientation.
Paracetamol,Tirofiban,CC(=O)NC1=CC=C(C=C1)O,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,Hydrogen bonding,Hydrogen bonds can form between the hydroxyl group (-OH) of the phenolic section of SMILES 1 and the sulfonamide nitrogen (N) of SMILES 2.,"SMILES 1 contains a phenolic hydroxyl group (O-H) in ""C1=CC=C(C=C1)O"". SMILES 2 contains a sulfonamide group ""S(=O)(=O)N"", and the nitrogen in this group is a potential hydrogen bond acceptor for the hydroxyl group from SMILES 1.",Moderate - Hydrogen bonds can significantly affect the solubility and bioavailability of the molecules and potentially lead to a change in their pharmacokinetic profiles.
Celecoxib,Imatinib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,"Hydrogen bonds can form between electronegative atoms and hydrogen atoms attached to electronegative atoms (such as oxygen or nitrogen). In physiological conditions, hydrogen bonds are a common non-covalent interaction between drug molecules.",SMILES 1 has a sulfonamide group with an -NH (S(=O)(=O)N) which could donate a hydrogen bond. SMILES 2 has a carbonyl group (NC(=O)) that can accept a hydrogen bond.,Moderate - This interaction could potentially influence the binding or disposition of each drug by facilitating or hindering a local interaction under physiological conditions.
Ranitidine,Zolpidem,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Hydrogen Bonding,A hydrogen bond could form between the nitro group's oxygen atoms in SMILES 1 and the potential hydrogen bond donor from the secondary amine in SMILES 2.,"In SMILES 1, the nitro group `[N+](=O)[O-]` provides a strong hydrogen bond acceptor with its oxygen atoms. In SMILES 2, the amide group `CC(=O)N(C)C` contains a secondary amine nitrogen which can donate a hydrogen atom, facilitating hydrogen bonding.","Moderate - Hydrogen bonding can significantly influence drug behavior, solubility, and interaction with biological targets, potentially affecting efficacy or side effects."
Dipyridamole,Sildenafil,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donors and acceptors within molecular structures, facilitated by proximity and compatible geometry.","The SMILES for Drug 1 includes multiple -OCCO groups, each containing oxygen atoms that can act as hydrogen bond acceptors. Drug 2 contains several nitrogen atoms in the triazole and sulfonamide groups, which can act as hydrogen bond donors or acceptors.","Moderate - Hydrogen bonding can influence solubility and binding affinity, but the impact would depend on the exact spatial arrangement and concentration within physiological contexts."
Ketoprofen,Pamidronic acid,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,SMILES 1 contains a carboxylic acid group (C(=O)O) that is capable of donating or accepting hydrogen bonds. SMILES 2 includes multiple phosphate groups (P(=O)(O)O) that possess hydroxyl groups capable of forming hydrogen bonds.,"In SMILES 1, the C(=O)O group is indicative of a carboxylic acid which can participate in hydrogen bonding. In SMILES 2, the P(=O)(O)O groups can serve as both hydrogen bond acceptors (through the oxygen in the phosphate group) and donors (through the hydroxyl group).","Moderate - Such interactions could potentially influence binding or solubility, affecting pharmacological activity."
Methylphenidate,Imatinib,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,"Potential hydrogen bonding can occur between the hydrogen atom attached to the nitrogen in the secondary amine group of SMILES 2 and the carbonyl oxygen in the ester group of SMILES 1. The nitrogen atom has a hydrogen that can serve as a hydrogen bond donor, and the carbonyl oxygen serves as a hydrogen bond acceptor.","The nitrogen group in SMILES 2 as depicted by the ""NC(=O)"" portion near the phenyl ring could potentially donate a hydrogen to the carbonyl oxygen in ""COC(=O)"" of SMILES 1.",Moderate - Such interactions can influence the pharmacokinetic and pharmacodynamic profiles of drug molecules.
Desloratadine,Darunavir,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Hydrogen bonding,"The presence of a secondary amine (N-H) in the second SMILES, which can act as a hydrogen bond donor, might interact with the pyridine nitrogen in the first SMILES, which can act as a hydrogen bond acceptor.","The second SMILES contains the group `NC(=O)`, suggesting the presence of an amide N-H bond that can donate a hydrogen atom to the electron pair on the nitrogen of the pyridine ring in the first SMILES string represented by `C=CC=N4`.","Moderate - Hydrogen bonding typically influences molecular recognition and binding, potentially affecting pharmacokinetics or binding to targets."
Labetalol,Metoprolol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors present in the molecular structures. The first SMILES features a primary amine group (N) and hydroxyl group (O), while the second SMILES includes a secondary amine (N) and multiple ether oxygens (O).","- SMILES 1: ""N"" in the amine and ""O"" in the hydroxyl group can act as hydrogen bond donors/acceptors.
- SMILES 2: ""N"" in the amine and ""O"" in the ether links can act as hydrogen bond donors/acceptors.",Moderate - Hydrogen bonding between these groups could influence binding affinities and physicochemical behaviors under physiological conditions.
Bumetanide,Torasemide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen Bonding,Hydrogen bonding can occur between hydrogen bond donors and acceptors present in the two molecules under physiological conditions.,"In SMILES 1, the carboxylic acid group (C(=O)O) features a hydrogen donor/acceptor due to its hydroxyl group and carbonyl oxygen. In SMILES 2, the sulfonamide group (S(=O)(=O)N) has oxygen atoms that can act as hydrogen bond acceptors, and the secondary amine (NC=O) could act as a donor. This provides potential sites for hydrogen bonding between oxygen atoms of the acid or sulfonamide groups (acceptors) and hydrogen atoms on the secondary amine or hydroxyl group (donors).",Moderate - This interaction may affect the pharmacological and binding properties due to the potential for forming more stable complexes through hydrogen bonds.
Cimetidine,Pamidronic acid,CC1=C(N=CN1)CSCCNC(=NC)NC#N,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,This interaction can occur between a hydrogen bond donor group (like an -OH or -NH group) on one molecule and a hydrogen bond acceptor group (like a =N- or -O-) on the other.,"- In SMILES 1, there is a cyano group (NC#N), which contains nitrogen atoms capable of acting as hydrogen bond acceptors.
- In SMILES 2, there are several hydroxyl (-OH) groups present in the phosphoric acid portions, which can act as hydrogen bond donors.",Moderate - Such hydrogen bonding might influence the solubility or distribution of these molecules together in biological systems but is unlikely to greatly impact their overall pharmacological activity.
indometacin,Torasemide,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors present in the two structures. In this case, the carboxylic acid group (-COOH) in SMILES 1 can interact with the sulfonamide group (SO2NH) in SMILES 2.","- SMILES 1 contains a carboxylic acid group, represented by the structure ""CC(=O)O"", which can act as both a hydrogen bond donor (OH) and acceptor (C=O).
- SMILES 2 includes a sulfonamide group ""S(=O)(=O)N"", which has polar sulfonyl oxygens that can act as hydrogen bond acceptors and an NH group that can act as a donor.","Moderate - This interaction could influence binding affinity, solubility, or stability, depending on the biological context and concentration."
Lamotrigine,Torasemide,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen Bonding,The hydrogen bonding interaction can occur between a hydrogen bond donor (such as NH groups) and a hydrogen bond acceptor (such as nitrogen in a heterocycle or a carbonyl oxygen) under physiological conditions.,"In SMILES 1, there is an NH group in the pyrazole ring (C2=C(N=C(N=N2)N)), which can act as a hydrogen bond donor. In SMILES 2, there is a carbonyl group (NC(=O)NC) which can act as a hydrogen bond acceptor.",Moderate - Hydrogen bonds can significantly influence drug binding and efficacy but are generally reversible and transient.
oxybutynin,Pirbuterol,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,Hydrogen bonding,"A hydrogen bond can form between a hydrogen donor in one molecule and an appropriate acceptor in the other molecule. In these SMILES, the phenolic -OH group in SMILES 2 and the ester carbonyl group in SMILES 1 are potential sites for hydrogen bond formation.","SMILES 1 contains an ester group ""COC(=O)"" where the oxygen can act as a hydrogen bond acceptor. SMILES 2 has the phenolic group ""C(=C(C=C1)O)"" where the -OH can donate a hydrogen to form a hydrogen bond with the carbonyl oxygen in SMILES 1.","Moderate - Hydrogen bonds can significantly affect drug interactions and stability, potentially influencing absorption, distribution, and activity."
Metoprolol,Bimatoprost,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor, such as an alcohol (-OH) or amine (-NH), and a hydrogen acceptor, such as a carbonyl oxygen or ether oxygen.","SMILES 1 contains an alcohol group (-O) at the end of the chain, as indicated by ""COC"" and ""O"" at the terminal part of the structure. SMILES 2 contains several alcohol groups, indicated by ""C(C1C=CC(CCC2=CC=CC=C2)O)O"" and an amide group ""CCNC(=O)"". The hydroxyl groups and amide oxygen in SMILES 2 can potentially interact with the alcohol in SMILES 1 via hydrogen bonds.",Moderate - Hydrogen bonding can influence drug solubility and binding affinity but typically does not result in highly adverse pharmacological interference.
Naproxen,oxybutynin,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Hydrogen Bonding,"The carboxylic acid group in the first molecule (SMILES 1) has both hydrogen bond donor (O-H) and acceptor (C=O) capabilities. In the second molecule (SMILES 2), the oxygen atom in the ester (C=O) and in the ether (C-O) groups can act as hydrogen bond acceptors. The O-H group from the carboxylic acid can form hydrogen bonds with these oxygen atoms.","SMILES 1 contains ""C(=O)O"", indicative of a carboxylic acid group, and SMILES 2 contains ""C(=O)"" (ester) and ""COC"" (ether) groups.",Moderate - The potential for hydrogen bonding can impact solubility and interaction with biological targets such as enzymes or receptors.
Cimetidine,Labetalol,CC1=C(N=CN1)CSCCNC(=NC)NC#N,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Hydrogen bonding,"Hydrogen bonds can form between hydrogen donors (like -OH or -NH groups) and hydrogen acceptors (such as carbonyl groups or nitrogen atoms in aromatic rings). In SMILES 2, there is a phenolic -OH group, and in SMILES 1, there is a nitrile group (NC#N) which can act as a hydrogen bond acceptor.","SMILES 1 has a nitrile group ('NC#N'), which contains a nitrogen atom capable of accepting hydrogen bonds. SMILES 2 contains a phenolic -OH group ('C2=CC(=C(C=C2)O)'), which can donate a hydrogen bond to the nitrile nitrogen.","Moderate - Hydrogen bonding can influence solubility and bioavailability, potentially affecting the pharmacokinetics and pharmacodynamics of the drug interaction."
Cimetidine,hydroxychloroquine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Hydrogen Bonding,"Hydrogen bonding can occur when an electron-deficient hydrogen atom (such as those bonded to nitrogen or oxygen) interacts with an electron-rich atom (like nitrogen, oxygen, or a halogen) from another molecule. In this case, there are potential donor (N-H) and acceptor groups (N, O atoms) in the structures.","- From SMILES 1: The NH groups in the segments `CNC(=NC)` can act as hydrogen bond donors.
- From SMILES 2: The oxygen atom in `CCO` and the nitrogen atom in the aromatic ring `NC=C1` can serve as hydrogen bond acceptors.","Moderate - While hydrogen bonding interactions are generally weak individually, they can have a significant impact in biological systems where multiple such interactions stabilize drug binding."
Gabapentin,hydroxychloroquine,C1CCC(CC1)(CC(=O)O)CN,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor and a hydrogen acceptor. In this case, the amino group (NH2) in SMILES 1 can serve as a hydrogen donor, and the oxygen atom in the alcohol group (CO) of SMILES 2 can act as a hydrogen acceptor.","In SMILES 1, the fragment ""CN"" includes an amine nitrogen with potential hydrogen attached, capable of donating hydrogen. In SMILES 2, the fragment ""CCO"" includes an alcohol oxygen that can accept hydrogen to form a hydrogen bond.",Moderate - Interaction could affect the pharmacokinetics or binding properties of the compounds.
Doxazosin,Fluorouracil,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,C1=C(C(=O)NC(=O)N1)F,Hydrogen Bonding,A hydrogen bond can potentially form between the hydrogen atom attached to the nitrogen in the urea group of SMILES 2 and the carbonyl oxygen in the amide linkage of SMILES 1. This occurs due to the presence of a polar proton donor (NH) and a polar proton acceptor (C=O).,"SMILES 1 contains a C=O group in the amide linkage, while SMILES 2 has an NH group in the urea moiety.",Moderate - Hydrogen bonding can influence the binding affinity and pharmacokinetics of drug interactions.
Metolazone,Sildenafil,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,"The interaction likely occurs between hydrogen bond donors and acceptors present in the two molecules. Specifically, the sulfonamide group in each SMILES string contains potential hydrogen bond donor and acceptor sites.","- SMILES 1 contains ""S(=O)(=O)N"" with distinct oxygen atoms (O) capable of acting as hydrogen bond acceptors.
- SMILES 2 contains another ""S(=O)(=O)N"" structure with similar potential for hydrogen bonding.","Moderate - Given the potential for multiple hydrogen bonds, this interaction could stabilize complex formation or alter molecular interactions and activity."
Celecoxib,Zaleplon,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,π-π Stacking,"π-π stacking occurs when two aromatic rings align parallel to each other, enabling electron cloud interactions between the rings. This type of interaction is non-covalent and can stabilize the complex formation.","Both SMILES contain multiple phenyl rings:
- SMILES 1: CC1=CC=C(C=C1)C2=CC(=NN2...) contains phenyl rings at C1=CC= and C2=CC=
- SMILES 2: CCN(C1=CC=CC(=C1)C2=CC=NC...) contains a phenyl ring at C1=CC=C.
These aromatic rings can align parallel to each other, leading to π-π stacking.","Moderate - While π-π stacking contributes to molecular interaction, the significance in pharmacological impact depends on the specific context and molecular environment."
acetazolamide,Citalopram,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Hydrogen bonding,"A hydrogen bond can occur between the sulfonamide group in SMILES 1 and the cyano group in SMILES 2. The hydrogen from the sulfonamide N-H can act as a hydrogen bond donor to the nitrogen in the cyano group, which serves as a hydrogen bond acceptor.","The SMILES 1 structure contains a sulfonamide group (S(=O)(=O)N) that has an N-H bond, providing a potential for hydrogen bonding. SMILES 2 contains a nitrile group (C#N), where the nitrogen has lone pairs that can accept a hydrogen bond.","Moderate - This hydrogen bond interaction could influence the orientation and proximity of the molecules, potentially affecting their pharmacokinetics or dynamics under certain conditions."
Gabapentin,Ketorolac,C1CCC(CC1)(CC(=O)O)CN,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Hydrogen Bonding,A hydrogen bond can form between a hydrogen donor on the carboxyl group of SMILES 1 and a hydrogen acceptor on the carbonyl oxygen of SMILES 2.,"SMILES 1 contains a carboxylic acid group (CC(=O)O) with an acidic hydrogen that can serve as a hydrogen donor. SMILES 2 also contains a carboxylic acid group (C(=O)O), where the carbonyl oxygen can act as a hydrogen acceptor.",Moderate - This type of non-covalent interaction is common and can influence binding affinity but may not significantly alter drug function without additional context.
Sildenafil,Acamprosate,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,CC(=O)NCCCS(=O)(=O)O,Hydrogen bonding,"The first SMILES contains a sulfonamide group (S(=O)(=O)N), which can act as a hydrogen bond acceptor due to the presence of two oxygen atoms with lone pairs. The second SMILES has a sulfonic acid group (S(=O)(=O)O), where the OH can act as a hydrogen bond donor.","SMILES 1 has S(=O)(=O)N indicating potential acceptor capability, and SMILES 2 contains S(=O)(=O)O, where the hydroxyl group (OH) at the end can donate a hydrogen bond.","Moderate - Hydrogen bonding can contribute to pharmacokinetics and drug interactions, influencing solubility and binding."
Naproxen,Zaleplon,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,Hydrogen Bonding,"The carboxylic acid group in SMILES 1 can act as a hydrogen bond donor, while the nitrogen atoms in the pyridine or triazine rings in SMILES 2 can serve as hydrogen bond acceptors.","SMILES 1 contains the group ""C(=O)O"", indicative of a carboxylic acid group, and SMILES 2 contains multiple nitrogen atoms within aromatic rings (""C2=CC=NC3=C(C=NN23)C#N""), which can act as acceptors for hydrogen bonds.",Moderate - The hydrogen bonding interaction can influence drug solubility and permeability but may not be the dominant interaction affecting pharmacokinetics.
Carvedilol,Tirofiban,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,Hydrogen Bonding,"The presence of hydroxyl groups (-OH) in both molecules enables the potential for hydrogen bonding. These groups can act as hydrogen bond donors and acceptors, facilitating an interaction between the drugs.","In SMILES 1, there is a phenolic hydroxyl group (OCC1=CC=CC=C1O). In SMILES 2, there is a carboxylic acid group (C(=O)O) and also an amide NH group (S(=O)(=O)NC).","Moderate - Hydrogen bonding can influence drug solubility and the formation of drug complexes, affecting pharmacodynamics. However, the overall pharmacological impact depends on additional factors not provided in the SMILES."
Cetirizine,vincristine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen Bonding,A hydrogen bond could potentially form between an oxygen atom (which can act as a hydrogen bond acceptor) in one molecule and an amine hydrogen (which can act as a hydrogen bond donor) in the other molecule.,"In SMILES 1, the carboxylate group (C(=O)O) can act as a hydrogen bond acceptor. Meanwhile, in SMILES 2, there are amine groups indicated by 'N', capable of donating hydrogen atoms for hydrogen bonding if the structure geometry permits.","Moderate - Hydrogen bonds can moderately impact the pharmacological profile by affecting the solubility, permeability, or binding affinity of the drugs."
Lamotrigine,Zaleplon,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,π-π Stacking,"The aromatic rings in both structures can stack on each other, facilitating a π-π interaction due to the presence of conjugated π-electron systems.","SMILES 1 contains a chlorinated phenyl ring (C1=CC(=C(C(=C1)Cl)Cl), and SMILES 2 contains multiple aromatic systems, including a phenyl ring (C1=CC=CC(=C1)) and a fused aromatic heterocycle (C2=CC=NC3=C2C=NN3).","Moderate - This kind of interaction can influence the pharmacokinetic or pharmacodynamic properties of the compounds, potentially affecting their activities in vivo through alterations in binding or solubility."
Celecoxib,Ibuprofen,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Hydrogen Bonding,Potential hydrogen bonding interaction between hydrogen bond donors and acceptors present in the structures.,"- In SMILES 1, there's a sulfonamide group (S(=O)(=O)N) which can act as a hydrogen bond acceptor due to the presence of oxygen atoms.
- In SMILES 2, the carboxylic acid group (C(=O)O) provides both a hydrogen bond donor (the hydroxyl group, -OH) and an acceptor (the carbonyl oxygen, =O).",Moderate - The interaction could influence drug solubility or alter the binding characteristics of either drug under physiological conditions.
Ketorolac,Oxaprozin,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,π-π Stacking,"π-π stacking occurs when aromatic rings align parallel to each other, allowing for stabilizing interactions between their π electron clouds.","Both SMILES strings contain phenyl rings. SMILES 1 has a phenyl ring in the C3=CC=CC=C3 moiety. SMILES 2 contains a phenyl ring in the C1=CC=C(C=C1) group and another in the C3=CC=CC=C3 group. These rings can potentially align parallelly, facilitating the π-π stacking interaction.",Moderate - π-π stacking can influence molecular binding and drug conformation but typically exerts a moderate effect relative to other non-covalent interactions like hydrogen bonds or ionic interactions.
phenytoin,Propofol,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CC(C)C1=C(C(=CC=C1)C(C)C)O,π-π Stacking,"π-π stacking interactions typically occur between aromatic rings and involve the delocalized π-electrons from the rings interacting with each other. This is common when aromatic systems are close in space, often leading to stabilization through these interactions.","SMILES 1 contains two aromatic phenyl rings (C1=CC=C(C=C1) and C3=CC=CC=C3), and SMILES 2 contains an aromatic phenyl ring (C1=C(C(=CC=C1))). The proximity of these aromatic rings can lead to π-π interactions.",Moderate - π-π stacking interactions can influence the binding properties and orientation of molecules but are generally not as strong as hydrogen bonds or ionic interactions. The pharmacological impact depends on the specific context within a formulation or binding site.
Modafinil,Bimatoprost,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Hydrogen bonding,"The carbonyl group in the sulfone structure of SMILES 1 can act as a hydrogen bond acceptor with the hydroxyl groups present in SMILES 2, which can act as hydrogen bond donors.","In SMILES 1, the C(=O)N represents a carbonyl group capable of accepting hydrogen bonds. In SMILES 2, the presence of multiple 'O' atoms in hydroxyl groups (e.g., 'O') indicates possible hydrogen bond donors.",Moderate - The hydrogen bonding interaction could influence the solubility or binding affinities of the drugs but is unlikely to drastically change their pharmacological actions without further context.
Fentanyl,Ketorolac,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen atom attached to an electronegative atom and another electronegative atom with a lone pair of electrons. In this case, the carbonyl oxygen in SMILES 2 and the nitrogen atom of the tertiary amine group in SMILES 1 can form a hydrogen bond if the protonated form of the amine is considered.","SMILES 1 has a tertiary amine (N(C1CCN(CC1)) and a carbonyl group (C(=O)), while SMILES 2 contains a carbonyl group (C(=O)C3) which can interact with protonated nitrogen.","Moderate - Due to the potential for forming intermolecular interactions in a physiological environment, which could affect the pharmacokinetics of the substances."
Fentanyl,Aminophylline,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,Hydrogen Bonding,Hydrogen bonding is possible between the carbonyl oxygen in the amide group of SMILES 1 and the primary amine group in SMILES 2 due to the presence of a hydrogen bond donor (NH2 of the primary amine) and a hydrogen bond acceptor (C=O of the amide).,"In SMILES 1, the carbonyl group ""(=O)"" next to the nitrogen ""N"" in the ""C(=O)N"" segment is a potential hydrogen bond acceptor. In SMILES 2, the primary amine ""C(CN)N"" provides potential hydrogen bond donors (NH2 group).",Moderate - This interaction can influence the solubility and distribution of the drugs under physiological conditions.
Ibuprofen,Propofol,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CC(C)C1=C(C(=CC=C1)C(C)C)O,Hydrogen Bonding,Hydrogen bonds can form between a hydrogen atom bonded to an electronegative atom (such as oxygen in a hydroxyl group) and another electronegative atom with a lone pair (such as the oxygen in a carboxylic acid group).,"In SMILES 1, the carboxylic acid group ""C(=O)O"" includes an oxygen with lone pairs which can act as a hydrogen bond acceptor. In SMILES 2, the phenol group contains ""O"" which can donate hydrogen for bonding.",Moderate - This interaction could influence the local environment or binding affinities in a pharmacological context.
Fentanyl,Dexpramipexole,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CCCNC1CCC2=C(C1)SC(=N2)N,Hydrogen bonding,A hydrogen bond can form between the carbonyl oxygen in SMILES 1 and the secondary amine hydrogen in SMILES 2.,"SMILES 1 contains a carbonyl group (C=O) as part of the acetamide moiety, while SMILES 2 contains a secondary amine (NC) which can donate a hydrogen for hydrogen bonding.","Moderate - Hydrogen bonding can influence the binding affinity and solubility, which may affect pharmacokinetics and dynamics."
Amlodipine,Exemestane,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,Pi-Pi stacking,"Pi-Pi stacking interactions occur when aromatic rings in one molecule interact with aromatic rings in another molecule. This can occur through overlapping p-orbitals in the aromatic rings, which can stabilize the interaction.","In SMILES 1, there is a benzene ring (C2=CC=CC=C2Cl), and in SMILES 2, there is a naphthalene-like structure (C4=CC(=O)C=CC34). These aromatic structures are capable of engaging in pi-pi stacking interactions.","Moderate - Pi-Pi interactions can significantly impact molecular binding and pharmacological properties, but are typically not as critical as covalent or ionic interactions."
Alprazolam,Ciclopirox,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,Hydrogen Bonding,The presence of a hydroxyl group (-OH) in SMILES 2 and a nitrogen atom in an aromatic ring in SMILES 1 could facilitate hydrogen bonding under physiological conditions.,"The nitrogen atoms within the triazole ring (NN=C) of SMILES 1 can act as hydrogen bond acceptors, while the hydroxyl group (-OH) on the lactam structure in SMILES 2 serves as a hydrogen bond donor.",Moderate - Such a hydrogen bond could stabilize transient interactions but is unlikely to have a major pharmacological impact unless occurring at a high-affinity site or present at high concentrations.
Desloratadine,Telithromycin,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Hydrogen Bonding,"Hydrogen bonding can occur when a hydrogen atom covalently bonded to an electronegative atom, like nitrogen or oxygen, is attracted to another electronegative atom with a lone pair of electrons. In this case, both SMILES represent structures that contain potential hydrogen bond donors (e.g., -NH- groups) and acceptors (e.g., =O groups).","- SMILES 1 contains several aromatic nitrogen atoms (in pyridine ring), which can act as hydrogen bond acceptors.
- SMILES 2 contains multiple carbonyl groups (C=O) and an amine group, both of which can function as hydrogen bond donors and acceptors, respectively.","Moderate - The presence of these hydrogen bonding sites suggests potential interactions that can influence the molecular interactions under physiological conditions, affecting drug absorption or binding affinity."
Risedronic acid,Trazodone,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Hydrogen Bonding,The drug represented by SMILES 1 contains two phosphonic acid groups (P(=O)(O)O) capable of acting as hydrogen bond donors and acceptors. The nitrogen atoms in the pyrrole and pyridine units of SMILES 2 can serve as hydrogen bond acceptors.,"In SMILES 1, the phosphonic acid groups with -OH termini (P(=O)(O)O) indicate potential hydrogen bond donors. In SMILES 2, the nitrogen atoms in the pyridine ring (N3C=CC=CC3=N2) can act as hydrogen bond acceptors.","Moderate - While hydrogen bonds can significantly affect drug interactions, their overall impact depends on the specific binding context in a biological environment."
Naproxen,Pirbuterol,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,Hydrogen bonding,There is potential for hydrogen bonding between the carboxylic acid group in SMILES 1 and the secondary amine in SMILES 2.,"SMILES 1 contains a carboxylic acid group (C(=O)O) and SMILES 2 contains a secondary amine (N). The oxygen of the carboxylic acid can act as a hydrogen bond acceptor, and the hydrogen on the nitrogen in the secondary amine can act as a hydrogen bond donor.",Moderate - Hydrogen bonding can affect the pharmacokinetic properties and interactions of drugs by altering solubility and binding potential.
Duloxetine,Desloratadine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,π-π Stacking,"π-π stacking occurs when aromatic rings interact with each other through overlapping of their π-electron clouds. In physiological contexts, this interaction can stabilize the binding of two aromatic-containing drugs.","- SMILES 1 contains phenoxy and thiophene groups: OC2=CC=CC3=CC=CC=C32 and C1=CC=CS1, providing planar aromatic systems.
- SMILES 2 contains multiple aromatic rings: Cl-substituted phenyl and isoquinoline, giving rise to planar structures conducive to π-π stacking.","Moderate - π-π interactions could influence binding or biotransformation rates, potentially impacting efficacy or metabolism."
Alfuzosin,Benazepril,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Hydrogen Bonding,The secondary amide (NH) group in the second SMILES can potentially form hydrogen bonds with the carbonyl oxygen or other electronegative atoms in the first SMILES.,"In SMILES 2, the segment ""NC2"" represents a nitrogen attached to a hydrogen atom that can act as a hydrogen bond donor. In SMILES 1, the ""C(=O)"" within the lactone ring or amide group can act as a hydrogen bond acceptor.",Moderate - Hydrogen bonding can influence the binding and pharmacokinetics of drugs but generally is less impactful than covalent or strong electrostatic interactions.
Amlodipine,Ganciclovir,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N,Hydrogen Bond,A hydrogen bond can potentially form between a hydrogen atom attached to an electronegative atom (like nitrogen or oxygen) in one molecule and an electronegative atom (typically a nitrogen or oxygen) in another.,"In SMILES 1, the structure contains several oxygen atoms, such as those in the ester groups (C(=O)O) and the ether oxygens (COCCN). In SMILES 2, there are multiple nitrogen atoms and an alcohol group (CO). Specifically, the nitrogen atoms in SMILES 2 can serve as hydrogen bond acceptors interacting with a neighboring hydrogen donor from one of the oxygens in SMILES 1.","Moderate - Hydrogen bonds are common molecular interactions and can influence solubility, binding specificity, and stability, especially in an aqueous environment."
Chloroquine,hydroxychloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Hydrogen Bonding,"The hydroxyl group (-OH) in the second SMILES string can act as a hydrogen bond donor. It may form a hydrogen bond with a nitrogen atom present in either the tertiary amine or the pyridine ring in the first SMILES string, which could act as hydrogen bond acceptors.","- SMILES 1 contains multiple nitrogen atoms: tertiary amine (NC) and pyridine ring (NC=C).
- SMILES 2 includes a hydroxyl group in the ethyl side chain (-CCO).","Moderate - Hydrogen bonding could influence how these two molecules interact if in close proximity, potentially affecting their solubility or interaction with biological targets."
acetazolamide,Dexpramipexole,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,CCCNC1CCC2=C(C1)SC(=N2)N,Hydrogen Bonding,Hydrogen bonds can form between hydrogen donors and acceptors. The structures contain functional groups capable of such interactions.,"1. In SMILES 1, the sulfonamide group (S(=O)(=O)N) acts as a hydrogen bond donor.
2. In SMILES 2, the nitrogen atom (N) within the imine group (SC(=N2)) can act as a hydrogen bond acceptor.","Moderate - Hydrogen bonding could impact molecular recognition or influence solubility, affecting pharmacological activity."
Citalopram,oxybutynin,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor in one molecule and a hydrogen bond acceptor in the other. Here, the hydroxyl group (-OH) in SMILES 2 could potentially interact with any available hydrogen bond acceptors in SMILES 1.","In SMILES 2, the hydroxyl group (-OH) attached to a tertiary carbon (not shown directly but inferred from the SMILES structure) contains an oxygen atom that can act as a hydrogen bond donor. In SMILES 1, the nitrogen atom in the nitrile group (-C#N) is a potential hydrogen bond acceptor.","Low - The presence of the tertiary structure around the hydroxyl group may limit the likelihood of interaction, and the distance and orientation in a three-dimensional space can also play a crucial role, which is not directly assessable from linear SMILES alone."
Desloratadine,solifenacin,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,π-π Stacking,"π-π stacking can occur between aromatic rings when they are in close proximity, allowing for an overlap of π-electron clouds, which stabilizes the interaction.","SMILES 1 contains aromatic rings, such as the pyridine moiety (C4=C1C=CC=N4) and benzene ring (C2=C(C=CC=C2)), while SMILES 2 contains aromatic phenyl rings (C4=CC=CC=C4 and C5=CC=CC=C5).",Moderate - π-π stacking can influence binding affinity or conformational stability but usually does not cause significant pharmacological impacts on its own unless part of a larger interaction network.
Ofloxacin,Torasemide,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen Bonding,"A potential hydrogen bond can form between a hydrogen bond donor and a hydrogen bond acceptor from each molecule. In the first SMILES, the OH group in the carboxylic acid (C(=O)O) can act as a hydrogen bond donor. In the second SMILES, the carbonyl oxygen (NC(=O)NC) or the sulfonamide oxygen S(=O)(=O) could act as a hydrogen bond acceptor.","In SMILES 1, the carboxylic acid section highlighted as C(=O)O is capable of donating a hydrogen bond. In SMILES 2, the carbonyl group NC(=O)NC or sulfonamide oxygen S(=O)(=O) could accept a hydrogen bond from the acidic hydrogen.","Moderate - This type of interaction can influence solubility, bioavailability, or binding properties, but its exact pharmacological impact would depend on the context of this interaction within a biological system."
alendronic acid,Dipyridamole,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donor and acceptor atoms. The first molecule contains multiple P(=O)(O)OH groups, which include hydrogen donors and acceptors (hydroxyl groups and phosphoryl oxygen atoms). The second molecule contains multiple nitrogen atoms and ether oxygen atoms which can act as hydrogen bond acceptors and, in some cases, donors if they possess hydrogen atoms.","- SMILES 1 has P(=O)(O)O groups that can act as hydrogen bond acceptors/donors.
- SMILES 2 contains nitrogen atoms in the aromatic rings and ether groups (CC(O)) that can act as hydrogen bond acceptors.","Moderate - The presence of multiple potential donor and acceptor sites in both molecules suggests a reasonable probability for interaction, though physiological relevance would depend on spatial conformation which is not dictated by SMILES alone."
Temazepam,Trazodone,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Hydrogen Bonding,"A hydrogen bond can form between a hydrogen donor and an acceptor. In SMILES 1, there is a carbonyl group (C1=O) that can act as a hydrogen bond acceptor. In SMILES 2, there are secondary amines (e.g., -N(CCN)C-) that can act as hydrogen bond donors.","SMILES 1 has the feature ""C1=O"", indicating a carbonyl group as a potential acceptor. SMILES 2 includes amine groups, such as ""N1(CN)"" and ""N(CCN)"", indicating potential hydrogen donors.",Moderate - The presence of a hydrogen bond can influence binding affinity and solubility under physiological conditions but depends on the molecular environment and concentration.
Furosemide,gadoversetamide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],Ionic Interaction,The positively charged gadolinium ion (Gd+3) can interact electrostatically with negatively charged carboxylate groups.,"SMILES 2 contains multiple carboxylate groups denoted as '[O-]', which are negatively charged, providing sites for electrostatic interaction with the '[Gd+3]' ion.","Moderate - The interaction could affect the pharmacokinetics or biodistribution of the complex, especially if it influences solubility or biodistribution of the compound."
Ketoprofen,Telithromycin,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors (such as -NH, -OH groups) and hydrogen acceptors (such as carbonyl groups, -C=O) under physiological conditions. In SMILES 1, the carboxylic acid group (-C(=O)O) can act as both a hydrogen bond donor and acceptor. In SMILES 2, there are several carbonyl groups (-C=O) and hydroxyl groups (-OH) that could potentially interact with the carboxylic acid group of SMILES 1.","- SMILES 1: Presence of a carboxylic acid group [C(=O)O]
- SMILES 2: Presence of carbonyl groups [C(=O)] and hydroxyl groups [O]","Moderate - this type of interaction can potentially affect the solubility and absorption of drugs, impacting their pharmacokinetics."
Candesartan,Sildenafil,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,"A hydrogen bond can potentially form when a hydrogen atom is covalently bonded to an electronegative atom, like nitrogen or oxygen, which can interact with another electronegative atom carrying a lone pair.","- SMILES 1 includes a carboxylic acid group (C(=O)O) that can donate or accept hydrogen for hydrogen bonding.
- SMILES 2 features an amide group (NC(=O)) and a sulfonamide group (S(=O)(=O)N) which can both act as hydrogen bond acceptors due to their electronegative oxygen atoms and lone pairs.",Moderate - This interaction could affect solubility and distribution of the molecules.
Isoniazid,Emtricitabine,C1=CN=CC=C1C(=O)NN,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,Hydrogen Bonding,"The interaction occurs between the hydrogen atom of the -NH group in the hydrazide moiety of the first molecule and the carbonyl oxygen of the amide group in the second molecule. This interaction is feasible because hydrogen atoms bonded to nitrogen can act as hydrogen bond donors, while carbonyl oxygens can act as hydrogen bond acceptors.","In SMILES 1, the sequence ""C(=O)NN"" suggests a carbonyl group (C=O) adjacent to an -NH group that could donate a hydrogen. In SMILES 2, the sequence ""C(=NC2=O)"" indicates a carbonyl oxygen that could accept a hydrogen bond.","Moderate - The presence of hydrogen bonding can influence the binding affinity, but may not significantly impact pharmacokinetics or dynamics without additional context."
Celecoxib,Oxaprozin,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,π-π Stacking Interaction,"π-π stacking interactions occur when aromatic rings align in a parallel arrangement, stabilizing through overlapping π orbitals, common in pharmacological contexts.","Both SMILES 1 and SMILES 2 contain phenyl rings, which are capable of π-π stacking. Specifically, SMILES 1 includes phenyl groups as part of the biphenyl system in the C1=CC=C(C=C1) and C3=CC=C(C=C3) portions. SMILES 2 also contains phenyl groups C1=CC=C(C=C1) and C3=CC=CC=C3, providing scope for aromatic interactions.",Moderate - Such interactions can affect binding affinity or alter the pharmacodynamic profile but are typically one of multiple interactions contributing to overall drug action.
Ibuprofen,Repaglinide,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,Hydrogen Bonding,"The hydrogen bonding can occur between hydrogen atoms bonded to nitrogen or oxygen and lone pairs on oxygen atoms. Both SMILES 1 and SMILES 2 contain carboxylic acid groups, which have the potential to form hydrogen bonds.","- SMILES 1 contains a carboxylic acid group represented by ""C(=O)O"".
- SMILES 2 also contains a carboxylic acid group represented by ""C(=O)O"" and an amide group ""NC(=O)"".","Moderate - The presence of hydrogen bonds can affect the solubility, stability, and interaction with other molecules, which can have moderate pharmacological implications."
Ibuprofen,Adapalene,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,Pi-Pi Stacking,"Pi-pi stacking occurs between aromatic rings present in different molecules when their electron clouds overlap, leading to stabilization.",SMILES 1 contains an aromatic ring 'CC1=CC=C(C=C1)' and SMILES 2 contains multiple aromatic rings 'C1=C(C=...' and 'C2=CC3=C(C=C2)...'. The proximity and planarity of these rings can facilitate a stacking interaction.,"Moderate - This type of interaction can influence how tightly molecules bind, affecting pharmacokinetic and dynamic properties."
Rofecoxib,Thalidomide,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,π-π Stacking,"π-π stacking occurs when aromatic rings in the molecules align with each other, allowing for the overlap of their electron clouds, which stabilizes the interaction.",Both SMILES contain aromatic rings. SMILES 1 has two phenyl rings as part of the sulfonamide phenyl group (C1=CC=C(C=C1)) and an isocoumarin structure (C2=C(C(=O)OC2)C3=CC=CC=C3). SMILES 2 also contains an aromatic phthalimide moiety (C3=CC=CC=C3). These aromatic rings can potentially align to enable π-π interactions.,Moderate - Given that aromatic π-π stacking interactions can influence binding affinity and specificity in pharmacological contexts.
Fentanyl,Ticlopidine,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Pi-Pi Stacking,"Aromatic rings in both molecules can align with one another, allowing for overlapping π-orbitals. This interaction is stabilized by the electron clouds of the aromatic systems.","SMILES 1 contains two phenyl rings (C2=CC=CC=C2 and C3=CC=CC=C3). SMILES 2 contains a phenyl ring (C3=CC=CC=C3), which can interact with the phenyl rings in SMILES 1.","Moderate - Pi-Pi stacking can influence binding affinity in biological systems, potentially altering drug efficacy or interaction with other molecules."
Ibuprofen,Midodrine,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,Hydrogen Bonding,The hydroxyl group (-OH) in SMILES 2 can form a hydrogen bond with the carboxylic acid group (-C(=O)O) in SMILES 1.,"- In SMILES 1, the carboxylic acid group is represented by C(=O)O, which can act as a hydrogen bond donor or acceptor.
- In SMILES 2, the hydroxyl group (C(CNC(=O)CN)O) can donate a hydrogen bond.","Moderate - A hydrogen bond interaction could affect the pharmacological behavior, potentially altering solubility or binding to biological targets."
Carvedilol,Ranolazine,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,Hydrogen Bonding,Hydrogen bonding may occur between the ether oxygen atoms (O) or nitrogen atoms (N) from one SMILES and hydrogen donors like hydroxyl (OH) groups from the other.,"In SMILES 1, the presence of an ether oxygen (O) and a hydroxyl group (OH) in the chain can serve as potential sites for hydrogen bonding. In SMILES 2, there is a hydroxyl group (OH) on an aliphatic chain which can act as a hydrogen donor.","Moderate - While hydrogen bonds are relatively weak individually, they can still play a significant role in stabilizing interactions, particularly if multiple sites are involved."
Fentanyl,Adapalene,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,π-π Stacking,"This interaction occurs when two aromatic rings face each other in a parallel or offset manner, allowing the π-electron clouds to overlap and stabilize the molecules relative to each other.","SMILES 1 contains two aromatic phenyl rings, indicated by `C3=CC=CC=C3` and `CCC2=CC=CC=C2`. SMILES 2 also contains multiple aromatic rings, specifically the `C1=C(C=CC=C1)` and `C2=CC=CC=C2` within the overall structure, allowing for potential π-π stacking interactions between these rings.",Moderate - Aromatic π-π stacking can significantly influence binding affinities and orientations in drug-protein or drug-drug interactions but often do not establish or break complexation on their own under physiological conditions.
alendronic acid,Pyridostigmine,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors. In SMILES 1, the phosphonate group contains oxygen atoms that can act as hydrogen bond acceptors. The amine nitrogen in the same SMILES can potentially donate a hydrogen. In SMILES 2, the amide nitrogen is a potential hydrogen bond donor through its attached hydrogens, and the carbonyl oxygen is a hydrogen bond acceptor. These functional groups allow for the possibility of hydrogen bonding between the two molecules.","- SMILES 1 contains phosphonate groups: P(=O)(O)O, which includes oxygen atoms that can participate in hydrogen bonding. 
- The carbonyl group in SMILES 2: OC(=O) provides an H-bond acceptor (oxygen).
- SMILES 2 includes an N-C bond in the amide, which likely provides hydrogen atoms for donation.","Moderate - Hydrogen bonds can stabilize interactions but are typically weaker than ionic interactions, thus moderately influencing pharmacological behavior depending on the context and specific placements."
Ciclopirox,hydroxychloroquine,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor, such as a hydrogen atom attached to electronegative atoms like nitrogen or oxygen, and a hydrogen acceptor, such as a lone pair on a nitrogen or oxygen atom.","SMILES 1 contains an N-O group (-N(C)O) that could act as both a hydrogen bond donor (NH) and acceptor (O). SMILES 2 includes an amine group (NC) which could act as a hydrogen bond donor, and an ether group (CCO), where the oxygen can serve as an acceptor. This suggests potential hydrogen bond interactions between these functional groups.","Moderate - While hydrogen bonding is typical and often facilitates drug binding to proteins or other drug molecules, it usually doesn't imply severe pharmacological impacts unless influencing critical binding sites."
Ofloxacin,thiotepa,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,C1CN1P(=S)(N2CC2)N3CC3,Electrostatic interaction,"The presence of a phosphorothioate group in SMILES 2 (P(=S)(N2CC2)N3CC3) may interact electrostatically with the carbonyl oxygen atoms in SMILES 1, which are present in the ester and ketone groups.","In SMILES 1, the ester group is represented by ""C(=O)O"" and the ketone by ""C(=O)"", both containing carbonyl oxygen atoms. In SMILES 2, the phosphorothioate group (P=O analogue with sulfur) is a known electrophilic center that can engage in electrostatic interactions with negatively charged acceptors like carbonyl groups.",Moderate - Electrostatic interactions can influence the pharmacokinetic or pharmacodynamic properties of drugs but typically are not as strong as covalent interactions.
Alprazolam,Doxazosin,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Hydrogen Bonding,"The second SMILES string contains a hydroxyl (-OH) group, which is a potential hydrogen bond donor, and the first SMILES string contains several nitrogen atoms in the pyrazole and pyrimidine rings, which can act as hydrogen bond acceptors.","- SMILES 1 contains nitrogen atoms in the pyrazole and pyrimidine rings, represented by 'N'.
- SMILES 2 contains a hydroxyl group, represented by 'O' in the context of C4=CC=CC=C5O4.","Moderate - Hydrogen bonds can play significant roles in molecular interactions that might affect the pharmacokinetic properties like solubility or binding to certain proteins, but they don't necessarily lead to drastic pharmacological impact without further context."
Amlodipine,vincristine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen atom donors and acceptors, such as electronegative atoms with lone pairs and hydrogen atoms attached to electronegative atoms.","In SMILES 1, the carbonyl oxygen atoms (C=O) and the nitrogen atom in the ""NC"" group can act as hydrogen bond acceptors. In SMILES 2, the amine nitrogen (N) in the ""N3"" group, and hydroxyl groups (O) can potentially donate or accept hydrogen bonds.","Moderate - This potential interaction could affect drug binding or solubility under physiological conditions, possibly altering drug potency or bioavailability."
Cimetidine,Palonosetron,CC1=C(N=CN1)CSCCNC(=NC)NC#N,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,Hydrogen Bonding,"The nitrogen atoms in compound one can act as hydrogen bond acceptors. The oxygen in the carbonyl group (C=O) in compound two can act as a hydrogen bond acceptor, and any nearby hydrogen in an appropriate configuration within physiological conditions could interact with nitrogen atoms.","SMILES 1 contains nitrogen atoms in groups such as ""N=CN"" and ""NC#N"", which are capable of participating in hydrogen bonding. SMILES 2 includes a carbonyl group ""C(=O)"", which often plays a role in hydrogen bonding interactions.",Moderate - Hydrogen bonding can potentially influence the pharmacological properties and solubility of drug molecules.
Diazepam,Fenofibrate,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,π-π Stacking,"π-π stacking occurs due to the aromatic rings in both structures potentially engaging in non-covalent interactions, which are prevalent under physiological conditions. These interactions arise due to favorable overlapping of the electron clouds of the aromatic systems.","- SMILES 1 contains a benzene ring as part of the quinazolinone structure: C3=CC=CC=C3
- SMILES 2 has two phenyl rings: OC1=CC=C(C=C1) and C2=CC=C(C=C2)Cl","Moderate - π-π stacking can affect the binding properties of the molecules, potentially altering their pharmacokinetics or bioavailability but generally are not as critical as covalent or ionic interactions."
Naproxen,Ketoprofen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,π-π Stacking,"π-π stacking occurs when aromatic rings interact with each other through their π-electron clouds, which can lead to stabilization due to sharing of electron density and alignment of electron clouds.","Both SMILES strings have phenyl rings:
- SMILES 1 contains ""C1=CC2=C(C=C1)C=C(C=C2)"", which is a naphthalene structure (fused benzene rings).
- SMILES 2 contains ""C1=CC(=CC=C1)C(=O)C2=CC=CC=C2"", indicating a single phenyl ring.","Moderate - π-π stacking can influence binding affinity in some biological contexts, but it depends on the environment and specific binding sites involved."
Lamotrigine,Pilocarpine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,CCC1C(COC1=O)CC2=CN=CN2C,Hydrogen Bonding,A potential hydrogen bond interaction may occur between the amine group in the first molecule and the carbonyl oxygen in the second molecule.,"In SMILES 1, the group ""N"" (which is part of the triazole moiety at C2) can act as a hydrogen donor. In SMILES 2, the ""C=O"" in the ""COC1=O"" part of the oxolane ring can act as a hydrogen bond acceptor due to the electronegative oxygen.",Moderate - This interaction could influence the orientation or binding conformation of the molecules if they are in proximity under physiological conditions.
Citalopram,Ranolazine,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,Electrostatic Interaction,"The presence of a cyano group (C#N) in SMILES 1 indicates a possible electrostatic interaction with positively charged or polar regions. In SMILES 2, the secondary amine group in the tertiary amine (CCN) region might interact with the partially negative nitrogen of the cyano group.","- SMILES 1 contains a cyano group: C#N
- SMILES 2 contains a tertiary amine: CN2CCN","Moderate - While electrostatic interactions can have significant effects on binding affinity and drug activity, the impact will depend on spatial alignment and other surrounding groups facilitating interaction."
Metronidazole,Duloxetine,CC1=NC=C(N1CCO)[N+](=O)[O-],CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,π-π Stacking Interaction,SMILES 1 contains an aromatic ring (pyridazine) and SMILES 2 contains an aromatic naphthalene structure. Aromatic rings can participate in π-π stacking interactions due to the delocalized electrons in their π-systems.,"In SMILES 1, the group ""C1=NC=C(N1)"" forms an aromatic pyridazine ring. In SMILES 2, the ""C2=CC=CC3=CC=CC=C32"" represents a fused aromatic naphthalene system.",Moderate - Such interactions could influence the pharmacokinetic properties by potentially altering receptor binding or facilitating aggregation in solution.
Sibutramine,Zolpidem,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,π-π Stacking,"π-π interactions occur between aromatic rings in proximity, allowing for stacking interactions due to delocalized electron clouds.","Both SMILES contain phenyl rings. In SMILES 1, the phenyl ring is represented by `C2=CC=C(C=C2)`. In SMILES 2, the phenyl ring is represented by `CC1=CC=C(C=C1)`.","Moderate - π-π stacking can influence molecular stability and drug activity, affecting pharmacodynamics."
Tramadol,Exemestane,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,Steric Clash,"A steric clash is likely due to both molecules having large, bulky groups that could physically interfere with each other when brought into proximity under physiological conditions.","- SMILES 1 contains a bulky cyclohexane ring attached to an aromatic methoxyphenyl group.
- SMILES 2 contains a bicyclic structure with multiple stereocenters and a fused aromatic ring, contributing to its bulky nature.","Moderate - Steric clashes can impact binding affinity or orientation in a binding pocket, potentially altering efficacy or metabolism."
Diazepam,Doxazosin,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,π-π Stacking,"π-π stacking occurs between aromatic rings when they are in proximity, allowing for interactions between their π-electron clouds. This type of non-covalent interaction can impact the overall structure and stability in a biological setting.",SMILES 1 contains a benzene ring component (C3=CC=CC=C3) and SMILES 2 also contains an aromatic benzene system in its structure. These aromatic systems facilitate π-π stacking interactions.,"Moderate - π-π interactions can influence drug binding to targets and alter pharmacokinetics, affecting potency or efficacy."
acetazolamide,Lidocaine,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor and an acceptor. In SMILES 1, the sulfonamide group (S(=O)(=O)N) has oxygens that can act as hydrogen bond acceptors. In SMILES 2, the amide group (NC(=O)) contains a hydrogen that can act as a bond donor.","SMILES 1 contains an SO2 group capable of accepting hydrogen bonds. SMILES 2 has an NH group in the amide (NC(=O)), which can donate a hydrogen for bonding.","Moderate - Hydrogen bonding can influence drug solubility and binding interactions, potentially altering pharmacokinetics or pharmacodynamics."
Fluorouracil,vincristine,C1=C(C(=O)NC(=O)N1)F,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen Bonding,Hydrogen bonds can form between a hydrogen atom attached to a highly electronegative atom (such as oxygen or nitrogen) in one molecule and a lone pair of electrons on a highly electronegative atom in another molecule.,"In SMILES 1, we have a carbonyl group (C=O) adjacent to a nitrogen, part of the urea moiety (C(=O)NC(=O)N). In SMILES 2, the structure contains a number of carbonyl oxygens (C=O) that could potentially act as hydrogen bond acceptors, particularly at the ester and amide functionalities.","Moderate - While hydrogen bonding can significantly impact molecular interactions and drug activity, the precise pharmacological impact depends on the context within which the drugs are used or encountered with biological targets. The multiple possible hydrogen bonding sites suggest a reasonable likelihood of interaction under physiological conditions."
Fentanyl,desvenlafaxine,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor and an acceptor. In this case, the hydroxyl (-OH) group on the second molecule (from SMILES 2) can act as a hydrogen bond donor, and the carbonyl (C=O) group on the first molecule (from SMILES 1) can act as a hydrogen bond acceptor.","SMILES 1 contains a carbonyl group [C(=O)], which is capable of accepting hydrogen bonds. SMILES 2 includes a hydroxyl group [C(C)(O)], which can donate hydrogen bonds to the carbonyl oxygen.","Moderate - Hydrogen bonding is a significant interaction that can impact pharmacological action, such as altering binding affinity, solubility, or stability of drug-drug interactions under physiological conditions."
Risedronic acid,Perindopril,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,A potential hydrogen bond interaction could occur between the oxygen atoms of the phosphonic acid groups in SMILES 1 and the hydrogen atoms of the amide NH groups in SMILES 2.,"- In SMILES 1, there are two phosphonic acid groups (P(=O)(O)O), each containing oxygens capable of acting as hydrogen bond acceptors.
- In SMILES 2, there are amide NH groups (NC(C)C(=O)) which can donate hydrogen atoms for hydrogen bonding.","Moderate - Since hydrogen bonds can contribute to drug-drug interactions, particularly in the presence of multiple binding groups, this could influence the pharmacokinetics or dynamics slightly."
Candesartan,Amiloride,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,Hydrogen Bonding,"Hydrogen bonding can occur between the hydrogen bond donors and acceptors present in the two molecules. In SMILES 1, there is a carboxylic acid group (-C(=O)O) which can act as a hydrogen bond acceptor, and in SMILES 2, there are several amine groups (-NH2) that can act as hydrogen bond donors.","In SMILES 1, the carboxylic acid group C(=O)O has an oxygen atom capable of accepting hydrogen bonds. In SMILES 2, the amine group N, which is part of the guanidine moiety (=N)N, can donate hydrogen atoms for bonding.","Moderate - While hydrogen bonding can influence stability and solubility, the overall pharmacological impact will depend on the context of the drug-target interaction."
Cetirizine,Sildenafil,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,The hydrogen bond can occur between the oxygen in the ester group (C=O) of SMILES 1 and the hydrogen bond acceptor atom in the sulfonamide group (S(=O)(=O)N) of SMILES 2.,"- SMILES 1 contains the ester group: (OCC(=O)O).
- SMILES 2 contains the sulfonamide group: (S(=O)(=O)N).
Both groups contain electronegative oxygen atoms that can participate in hydrogen bond interactions.","Moderate - While hydrogen bonds can contribute significantly to drug interaction, their actual pharmacological impact depends on the context of drug-receptor interactions and concentration."
Benazepril,Terazosin,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen bonding,"The first molecule contains a carboxylic acid group (-C(=O)O), which can act as a hydrogen bond donor or acceptor. The second molecule has a secondary amine group in the morpholine ring (N3CCN(CC3)), which can act as a hydrogen bond acceptor.","From SMILES 1, the terminal ""-C(=O)O"" indicates a carboxylic acid group which can donate a hydrogen for bonding. From SMILES 2, ""N3CCN(CC3)"" represents the presence of a secondary amine, which is known to accept hydrogen bonds from donors.",Moderate - The interaction between these polar functional groups could affect the pharmacokinetics or binding interactions of the drugs.
nevirapine,Ofloxacin,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Hydrogen Bonding,"A hydrogen bond can occur between a hydrogen donor and an acceptor. In SMILES 1, the NH group in the amide moiety serves as a hydrogen donor. In SMILES 2, the carbonyl oxygen in the methoxycarbonyl group or the ketone group can serve as a hydrogen acceptor.","- SMILES 1: The group ""C(=O)N"" indicates a possible NH donor site.
- SMILES 2: The ""C(=O)O"" and ""C(=O)"" indicate possible oxygen acceptor sites.","Moderate - Potential for moderate pharmacological impact due to stabilizing interaction, which might affect the pharmacokinetics or binding profile under certain conditions."
Gabapentin,Thalidomide,C1CCC(CC1)(CC(=O)O)CN,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Hydrogen Bonding,"A hydrogen bond can form between a hydrogen bond donor and a hydrogen bond acceptor. In SMILES 1, the compound has an amine group (-NH2), which can act as a hydrogen bond donor. In SMILES 2, there are multiple carbonyl groups (C=O), which can act as hydrogen bond acceptors. The interaction is possible between the NH group of SMILES 1 and one of the carbonyl oxygens in SMILES 2.","SMILES 1 contains 'CN', indicating a terminal amine group, while SMILES 2 contains multiple 'C=O' functionalities indicating carbonyl groups.",Moderate - This interaction is common under physiological conditions and may influence how the two molecules associate or affect each other's biological activity.
Alfuzosin,Famotidine,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Hydrogen Bonding,"Hydrogen bonds can form between donor and acceptor sites, such as NH and carbonyl (C=O) or nitrogen (N) groups in one molecule interacting with suitable acceptors or donors in the other.","- SMILES 1 contains amine groups (e.g., NCCC) and a carbonyl group (C=O on C1CCCO1).
- SMILES 2 contains several donor sites such as NH groups (e.g., N=C(N)N) and acceptor sites such as the S=O group (NS(=O)(=O)N).","Moderate - Hydrogen bonds can slightly affect molecular binding and interaction, potentially impacting pharmacological profiles, but they are typically weaker than covalent bonds."
Famotidine,Repaglinide,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,Hydrogen Bonding,"Hydrogen bonding occurs when a hydrogen atom, bound to a highly electronegative atom like nitrogen or oxygen, interacts with another electronegative atom. In these molecules, there are potential donors and acceptors capable of forming hydrogen bonds.","- SMILES 1 contains several nitrogen atoms in amino groups (e.g., ""N=C(N)N"") that can act as hydrogen bond donors or acceptors.
- SMILES 2 includes a carboxyl group (""C(=O)O"") and carbonyl groups (""C(=O)"") that can act as hydrogen bond acceptors.","Moderate - The ability to form hydrogen bonds can impact the binding affinity and solubility of compounds, affecting their pharmacological properties. However, the overall impact depends on their interaction context within biological systems."
Temazepam,Zolpidem,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,π-π Stacking,"π-π stacking interactions occur when aromatic rings align in a parallel or offset parallel orientation, allowing for overlapping π-electron clouds which stabilize the interaction.","SMILES 1 contains a phenyl ring (C3=CC=CC=C3), and SMILES 2 contains two aromatic systems: a phenyl ring (CC1=CC=C(C=C1)) and a heteroaromatic ring (C2=C(N3C=C(C=CC3=N2))). The presence of these aromatic rings in both structures suggests the potential for π-π stacking interactions.","Moderate - Such interactions can stabilize or promote binding between two molecules in close proximity, impacting their pharmacokinetics or dynamics."
Alprazolam,Benazepril,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors. In SMILES 1, the nitrogen atoms in the heterocyclic rings (N in NN=C and N in N1C2 and NC2) can act as hydrogen bond acceptors. In SMILES 2, the NH group in the carbamate linkage (NC2CCC) can act as a hydrogen bond donor.",SMILES 1 contains nitrogen atoms that are potential hydrogen bond acceptors. SMILES 2 contains an NH group as a hydrogen bond donor.,"Moderate - If hydrogen bonding occurs, it may affect binding affinity or solubility, potentially impacting pharmacological interactions between the drugs."
phenytoin,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donors (e.g., NH groups) and acceptors (e.g., C=O groups). In both structures, there are amide groups capable of such interaction.","SMILES 1 and SMILES 2 both contain amide groups (-C(=O)N-) that can participate in hydrogen bonding: the nitrogen can donate hydrogen, and the carbonyl oxygen can accept hydrogen from another molecule.",Moderate - Hydrogen bonding can influence molecular recognition and stability of complexes under physiological conditions.
Furosemide,hydralazine,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,C1=CC=C2C(=C1)C=NN=C2NN,Hydrogen Bond Donor-Acceptor Interaction,"The hydroxyl group of the carboxylic acid in SMILES 1 can act as a hydrogen bond donor, and the nitrogen atoms in the pyrazole ring of SMILES 2 can act as hydrogen bond acceptors.","- SMILES 1 contains the group C(=O)O, where the hydroxyl oxygen can donate a hydrogen bond.
- SMILES 2 contains a pyrazole ring (C=NN=C) with nitrogen atoms capable of accepting hydrogen bonds.","Moderate - This interaction can influence binding affinity, but its overall pharmacological impact depends on the context of the drug environment and the intrinsic properties of the full molecules."
Famotidine,Sildenafil,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,"The interaction between a hydrogen bond donor and a hydrogen bond acceptor occurs when specific functional groups are in proximity, facilitating the sharing of a hydrogen atom.","In SMILES 1, the sulfonamide group (S(=O)(=O)N) contains oxygen atoms which can act as hydrogen bond acceptors. In SMILES 2, the NH group within the triazole provides a hydrogen bond donor capability due to the hydrogen on the nitrogen.",Moderate - Such interactions could modulate binding affinity and pharmacokinetics if both drugs were present simultaneously in a physiological environment.
Amlodipine,Pamidronic acid,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors (e.g., -NH or -OH groups) and hydrogen bond acceptors (e.g., carbonyl oxygen, -O-, or phosphate oxygen groups).","SMILES 1 contains an amine group (COCCN) that can act as a hydrogen bond donor, and SMILES 2 contains multiple phosphate groups (P(=O)(O)O) with oxygen atoms that can serve as hydrogen bond acceptors.",Moderate - Hydrogen bonds can significantly impact the stability and conformation of molecular complexes and potentially affect pharmacological properties.
alendronic acid,Lamivudine,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen bond donors and acceptors. In SMILES 1, the hydroxyl groups and the phosphoric acid groups (-P(=O)(O)O) can act as hydrogen bond donors or acceptors. In SMILES 2, the carbonyl group (C=O) and the secondary amine (N-H in the pyrimidine ring) can participate in hydrogen bonding.","SMILES 1 contains hydroxyl and phosphoric groups indicative of potential hydrogen bond donors and acceptors. SMILES 2 contains a carbonyl group (C=O) and a secondary amine (N-H), which can accept and donate hydrogen bonds, respectively.",Moderate - such hydrogen bonds are common and can slightly alter the pharmacokinetic or pharmacodynamic profiles by changing solubility or receptor binding affinity.
Gabapentin,Ibuprofen,C1CCC(CC1)(CC(=O)O)CN,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Hydrogen Bond,"The carboxylic acid group from SMILES 2 can donate a hydrogen to the nitrogen in the amine group from SMILES 1, forming a hydrogen bond.",SMILES 1 contains an amino group (CN) which can act as a hydrogen bond acceptor. SMILES 2 contains a carboxylic acid group (C(=O)O) which can donate a hydrogen atom.,Moderate - This interaction can influence drug binding affinity or alter solubility and pharmacokinetic properties.
Duloxetine,Sorafenib,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors. In SMILES 1, the ether oxygen (OC) on the aromatic ring is capable of acting as a hydrogen bond acceptor. In SMILES 2, the secondary amine (CNC(=O)) and amide groups (NC(=O)) contain hydrogen atoms that can act as possible donors for hydrogen bonding.","- SMILES 1: OC2=CC=CC3=CC=CC=C32 (ether oxygen)
- SMILES 2: CNC(=O), NC(=O) (hydrogens on nitrogen)",Moderate - Hydrogen bonding influences drug solubility and binding affinity but does not typically prevent drug activity by itself. This interaction may affect solubility or binding properties but is not necessarily disruptive.
Gabapentin,Palonosetron,C1CCC(CC1)(CC(=O)O)CN,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,Hydrogen Bond (H-bond) formation,"A hydrogen bond could form between the amine group (-NH2) of SMILES 1 and the carbonyl oxygen in the cyclic structure of SMILES 2. The hydrogen atom of the amine could be a hydrogen bond donor, and the carbonyl oxygen is a potential hydrogen bond acceptor.","SMILES 1 contains a primary amine group as evidenced by ""CN"" (where the nitrogen can be protonated to NH2 under physiological conditions). SMILES 2 contains a carbonyl group ""C(=O)"" within a bicyclic system that can participate in hydrogen bonding.","Moderate - Hydrogen bonds are moderate in strength and commonly influence the orientation and interaction of molecules, especially in drug-protein and drug-drug interactions."
Methylphenidate,Etiracetam,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CCC(C(=O)N)N1CCCC1=O,Hydrogen Bonding,Hydrogen bonding can occur between a hydrogen donor (such as -NH or -OH groups) and an acceptor (such as C=O or an aromatic ring with delocalized pi electrons).,"In SMILES 2, there is an amide group (C(=O)N) which includes a hydrogen donor (N-H) and a carbonyl group which can act as an acceptor. In SMILES 1, there is an ester carbonyl group (C(=O)) that can act as a hydrogen bond acceptor.","Moderate - While the potential for hydrogen bonding indicates a specific interaction, the strength and pharmacological impact would depend on the distance and orientation within the physiological environment."
Fentanyl,vincristine,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Steric clash,"A steric clash may occur when bulky groups from both molecules are located in close proximity and physically hinder one another, potentially affecting their binding and function.","SMILES 1 contains a bulky benzene ring (C3=CC=CC=C3) attached to a tertiary amine, and SMILES 2 contains multiple bulky structures, including fused rings and ester linkages, that create a dense and complex three-dimensional shape with several potential points of steric hindrance. The overlapping presence of multiple aromatic and saturated cyclic structures in close proximity is indicative of potential steric clashes when considered in the context of one another.","Moderate - The dense array of aromatic and cyclic groups in both SMILES may influence each other, leading to changes in their spatial conformation or affecting binding interactions with biological targets."
Furosemide,melphalan,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,Hydrogen Bonding,A hydrogen bond can form between the acidic hydrogen of the carboxylic acid group from the second SMILES and the sulfonamide group in the first SMILES.,"In SMILES 1, the sulfonamide group (S(=O)(=O)N) in proximity to an aromatic ring can act as a hydrogen bond acceptor. In SMILES 2, the carboxylic acid group (C(=O)O) can provide a hydrogen for donation.","Moderate - Hydrogen bonding can impact the pharmacokinetics or solubility profile of drugs, altering absorption or binding characteristics without entirely inhibiting function unless critical to the activity site."
Diazepam,Imatinib,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor (like an -NH or -OH group) and a hydrogen bond acceptor (such as a carbonyl (C=O), nitrile (C≡N), or a nitrogen atom in a ring).","In SMILES 1, the carbonyl group (C=O) within the pyrimidinone moiety could act as a hydrogen bond acceptor. In SMILES 2, the secondary amine (-NH-) within the compound, part of the aniline moiety, can donate a hydrogen atom for hydrogen bonding.","Moderate - Hydrogen bonding can affect binding affinity and solubility, possibly impacting pharmacokinetics without necessarily leading to toxic or highly adverse interactions."
Cetirizine,Moexipril,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,Hydrogen Bonding,A hydrogen bond may form between the carbonyl oxygen in the ester group of SMILES 1 and a proton in the amide group of SMILES 2.,"- The ester group in SMILES 1: O=C-O
- The proton donor in SMILES 2 is part of the amide group: N-H",Moderate - Hydrogen bonds can influence molecular binding and solubility but typically do not cause drastic pharmacological effects on their own.
Naproxen,Ondansetron,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Hydrogen bonding,"Hydrogen bonding can occur between a hydrogen attached to an electronegative atom (donor) and another electronegative atom with a lone pair of electrons (acceptor). In the provided SMILES, potential hydrogen bond donors and acceptors can lead to interactions between the two molecules.","In SMILES 1, the carboxylic acid group (C(=O)O) provides an oxygen that can serve as a hydrogen bond acceptor or donor. In SMILES 2, the carbonyl oxygen (C=O) and the nitrogen in the heterocyclic rings can also serve as hydrogen bond acceptors.",Moderate - Hydrogen bonding between these structural features can moderately affect pharmacological interactions by influencing binding affinity or solubility.
Amlodipine,Propofol,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CC(C)C1=C(C(=CC=C1)C(C)C)O,Hydrogen bonding,A hydrogen bond donor (amine group) from the first SMILES string can interact with the hydrogen bond acceptor (hydroxyl group) from the second SMILES string.,"The first SMILES string includes a nitrogen atom in the amine group (COCCN), which can act as a hydrogen bond donor. The second SMILES string contains an -OH group (hydroxyl group) attached to the aromatic ring (C1=C(C(=CC=C1)O)), which is a potential hydrogen bond acceptor.","Moderate - Given that hydrogen bonds can significantly influence the pharmacology of interactions in the body, this interaction might moderately affect the binding or activity of these compounds when in close proximity."
Famotidine,Metolazone,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Hydrogen Bonding,"The first SMILES has an amine group (N=C(N)N) in the thiazole ring, which can act as a hydrogen bond donor. The second SMILES contains a sulfonamide group (S(=O)(=O)N) that could serve as a hydrogen bond acceptor.",The presence of NH groups in SMILES 1 and SO2N group in SMILES 2.,Moderate - This interaction could disrupt binding or modify the affinity of hydrogen bond donors/acceptors within a biological target's active site or binding pocket.
Lidocaine,Torasemide,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donors and acceptors. In the given SMILES, the secondary amine group (-NH-) in SMILES 1 and the sulfonamide group (S(=O)(=O)N-) in SMILES 2 provide potential for hydrogen bond formation.",SMILES 1 contains the amide group 'NC1' which has a hydrogen donor (NH). SMILES 2 contains sulfonamide group 'S(=O)(=O)N' which has oxygens that can act as hydrogen bond acceptors.,Moderate - Hydrogen bonds can influence the binding affinity or solubility of drugs without necessarily leading to strong pharmacological interactions.
Candesartan,Fenofibrate,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Pi-Pi Stacking,"Aromatic rings in close proximity can interact via π-π stacking, where the delocalized electrons in the pi orbitals of one aromatic ring interact with those in another, stabilizing their relative positions.","Both SMILES strings contain multiple aromatic rings. Specifically, SMILES 1 has multiple phenyl groups and heteroaromatic rings, such as C1=NC2 and C=C3, while SMILES 2 contains aromatic structures like C1=CC=C(C=C1) and C2=CC=C(C=C2)Cl.","Moderate - While π-π interactions can influence the binding affinity and orientation of molecules, the actual pharmacological impact depends on the specific physiological context, which is not specified here."
Gabapentin,Tramadol,C1CCC(CC1)(CC(=O)O)CN,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors. In these structures, the secondary amine in SMILES 1 (CN group) could donate a hydrogen atom to form a hydrogen bond with the hydroxyl group in SMILES 2.",The secondary amine group (-NH-) in SMILES 1 and the hydroxyl group (-OH) in SMILES 2 are capable of forming hydrogen bonds due to the presence of the electron lone pairs on the oxygen atom and the hydrogen attached to the nitrogen atom.,Moderate - Such hydrogen bonding can stabilize complexes but typically has moderate impact unless it significantly alters binding affinities or drug solubility.
Cetirizine,Temozolomide,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,Hydrogen bonding,"Hydrogen bonds can form between hydrogen bond donors and acceptors. In SMILES 1, the carbamate group `C(=O)O` includes a carbonyl oxygen that can act as a hydrogen bond acceptor. In SMILES 2, the amide group `C(=O)N` includes a hydrogen on the nitrogen that can act as a hydrogen bond donor.","- SMILES 1 contains the sequence `C(=O)O` indicating a carbonyl group where the oxygen can act as a hydrogen bond acceptor.
- SMILES 2 contains the sequence `C(=O)N` which provides an NH where the hydrogen can act as a hydrogen bond donor.","Moderate - This type of interaction could impact drug-binding kinetics under physiological conditions, influencing pharmacodynamics and pharmacokinetics."
Diazepam,Ofloxacin,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Hydrogen Bonding Potential,Hydrogen bonding can occur when a hydrogen atom is covalently bonded to an electronegative atom (such as nitrogen or oxygen) and is in proximity to another electronegative atom with a lone pair of electrons.,"In SMILES 1, the carbonyl group (C=O) attached to the nitrogen atom in the structure has a potential hydrogen bond acceptor (the oxygen). In SMILES 2, the presence of multiple nitrogen atoms (like in the pyridine or piperazine structure) and carbonyl oxygen (C=O) can potentially act as hydrogen bond donors or acceptors under physiological conditions.","Moderate - Hydrogen bonding can influence binding affinity and drug bioavailability but is generally weaker than covalent interactions, unless it significantly alters conformation or activity."
Citalopram,Fenofibrate,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,π-π Stacking,"π-π stacking involves interactions between aromatic rings, which can stabilize bound orientations due to overlap of their respective π-electron clouds.","SMILES 1 contains an aromatic system represented by the phenyl ring ""C3=CC=C(C=C3)F"", and SMILES 2 has two aromatic systems represented by the phenyl rings ""C1=CC=C(C=C1)"" and ""C2=CC=C(C=C2)Cl"". These aromatic rings could engage in π-π stacking interactions.","Moderate - Such interactions may influence binding affinity or specificity in a pharmacological context, depending on the precise orientation and environment of the molecules in a biological setting."
Zolpidem,Bimatoprost,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors. In these SMILES, the carbonyl oxygen from SMILES 1 can serve as a hydrogen bond acceptor, while the hydroxyl groups in SMILES 2 can act as hydrogen bond donors.","The carbonyl group in SMILES 1 is represented by ""CC(=O)N"", providing an oxygen atom that can act as a hydrogen bond acceptor. SMILES 2 contains ""C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O"", representing hydroxyl groups that can donate hydrogen.","Moderate - Hydrogen bonds can significantly influence pharmacokinetic and pharmacodynamic properties, such as solubility and receptor binding."
Ketoprofen,oxybutynin,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Hydrogen Bonding,"The carboxylic acid group in SMILES 1 can act as a hydrogen bond donor through its hydroxyl (OH) group, while an ester oxygen in SMILES 2 can act as a hydrogen bond acceptor.","In SMILES 1, the presence of ""C(=O)O"" indicates a carboxylic acid group capable of donating a hydrogen bond. In SMILES 2, the segment ""COC(=O)"" suggests an ester oxygen which could accept a hydrogen bond from the hydroxyl group.","Moderate - This interaction could slightly alter the solubility or binding affinity of the drugs under certain circumstances, potentially affecting pharmacokinetics or dynamics."
Gabapentin,Terazosin,C1CCC(CC1)(CC(=O)O)CN,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen Bonding,The presence of hydrogen bond donors and acceptors in the molecular structures can lead to possible hydrogen bonding interactions between these two compounds under physiological conditions.,"- SMILES 1 has a carboxylic acid group (CC(=O)O) which can serve as a hydrogen bond donor (OH) and an acceptor (C=O).
- SMILES 2 contains multiple nitrogen atoms with lone pairs (such as in the pyrazine ring and the tertiary amine N3CCN) and carbonyl groups which can act as hydrogen bond acceptors.","Moderate - Hydrogen bonding can impact solubility and interaction with biomolecules, potentially influencing the bioavailability or binding profile of the drugs."
Risedronic acid,Amiloride,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,Hydrogen Bonding,"The second SMILES string contains numerous amine and amide functional groups capable of donating and accepting hydrogen bonds. The first SMILES string contains hydroxyl and phosphate groups, which can also participate in hydrogen bonding.","- SMILES 1: ""CC(O)"" indicates a hydroxyl group, and ""P(=O)(O)O"" indicates phosphate groups with oxygen atoms capable of hydrogen bond interactions.
- SMILES 2: ""C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N"" contains numerous nitrogen atoms in amine and imine groups (""N"") and oxygen in the amide group (""C(=O)"").","Moderate - The ability of these groups to form hydrogen bonds can affect solubility and bioavailability, potentially influencing drug activity or stability under physiological conditions."
Citalopram,Fluphenazine,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,Hydrogen Bonding,A hydrogen bond could potentially form between an electronegative atom (oxygen from an alcohol or amine group) and an available hydrogen donor present in these molecules.,"- In SMILES 1, there is an alcohol group represented by the 'CO1' segment, indicating the presence of an oxygen atom in a ring structure that can potentially engage in hydrogen bonding.
- In SMILES 2, the presence of a tertiary amine 'N(CCN1CCCN)' suggests there are available hydrogens that may donate to the oxygen atom observed in SMILES 1.","Moderate - The presence of potential hydrogen bonding could influence drug solubility or stability and alter pharmacological activity, but the interaction isn't overly strong compared to other non-covalent interactions."
Telmisartan,Cinacalcet,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,Pi-Pi Stacking Interaction,Pi-pi stacking interactions occur between aromatic rings due to the electron cloud delocalization of the ring systems. This leads to attractive forces that stabilize the interaction.,"- SMILES 1 contains phenyl rings within ""CC3=CC=C(C=C3)"" and ""C4=CC=CC=C4"".
- SMILES 2 contains phenyl rings within ""C1=CC=CC2=CC=CC=C21"".","Moderate - While pi-pi stacking can influence the physical properties and binding affinity, its impact on pharmacological action is generally less pronounced compared to other stronger interactions like hydrogen bonding. However, the interaction could influence drug alignment or orientation in a multi-binding site scenario."
Fluorouracil,mitomycin C,C1=C(C(=O)NC(=O)N1)F,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,Hydrogen Bond (Donor-Acceptor),"The first drug (SMILES 1) contains an amide group with a carbonyl oxygen that can act as a hydrogen bond acceptor. The second drug (SMILES 2) features a secondary amine within its bicyclic structure, which can act as a hydrogen bond donor.","In SMILES 1, the carbonyl group is noted by ""NC(=O)"" in the amide. In SMILES 2, the bicyclic structure including ""N3"" in the secondary amine can donate a hydrogen for hydrogen bonding.","Moderate - This interaction could influence how the drugs affect each other's solubility, stability, or interaction with biological targets, potentially altering pharmacological effects."
Diazepam,desvenlafaxine,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,Hydrogen Bonding,"Hydrogen bonding can occur between the hydroxyl (-OH) group in SMILES 2 and the carbonyl group (C=O) in SMILES 1. The hydrogen in the hydroxyl group can act as a hydrogen bond donor, while the oxygen in the carbonyl group can act as an acceptor.","The hydroxyl group is present in SMILES 2 as ""-C1=CC=C(C=C1)O"" and the carbonyl group in SMILES 1 is represented by the ""C(=O)"" near the central ring structure.","Moderate - Such interactions can influence solubility, stability, or binding affinity under physiological conditions."
Paracetamol,Midodrine,CC(=O)NC1=CC=C(C=C1)O,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,Hydrogen Bonding,A hydrogen bond can potentially form between the hydrogen atom of the hydroxyl group (-OH) in SMILES 1 and the carbonyl oxygen (C=O) in SMILES 2.,SMILES 1 contains an OH group attached to the phenyl ring. SMILES 2 has a carbonyl group (C=O) within the amide (CNC(=O)CN) segment that can act as a hydrogen bond acceptor.,"Moderate - This type of interaction may impact the pharmacological profiles by influencing solubility, binding, or stability under physiological conditions."
Citalopram,Isoniazid,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,C1=CN=CC=C1C(=O)NN,Hydrogen Bonding,"The NH group from the hydrazide (-NNH-) of SMILES 2 can act as a hydrogen bond donor, while the nitrogen in the cyano group (-C#N) of SMILES 1 can act as a hydrogen bond acceptor.","SMILES 1 includes a cyano group indicated by 'C#N', and SMILES 2 contains a hydrazide group indicated by '-C(=O)NN'. The terminal NH group of '-NN' can donate a hydrogen to the lone pair of electrons on the nitrogen of the '-C#N'.",Moderate - Hydrogen bonding can potentially affect drug binding and solubility.
Candesartan,mitomycin C,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,Hydrogen Bonding,A potential hydrogen bond donor from SMILES 1 can interact with a hydrogen bond acceptor on SMILES 2 under physiological conditions.,"In SMILES 1, there is a carboxylic acid group indicated by ""C(=O)O"" that can act as a hydrogen bond donor. In SMILES 2, there is a carbonyl group in the diketopiperazine moiety ""C1=C(C(=O)..."" that can act as a hydrogen bond acceptor.","Moderate - Hydrogen bonds can significantly affect molecule binding affinities and solubility, potentially impacting pharmacological interactions."
indometacin,vincristine,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen Bonding,A hydrogen bond can form between a hydrogen bond donor (such as an -OH or -NH group) and an acceptor (such as a carbonyl oxygen).,"In SMILES 1, there is a carboxylic acid group, ""CC(=O)O"", where the carbonyl group (C=O) can act as a hydrogen bond acceptor. In SMILES 2, several functional groups are present, including carbamate (OC(=O)N) and ester (C(=O)OC) functionalities, where the carbonyl oxygen can act as both donor and acceptor in a hydrogen bond. The proximity and conformation of these groups, though not precisely definable from SMILES alone, suggest potential sites for hydrogen bonding.",Moderate - Hydrogen bonding is a common interaction that can affect solubility and binding but generally does not drastically alter pharmacological activities unless it involves critical functional groups in active or binding sites.
Methylphenidate,Metronidazole,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CC1=NC=C(N1CCO)[N+](=O)[O-],Hydrogen Bonding,Hydrogen bonds can form between hydrogen donors and acceptors when in proximity. The oxygen atoms in nitro groups can act as hydrogen bond acceptors.,"SMILES 1 has an ester oxygen and an amine nitrogen, which can potentially serve as hydrogen bond donors, while SMILES 2 has nitro group oxygens that can act as hydrogen bond acceptors.",Moderate - This interaction could influence binding affinity or solubility under physiological conditions.
Ondansetron,Pirbuterol,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,Hydrogen Bond,The hydroxyl group in SMILES 2 can donate a hydrogen bond to the pyridine nitrogen in SMILES 1.,SMILES 1 contains a pyridine nitrogen ('NC=CN'). SMILES 2 contains a hydroxyl group ('CC(C1)...CO').,"Moderate - While hydrogen bonding can influence drug binding and solubility, the overall pharmacological impact varies depending on the context and concentrations."
Rofecoxib,Trazodone,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,π-π Stacking,"π-π stacking occurs between aromatic rings in close proximity, stabilizing the interaction through delocalized electron clouds.","SMILES 1 contains multiple aromatic rings: ""C1=CC=C(C=C1)"" (phenyl ring) and ""C3=CC=CC=C3"" (another phenyl ring). SMILES 2 also contains multiple aromatic rings: ""C=CC=CC3"" (part of a bicyclic system) and ""C4=CC(=CC=C4)Cl"" (chlorinated phenyl ring). These rings may align in physiological conditions, promoting π-π stacking.","Moderate - Depending on the orientation and distance of these aromatic rings in physiological conditions, this interaction may moderate the bioavailability or receptor binding profiles of the drugs."
Cimetidine,Citalopram,CC1=C(N=CN1)CSCCNC(=NC)NC#N,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Hydrogen Bond,"Nitrogen atoms in the triazole and cyanamide groups of SMILES 1 can act as hydrogen bond acceptors, while hydrogen atoms bonded to nitrogen in the secondary amines of SMILES 2 can serve as hydrogen bond donors.","SMILES 1 contains nitrogen atoms in ""C1=C(N=CN1)"" and ""NC#N"", which can accept hydrogen bonds. SMILES 2 has a secondary amine ""CN(C)"" which can donate hydrogen atoms.","Moderate - Hydrogen bonding can significantly impact the interaction between molecules, affecting their solubility and binding characteristics."
Ketorolac,oxybutynin,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Hydrogen Bonding,A hydrogen bond could potentially form between a hydrogen bond donor and acceptor present in the structures of the drugs.,"In SMILES 1, the carboxylic acid group (C(=O)O) provides a hydrogen bond donor (the hydroxyl hydrogen) and acceptor (the carbonyl oxygen). In SMILES 2, the ester group (OC(=O)) has a carbonyl oxygen that can serve as a hydrogen bond acceptor.","Moderate - Hydrogen bonding is a common and potentially relevant interaction in physiological environments, affecting solubility and binding interactions, though it might not always result in significant pharmacological impact directly unless occurring at specific binding sites."
Dapsone,Pyrimethamine,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,Hydrogen Bonding,"The hydrogen bonding interaction can occur between the amine groups on one molecule and the nitrogen or oxygen-containing groups on the other. Specifically, the amine groups (-NH2) from SMILES 2 can act as hydrogen bond donors to the sulfonyl group (S(=O)(=O)) that contains oxygen atoms capable of acting as hydrogen bond acceptors in SMILES 1.","SMILES 1 contains a sulfonyl group with oxygen atoms: S(=O)(=O). SMILES 2 has amino groups: C(=NC(=N1)N)N, which can donate hydrogen atoms for bonding.","Moderate - This interaction is likely due to the presence of multiple functional groups capable of forming hydrogen bonds, which may influence the pharmacological activity or bioavailability of the drugs when present together."
Ibuprofen,Balsalazide,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O,Hydrogen Bonding,"A hydrogen bond can form between hydrogen donors (e.g., -NH or -OH groups) and hydrogen acceptors (e.g., carbonyl groups =C=O).","In SMILES 1, the -OH in the carboxylic acid group (-C(=O)O) can act as a hydrogen bond donor. In SMILES 2, the carbonyl oxygens in the amide (-C(=O)N-) group and the carboxylic acid group (-C(=O)O) can act as hydrogen bond acceptors.","Moderate - This interaction may impact the solubility and binding characteristics of the drugs when co-administered, influencing their pharmacokinetics and pharmacodynamics."
Diazepam,Pyridostigmine,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,π-π stacking,"π-π stacking interactions can occur between aromatic rings when they are in close proximity, allowing the overlapping p orbitals to stabilize each other through weak van der Waals forces.","SMILES 1 contains a phenyl ring (C3=CC=CC=C3) and a chlorinated pyridine ring (C2=C1C=CC(=C2)Cl), while SMILES 2 contains a pyridinium ring (C[N+]1=CC=CC(=C1)). The presence of these aromatic rings in both structures supports the possibility of π-π stacking interactions.","Moderate - While π-π stacking interactions can influence binding affinities and drug-protein interactions, their physiological impact varies depending on the context and environment in which these compounds are acting."
Cetirizine,Terazosin,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen Bonding,"The carbonyl oxygen in SMILES 1 can act as a hydrogen bond acceptor, while the secondary amine nitrogen in SMILES 2 can provide a hydrogen for bonding.","In SMILES 1, the segment ""CC(=O)O"" contains a carbonyl group capable of accepting hydrogen bonds. In SMILES 2, the segment ""NC(=N2)"" includes a nitrogen that can act as a donor under certain conditions.","Moderate - This type of interaction can assist in stabilizing the molecular complex or influence each other's binding in a target site, but is generally not as critical as covalent interactions."
Aciclovir,Emtricitabine,C1=NC2=C(N1COCCO)NC(=NC2=O)N,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,Hydrogen Bonding,Hydrogen bonding can occur between donor and acceptor groups. The first SMILES string contains a secondary amine (NH) which can act as a hydrogen bond donor. The second SMILES string contains a carbonyl group (C=O) which can act as a hydrogen bond acceptor.,"The secondary amine group present in SMILES 1 is denoted by 'N', specifically in the substructure 'NC(=N)'. The carbonyl group in SMILES 2 is represented by 'C=O', specifically in 'C(=NC2=O)'.","Moderate - Hydrogen bonding is a common interaction that can affect the pharmacokinetics or pharmacodynamics of drug molecules by modifying solubility or binding profiles, but without more context, the specific impact is moderate."
Ondansetron,Pimecrolimus,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,Steric Clash,"Steric clashes occur when two molecules are in close proximity, leading to physical hindrance due to overlapping atomic volumes. In a physiologically relevant context, bulky groups or rigid structural regions may come into contact and result in reduced compatibility or binding in a shared environment, such as within a receptor or an enzyme's active site.","SMILES 1 features a tricyclic structure with rings and several carbon atoms that can contribute to a relatively rigid, bulky formation. SMILES 2 shows an even more complex structure with multiple cyclic and branch groups, including multiple oxygen-containing substituents and a chlorinated bulky ring system. The combination of these bulky and complex sections in both SMILES suggests potential for steric clashes.","Moderate - A steric clash could potentially impact the pharmacokinetics by interfering with the binding of each molecule to their respective targets or to the same binding site, influencing efficacy or leading to competitive interactions. However, the exact impact would depend on the spatial orientations in a physiological (e.g., binding) context, which we do not determine solely from the SMILES."
Amlodipine,Rosiglitazone,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor and a hydrogen acceptor. In SMILES 1, there is a secondary amine (-NH-) in the pyrrole ring, and in SMILES 2, there is a carbonyl oxygen (=O) attached to the thiazolidinone ring serving as a potential hydrogen bond acceptor.","SMILES 1 contains the sequence ""NC(=C"" indicating a nitrogen atom adjacent to a double-bonded carbon. SMILES 2 contains ""C(=O)N"", indicating a carbonyl group adjacent to an amine, providing a suitable acceptor/donor pair.","Moderate - Hydrogen bonds can influence drug binding and can lead to changes in pharmacokinetic properties like solubility and permeability, thus altering the drugs' pharmacological activity. However, the overall impact will depend on the strength and stability of these interactions in physiological conditions."
Alprazolam,Bumetanide,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor (such as an N-H or O-H group) and an acceptor (like a carbonyl oxygen C=O or a nitrogen atom N with a lone pair). Here, the secondary amine in SMILES 2 (N-H) can act as a hydrogen donor, and the nitrogen atoms in the triazole ring of SMILES 1 can act as hydrogen bond acceptors.","SMILES 2 contains an amine group (N bonded to hydrogen via ""CCCNC""), which can donate a hydrogen, while SMILES 1 has nitrogen atoms in the triazole ring (""N1C"") that can accept a hydrogen bond.","Moderate - This interaction could affect the binding affinity of one or both molecules to their respective targets, but is unlikely to cause a significant overall change without further contextual pharmacological information."
Lamotrigine,Metolazone,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Hydrogen Bonding,"A hydrogen bond may form between a hydrogen bond donor and a hydrogen bond acceptor. In SMILES 1, the NH group in the triazole ring can act as a hydrogen bond donor, while the carbonyl oxygen in the sulfonamide group of SMILES 2 can serve as a hydrogen bond acceptor.","SMILES 1 contains a hydrogen on the nitrogen atom in the triazole ring (C2=C(N=C(N=N2)N)), and SMILES 2 has a sulfonamide group with an oxygen (S(=O)(=O)N).",Moderate - This type of interaction could potentially influence binding affinity or solubility under biological conditions.
Famotidine,Trimethoprim,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors. In the given SMILES, some nitrogen atoms can act as hydrogen bond donors through their bonded hydrogen (e.g., -NH groups), while others, such as carbonyl oxygens and nitrogens, can serve as hydrogen bond acceptors.","- **SMILES 1** exhibits several hydrogen bond donor features (e.g., -NH in the guanidine-like moiety `N=C(N)N` and -NH adjacent to sulfonamide `NS(=O)(=O)N`).
- **SMILES 2** has nitrogen atoms as potential hydrogen bond acceptors in the triazolopyrimidine moiety `CN=C(N=C2N)N`.","Moderate - Hydrogen bonding is a common moderate-strength interaction that plays a significant role in drug-receptor and drug-drug interactions, potentially influencing binding affinity and pharmacodynamics."
Furosemide,desvenlafaxine,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor, such as an -OH group, and a hydrogen acceptor, such as a carbonyl oxygen or a sulfonyl oxygen.","In SMILES 1, the carboxylic acid group (C(=O)O) and the sulfonamide group (S(=O)(=O)N) contain oxygens capable of acting as hydrogen bond acceptors. In SMILES 2, there is a phenolic -OH group (C1=CC=C(C=C1)O) that can act as a hydrogen bond donor.","Moderate - Such interactions can influence binding affinity in biochemical contexts, potentially altering the pharmacokinetics or pharmacodynamics of the involved drugs."
Alprazolam,Sibutramine,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,Steric Clashes,"The bulky aromatic and cyclic groups in both SMILES could lead to steric clashes if they are in close proximity to each other. Steric clashes occur when the physical space occupied by groups from different molecules overlaps, leading to a physical barrier to interaction.","- SMILES 1 includes a fused benzene and pyrazole ring system with a chlorine-substituted phenyl group.
- SMILES 2 contains a 1-phenylcyclohexyl group with a chlorine atom on the phenyl ring.","Moderate - While steric clashes may hinder some molecular interactions or binding processes, they typically do not cause significant pharmacological interactions without a specific target context."
Doxazosin,Darunavir,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Hydrogen Bonding,"The SMILES strings indicate the presence of potential hydrogen bond donors and acceptors that can form a hydrogen bond interaction. In SMILES 1, the molecule contains an -NH group within the triazine ring structure, which is a possible hydrogen bond donor. In SMILES 2, the S(=O)(=O) group (sulfonamide functional group) incorporates oxygen atoms that can act as hydrogen bond acceptors.","- SMILES 1: The presence of an -NH group in the triazine ring (NC(=N)N) which can donate a hydrogen atom.
- SMILES 2: The sulfonamide group (S(=O)(=O)) that contains oxygen atoms capable of accepting hydrogen bonds.","Moderate - Hydrogen bonding can moderately influence solubility and drug-receptor interactions, impacting pharmacokinetic and pharmacodynamic profiles."
Doxazosin,Formoterol,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors. In these SMILES strings, there are multiple potential hydrogen bond donors and acceptors.","- From SMILES 1: The amine groups within the diazine ring (C1=C2N=CN=C1) and possible enolic forms can act as hydrogen bond acceptors.
- From SMILES 2: The hydroxyl (-OH) group attached to the aliphatic chain (CC(C2=CC(=C(C=C2)O)NC=O)O) can act as a hydrogen bond donor.","Moderate - The exact impact would depend on the spatial orientation and steric access of these groups within the physiological environment, but hydrogen bonding can significantly affect pharmacokinetic and pharmacodynamic properties."
Aciclovir,Lidocaine,C1=NC2=C(N1COCCO)NC(=NC2=O)N,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors found in the structures of the molecules. In physiological conditions, this usually occurs between electronegative atoms (like nitrogen or oxygen) bonded to hydrogen (hydrogen donor) and a lone pair on another electronegative atom (hydrogen acceptor).","- SMILES 1 contains an amine group (-NH) at the end of the structure as a potential hydrogen donor.
- SMILES 2 contains a carbonyl group (C=O) that can act as a hydrogen acceptor.","Moderate - Hydrogen bonding can affect the binding affinity and alter the pharmacokinetic properties of the drugs involved, potentially impacting their activity or effectiveness."
Zafirlukast,Rosiglitazone,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Hydrogen bonding,The presence of complementary hydrogen bond donor and acceptor groups in the structures.,"In SMILES 1, there is an amide group ""-C(=O)N-"" which can serve as a hydrogen bond donor or acceptor. In SMILES 2, there is a urea group ""-N(C=O)N-"" and a sulfonamide group ""-N(C=O)S-"" that can serve as hydrogen bond acceptor or donor sites.","Moderate - Considering the relevance of hydrogen bonding in drug interactions and molecular stability, this interaction could influence pharmacodynamics or pharmacokinetics under physiological conditions."
Tramadol,Ziprasidone,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor and a hydrogen bond acceptor, typically involving -OH or -NH groups as donors and -O, -N, or -Cl atoms as acceptors.","In SMILES 1, there is a hydroxyl group (O) which can act as a hydrogen bond donor. In SMILES 2, there is a carbonyl oxygen (C(=O)N) which can act as a hydrogen bond acceptor.","Moderate - Hydrogen bonding is considered a moderate interaction, impacting solubility and potentially affecting binding to targets."
Bumetanide,Ranolazine,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donors and acceptors. In SMILES 1, the carboxylic acid group (C(=O)O) acts as both a hydrogen donor and acceptor. SMILES 2 has a hydroxyl group (CC(COC3=CC=CC=C3OC)O), which is a potential hydrogen bond donor.","SMILES 1 contains a carboxylic acid group C(=O)O, and SMILES 2 contains a hydroxyl group O in CC(COC3=CC=CC=C3OC)O.","Moderate - Hydrogen bonding can significantly affect the pharmacokinetic properties by influencing solubility and binding characteristics, but the overall pharmacological impact would depend on the context in which these drugs are used."
Alprazolam,Lidocaine,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Hydrogen Bonding,A potential hydrogen bond donor-acceptor pair is present in the structures. The carbonyl oxygen (C=O) in SMILES 2 can act as a hydrogen bond acceptor. The aromatic nitrogen (N) in the triazole ring in SMILES 1 can act as a hydrogen bond donor owing to the possible presence of partial positive character on hydrogen neighbor atoms.,The carbonyl group (C=O) in the amide of SMILES 2 and the aromatic nitrogen atoms in the heterocycle of SMILES 1 indicate strong acceptor and donor potential respectively.,"Moderate - While hydrogen bonds can influence molecular interactions in biological systems, the overall pharmacological impact depends on binding pharmacokinetics and dynamics in vivo."
Naproxen,Minoxidil,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Hydrogen Bonding,The interaction occurs as a result of hydrogen bond donor and acceptor groups present within the molecular structures.,"In SMILES 1, the -OH group of the carboxylic acid can act as a hydrogen bond donor. In SMILES 2, the -N=C-N group in the pyrimidine ring can serve as a hydrogen bond acceptor due to the presence of multiple nitrogen atoms capable of hosting hydrogen bonds.","Moderate - This hydrogen bonding interaction could contribute to the stability of a drug-drug complex in physiological conditions, potentially affecting pharmacological availability."
Fentanyl,Dobutamine,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,Hydrogen Bonding,The hydrogen bond can occur between a hydrogen bond donor (hydroxyl group) in the second molecule and a hydrogen bond acceptor (carbonyl oxygen) in the first molecule.,"The second SMILES string contains hydroxyl groups (-OH) which can act as hydrogen bond donors, particularly the phenolic -OH group. The first SMILES string contains a carbonyl group (=O) as part of an amide which can act as a hydrogen bond acceptor. Specifically, in SMILES 1, the carbonyl oxygen is part of the amide group ""CCC(=O)N"", while SMILES 2's second aromatic ring has two hydroxyl groups ""C2=CC(=C(C=C2)O)O"".","Moderate - Hydrogen bonding could stabilize interactions between the molecules, potentially altering solubility or bioavailability, but is usually not the primary mode of potent pharmacological action."
Cimetidine,Duloxetine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Hydrogen Bonding,A potential hydrogen bond donor (primary amine -NH2) in SMILES 1 can form a hydrogen bond with possible acceptor atoms such as oxygen (O) in SMILES 2.,"SMILES 1 contains an amine group (-N) as part of the C(NC(N)=NC#N) structure, which can donate hydrogen. SMILES 2 contains an ether oxygen (O) in the motif OC2=CC=CC3=CC=CC=C32, which can accept hydrogen bonds.",Moderate - This interaction could influence the solubility or binding affinity in biological environments.
Orphenadrine,Sumatriptan,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Hydrogen Bonding,"The hydroxyl group (O-H) in SMILES 1 can act as a hydrogen bond donor, and the sulfonamide group (S(=O)(=O)N) in SMILES 2 has oxygen atoms and a nitrogen atom that can act as hydrogen bond acceptors.","- SMILES 1 has a hydroxyl group represented by ""OCC"" (where ""O"" is the hydroxyl group which can donate a hydrogen bond).
- SMILES 2 includes a sulfonamide group ""S(=O)(=O)"" and ""N"" which are capable of accepting hydrogen bonds.","Moderate - Hydrogen bonding could impact drug-solvent interactions or solubility, potentially affecting bioavailability or pharmacokinetics."
Alprazolam,Indapamide,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,π–π Stacking,π–π stacking occurs due to the interaction between aromatic rings present in both structures. These rings can stack in a parallel or offset fashion enhancing interaction.,"Both SMILES have aromatic rings: SMILES 1 contains a chlorophenyl and a phenyl ring, while SMILES 2 contains a phenyl ring and a chlorophenyl group. The presence of these aromatic systems suggests potential π–π stacking interactions under physiological conditions.","Moderate - π–π stacking can influence the binding affinity and distribution of drugs, potentially altering their pharmacological profiles."
Aciclovir,Dapsone,C1=NC2=C(N1COCCO)NC(=NC2=O)N,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen bond donors and acceptors. In drug molecules, common hydrogen bond donors include -NH and -OH groups, while common acceptors include carbonyl groups (>C=O) and amine groups (N).","- From SMILES 1, the nitrogen atom in the amine group (N) connected to the ring (C1=NC2=C(N1COCCO)NC(=NC2=O)N) can act as a hydrogen bond donor.
- From SMILES 2, the sulfonyl group (S(=O)(=O)) can act as a hydrogen bond acceptor due to the electronegative oxygens.","Moderate - Hydrogen bonding can affect molecular conformation and binding affinity to biological targets, potentially impacting the pharmacokinetic or pharmacodynamic properties of the drugs."
Furosemide,Lamotrigine,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Hydrogen Bonding,"The carboxylic acid group (-C(=O)O) in SMILES 1 can act as a hydrogen bond donor or acceptor. It can potentially form a hydrogen bond with the amino group (-N) in the tetrazole ring in SMILES 2, which can act as a hydrogen bond donor or acceptor.","In SMILES 1, the presence of the carboxylic acid group (-C(=O)O) is a typical hydrogen bond acceptor/donor. In SMILES 2, the amino group (-N) present in the tetrazole ring (highlighted by the sequence of alternating nitrogen and carbon atoms) can participate as a hydrogen bond donor or acceptor.",Moderate - Hydrogen bonding can influence binding affinity and stability in pharmacological scenarios.
Aciclovir,Pamidronic acid,C1=NC2=C(N1COCCO)NC(=NC2=O)N,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen bonding,"The presence of hydrogen bond donors and acceptors in both molecules allows for potential hydrogen bond interactions. In SMILES 1, the amine group (–NH) and carbonyl oxygen (=O) can participate as hydrogen bond donor and acceptor, respectively. In SMILES 2, the hydroxyl group (O-H) and phosphate oxygens (P(=O)(O)O) can serve as hydrogen bond donor and acceptors.","- SMILES 1: The group 'N' from the amines and 'O' from the carbonyl are potential donor and acceptor sites.
- SMILES 2: The group 'O' from the hydroxyl and 'P(=O)(O)O' (phosphate) offer donor and acceptor sites.",Moderate - Hydrogen bonds could influence binding interactions significantly but may not drastically alter pharmacological behavior without additional context.
Megestrol,Duloxetine,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Pi-Pi Stacking,"Pi-pi stacking is a non-covalent interaction between the aromatic rings of molecules. It occurs when the electron clouds of aromatic systems overlap, leading to attractive interactions.","The SMILES for the second molecule, ""OC2=CC=CC3=CC=CC=C32"", indicates a fused biphenyl-like aromatic system. Although the first SMILES does not have isolated aromatic rings, non-covalent stacking could still potentially occur between bicyclic or spirocyclic parts, but it’s speculative without clear aromatic units from SMILES 1.","Low - In the absence of strong evidence of an aromatic system in the first molecule's SMILES, any potential stacking interaction is speculative and likely weak. 

Upon further examination considering only reproducible SMILES 1, an additional spiro or multi-ring interaction could be speculated due to complex bicyclic structures but does not solidly categorize as pi-pi stacking without definitive aromatic rings.

This interaction considers only available structural geometry, resulting in a tentative suggestion rather than a solid conclusion due to partial evidence."
Ranitidine,Thalidomide,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Hydrogen Bonding,"The first molecule (SMILES 1) contains a nitro group (-N(=O)[O-]) and a secondary amine nitrogen (-N(C)C) that could potentially act as hydrogen bond acceptors. The second molecule (SMILES 2) contains a secondary amine (-NC(=O)-) and multiple carbonyl oxygen atoms (=O), which can act as hydrogen bond donors and acceptors, indicating the possibility for hydrogen bonding.","SMILES 1 features -N(=O)[O-] and -N(C)C, which are known to participate in hydrogen bonding. SMILES 2 includes carbonyl groups (=O) within a cyclic structure that can either donate or accept hydrogen bonds.",Moderate - This interaction could affect the pharmacokinetics or pharmacodynamics by altering solubility or binding characteristics under physiological conditions.
Ranitidine,Fosphenytoin,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Hydrogen Bonding,"The COOH group from the second SMILES (specifically the O=P(OH)(O) moiety) can form hydrogen bonds with the amino groups in the first SMILES, such as the amine connected to the CNC(=C[N+](=O)[O-]) moiety.","In SMILES 1, there are nitrogen atoms present in the CNC(=C[N+](=O)[O-])NCC moiety that can act as hydrogen bond donors. In SMILES 2, there are hydroxyl groups attached to the phosphorus and carbonyl oxygens that can act as hydrogen bond acceptors.","Moderate - This interaction could influence the pharmacokinetic properties, such as solubility or binding, without causing significant physiological interference."
Alprazolam,Gemfibrozil,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Hydrogen bonding,"The carbonyl group in the second SMILES (SMILES 2) can act as a hydrogen bond acceptor and potentially interact with any hydrogen bond donor that may be present in the first SMILES (SMILES 1). The nitrogen atoms within the heterocyclic rings in SMILES 1 can act as hydrogen bond acceptors, specifically those in the triazole ring.","- SMILES 1 contains nitrogen atoms within the triazole and pyrimidine rings (NN=C and C=N groups), which can act as hydrogen bond acceptors.
- SMILES 2 has a carbonyl group (C=O) which is typically a good hydrogen bond acceptor.","Low - While hydrogen bonds can affect interactions, their impact in terms of pharmacological interactions between these two structures without predefined hydrogen bond donors may be limited under physiological conditions."
Etiracetam,Erlotinib,CCC(C(=O)N)N1CCCC1=O,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,Hydrogen Bonding,"Hydrogen bonding can occur between the carbonyl group in SMILES 1 and the amine group in SMILES 2. The amide oxygen in SMILES 1 can act as a hydrogen bond acceptor, and the hydrogen from the amine group in SMILES 2 can act as a donor.","SMILES 1 contains the group C(=O)N, where the carbonyl oxygen could accept a hydrogen bond. SMILES 2 has the group C(=NC=N)-, where the primary amine nitrogen can donate a hydrogen.","Moderate - This interaction may stabilize the molecular complex, potentially affecting the bioactivity of the drugs."
Amphetamine,Modafinil,CC(CC1=CC=CC=C1)N,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,Hydrogen Bond,The interaction occurs between the amine group (N-H) of SMILES 1 and the carbonyl oxygen (C=O) of SMILES 2. Hydrogen bonds are facilitated by the presence of a hydrogen donor (N-H) and a hydrogen acceptor (C=O).,"In SMILES 1, the group ""-CC(CC1=CC=CC=C1)N"" contains an amine nitrogen with an available hydrogen. In SMILES 2, ""C(=O)N"" includes a carbonyl group with an oxygen that can act as a hydrogen bond acceptor.","Moderate - This interaction could impact how the molecules bind to enzymes or receptors, but its pharmacological impact depends on the specific context of their use."
Pamidronic acid,thiotepa,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,C1CN1P(=S)(N2CC2)N3CC3,Hydrogen Bonding,"The first compound has hydroxyl (-OH) groups and phosphate/phosphonate groups, which can act as hydrogen bond donors/acceptors. The second compound contains a phosphonothioate group with potential to form hydrogen bonds.","- SMILES 1: The presence of an -OH group and phosphate groups (P(=O)(O)O).
- SMILES 2: Phosphonothioate group (P(=S)(N)).","Moderate - While hydrogen bonds contribute to binding affinity, the presence of multiple potential donors and acceptors suggests a moderate impact."
Naproxen,alendronic acid,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,Hydrogen Bonding,"The carboxylic acid group in SMILES 1 has a hydroxyl group (–OH), which can act as a hydrogen bond donor. In SMILES 2, the phosphoric acid groups have oxygen atoms that can act as hydrogen bond acceptors.","SMILES 1 contains ""C(=O)O"", indicating a carboxylic acid group, and SMILES 2 contains ""P(=O)(O)O"", indicating phosphoric acid groups.",Moderate - The presence of potential hydrogen bond interactions could influence pharmacokinetic properties like solubility and receptor binding.
Carvedilol,Efavirenz,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,π-π Stacking,"The presence of aromatic rings in both structures allows for π-π stacking interactions, where aromatic rings align with each other due to the overlap of their electron clouds.","In SMILES 1, the aromatic rings are present in fragments like ""C1=CC=CC=C1"" and ""C2=CC=CC3=C2C4=CC=CC=C4"". In SMILES 2, the aromatic ring is part of ""C3=C(C=CC(=C3)Cl)"".",Moderate - π-π stacking can stabilize interactions under physiological conditions but may influence binding affinities and pharmacokinetics depending on the proximity and orientation of the rings.
Carvedilol,Dobutamine,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,Hydrogen Bonding,"This interaction occurs when a hydrogen atom covalently bonded to an electronegative atom, such as oxygen, forms a noncovalent interaction with another electronegative atom.","Both SMILES contain hydroxyl (OH) groups. In SMILES 1, there are hydroxyl groups in the fragments `C1=CC=C(O)C=C1` and `CC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O`. In SMILES 2, hydroxyl groups can be seen in `CCC1=CC=C(C=C1)O` and `C2=CC(=C(C=C2)O)O`. These groups are capable of forming hydrogen bonds with one another.","Moderate - Given that both drugs have multiple hydroxyl groups, the potential for forming hydrogen bonds is significant but would depend on their relative orientation and spatial arrangement, which cannot be fully determined from SMILES alone."
chlortalidone,Sildenafil,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,"Hydrogen bonding can occur between the hydrogen bond donors and acceptors present in these molecules. In the given SMILES, there are amide groups and sulfonamide groups that can participate in hydrogen bonding interactions.","- In SMILES 1, the amide group (C(=O)NC) and the sulfonamide group (S(=O)(=O)N) provide potential hydrogen bond donors and acceptors.
- In SMILES 2, the sulfonamide group (S(=O)(=O)N) and nearby functional groups (e.g., the secondary amine in the piperazine ring) can engage in hydrogen bonding.","Moderate - This type of interaction could affect pharmacokinetics and pharmacodynamics through potential binding affinities and solubility changes, but typically isn't as strong as ionic or covalent interactions."
Ibuprofen,Metoprolol,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Hydrogen Bonding,The carboxyl group (-C(=O)O) in SMILES 1 can act as a hydrogen bond acceptor due to the oxygen atoms. The hydroxyl group (-O) in SMILES 2 can serve as a hydrogen bond donor due to the presence of the hydrogen atom.,"In SMILES 1, the group C(=O)O indicates a carboxyl group, capable of accepting hydrogen bonds. In SMILES 2, the presence of an O atom adjacent to a C (indicated by -COC) with an attached hydroxyl group (suggested by the -OH terminus from the elaboration after the central chain) implies potential to donate a hydrogen bond.",Moderate - This interaction could potentially alter the solubility or the binding affinity of the drugs in their respective active sites or environments.
Candesartan,Citalopram,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,π-π Stacking,π-π stacking interactions occur when the aromatic rings from each compound align in a way that allows for electron cloud overlap between the rings. This type of interaction can stabilize the relative orientation of the two molecules.,"SMILES 1 contains several aromatic rings, notably the naphthalene-like biphenyl structure represented by ""CC3=CC=C(C=C3)C4=CC=CC=C4"". SMILES 2 contains an aromatic fluorobenzene ring ""C3=CC=C(C=C3)F"". The presence of these planar, electron-rich aromatic systems suggests the possibility of π-π interactions.","Moderate - This interaction may influence the relative orientation or binding affinity in a biological system, but the impact would heavily depend on the precise spatial arrangement, which is not fully determined by SMILES alone."
Ibuprofen,desvenlafaxine,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,Hydrogen Bonding,Hydrogen bonding can occur between the carboxylic acid group (-C(=O)O) in SMILES 1 and the phenol group (-C=C(C=C1)O) in SMILES 2.,"The carboxylic acid group in SMILES 1 has a proton donor (the hydroxyl hydrogen) and a carbonyl oxygen, both of which can participate in hydrogen bonding. The phenolic hydroxyl in SMILES 2 can serve as both a proton donor and acceptor.",Moderate - This hydrogen bonding potential may affect the binding affinity and solubility of the drugs when in proximity but is unlikely to prevent their primary pharmacological action significantly.
Ziprasidone,Desloratadine,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,π-π Stacking,"Both SMILES strings contain aromatic systems (benzene rings) that may align parallel to each other, allowing for π-π stacking interactions. These interactions occur when the electron clouds of the aromatic rings overlap, resulting in a non-covalent interaction.","SMILES 1 contains an aromatic system involving the thiophene and benzene groups within the ""C4=NSC5=CC=CC=C54"" section, and SMILES 2 contains several benzene rings, such as the ""C1CC2=C(C=CC(=C2)Cl)...C4=C1C=CC=N4"" sequence.",Moderate - π-π stacking interactions can influence the binding affinity and pharmacokinetics of the drugs but typically do not cause significant changes in pharmacology alone.
indometacin,Salmeterol,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Hydrogen Bonding,"Hydrogen bonding can occur between a proton donor and a proton acceptor. In these SMILES strings, the hydroxyl groups (-OH) on both molecules are potential sites for hydrogen bonds.","In SMILES 1, the carboxylic acid group (CC(=O)O) provides both a proton donor and an acceptor. In SMILES 2, there are multiple hydroxyl groups (e.g., -O in C2=CC(=C(C=C2)O)CO and the aliphatic alcohol in CCCCCNCC(C2=...)), which can act as hydrogen bond donors and acceptors.",Moderate - The presence of multiple hydroxyl groups and carboxylic acids could potentially lead to moderate pharmacological interaction through competition for hydrogen bonding in a physiological environment.
Lamotrigine,Salmeterol,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Hydrogen Bond,"The presence of a hydrogen bond donor in SMILES 2, specifically the hydroxyl group (-OH), can form a hydrogen bond with a nitrogen atom in the triazole ring of SMILES 1.",SMILES 1 contains a triazole ring with nitrogen atoms that can act as hydrogen bond acceptors (N). SMILES 2 has a phenolic hydroxyl group (O) that can act as a hydrogen bond donor.,"Moderate - This interaction could stabilize the complex between these two molecules, potentially impacting pharmacokinetics by influencing solubility or binding to other targets."
Gemfibrozil,Sildenafil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen bonding,A hydrogen bond can potentially form between the carbonyl oxygen of the ester group in SMILES 1 and the hydrogen on the sulfonamide N-H (implied by context even though explicit hydrogen is not shown in SMILES) in SMILES 2.,"The carbonyl group in SMILES 1 is represented by ""C(=O)"", and the sulfonamide group in SMILES 2 is represented by ""S(=O)(=O)N"", where the sulfonamide nitrogen might participate in hydrogen bonding.",Moderate - This type of interaction can influence the binding affinities of the molecules if they interact in a biological system.
alendronic acid,Pimecrolimus,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen bond donors and acceptors that are within a suitable distance. In this case, the amine group in SMILES 1 can act as a hydrogen bond donor, and the carbonyl oxygen in SMILES 2 can act as a hydrogen bond acceptor.","- SMILES 1 contains the primary amine group 'CN' which can donate hydrogen.  
- SMILES 2 contains multiple carbonyl groups '(C=O)' which can accept hydrogen bonds.","Moderate - This interaction can affect the binding affinity or solubility of the involved molecules, with potential moderate impact on their pharmacological behavior."
nevirapine,oxybutynin,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Pi-Pi Stacking,"Pi-pi stacking occurs between aromatic rings, where the electron clouds of the pi bonds overlap, resulting in attractive Van der Waals forces between the rings.","The first SMILES contains two aromatic rings, indicated by ""C1=C2C(=NC=C1)"" and ""C3=C(C=CC=N3)."" The second SMILES has an aromatic ring, ""C2=CC=CC=C2."" These structural features provide the planar aromatic systems required for pi-pi stacking interactions.","Moderate - This interaction may affect the pharmacokinetics and solubility of the drug molecules, especially at high concentrations, but its impact at physiological conditions is typically moderate."
Aciclovir,Doxazosin,C1=NC2=C(N1COCCO)NC(=NC2=O)N,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Hydrogen Bonding,The SMILES structures indicate that there are potential hydrogen bond donors and acceptors present in both molecules. These can participate in hydrogen bonding interactions with one another.,"- SMILES 1 contains an amine group (N) that can act as a hydrogen bond donor as well as a carbonyl group (C=O) that serves as a hydrogen bond acceptor.
- SMILES 2 contains several nitrogen atoms within an aromatic heterocycle and a methoxy group (OC) which can function as hydrogen bond acceptors.",Moderate - Hydrogen bonding interactions can significantly affect the binding affinity in molecular complexes and thereby influence pharmacological activity.
Diazepam,Duloxetine,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,π-π Stacking Interaction,"π-π stacking interaction occurs between aromatic rings. These interactions are typically driven by the overlap of π-electron clouds between aromatic systems, which can play a role in stabilizing the molecular interaction under physiological conditions.","The first SMILES has an aromatic phenyl group as part of the isoindole moiety (C3=CC=CC=C3), and the second SMILES also contains aromatic phenyl rings as evidenced by the fused aromatic system on the right side of the SMILES (OC2=CC=CC3=CC=CC=C32). The proximity and parallel orientation potential of these aromatic systems suggest possible π-π stacking.","Moderate - While π-π interactions are common in pharmacology, they depend on the relative orientation and position of the molecules, which can moderately impact drug activity or binding in a biological context."
Famotidine,Ticlopidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Hydrogen Bonding,"Hydrogen bonding can arise when a hydrogen atom, which is covalently bonded to an electronegative atom such as nitrogen, interacts with another electronegative atom, such as nitrogen or oxygen, which can act as a hydrogen bond acceptor.","In SMILES 1, there are amine groups (N=C(N)N) and a sulfonamide group (S(=O)(=O)N), both capable of engaging in hydrogen bonding. In SMILES 2, there are no apparent electronegative atoms directly bonded to hydrogen but there are potential lone pair donors like the sulfur atom in the thiophene ring (SC=C2), which may weakly interact with hydrogen donors under certain conditions.",Low - The lack of optimal geometric configuration or alignment and the limited presence of conventional hydrogen bond acceptors/donors suggests that this interaction would not be highly significant pharmacologically.
Alprazolam,Terazosin,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen Bonding,"Hydrogen bonding interactions are possible between hydrogen bond donors and acceptors. In SMILES 1, there are nitrogen atoms in ring structures which can act as hydrogen bond acceptors. In SMILES 2, there is an amine group (N) in the piperazine ring which can serve as a hydrogen bond donor.",SMILES 1 contains nitrogen in the triazole and pyrimidine rings capable of accepting hydrogen bonds. SMILES 2 has a secondary amine in the piperazine ring (N3) capable of donating hydrogen bonds.,"Moderate - The interaction could potentially influence binding affinity if both molecules are present in a biological system, but would depend on the specific physiological context."
Amlodipine,Cinacalcet,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,π-π Stacking,"Both SMILES structures feature aromatic rings that can engage in π-π stacking interactions, a common non-covalent interaction where electron clouds of aromatic rings overlap, stabilizing the complex.","- SMILES 1 contains an aromatic phenyl group within the portion ""C2=CC=CC=C2Cl"".
- SMILES 2 contains a biphenyl structure ""C1=CC=CC2=CC=CC=C21"".","Moderate - π-π interactions can contribute to the binding affinity between molecules, potentially affecting the pharmacokinetics if these drugs are co-administered."
Candesartan,Pamidronic acid,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bond,The interaction can occur between the hydrogen bond donor (hydroxyl group in the phosphate moiety) and a hydrogen bond acceptor (carbonyl group and possibly a nitrogen atom in the heterocyclic rings in the first molecule) under physiological conditions.,"In SMILES 1, the carbonyl group (C(=O)O) is a potential hydrogen bond acceptor. SMILES 2 contains hydroxyl groups (P(=O)(O)O) which serve as hydrogen bond donors.","Moderate - Hydrogen bonding can influence the pharmacokinetics or solubility of the drugs, but may or may not lead to significant pharmacological interactions depending on the biological context."
alendronic acid,Salmeterol,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Hydrogen Bonding,Hydrogen bonds can form between hydrogen atoms attached to electronegative atoms (such as nitrogen or oxygen) and lone pair electrons on another electronegative atom.,"- From SMILES 1: The functional group with hydroxyl (OH) in ""CC(O)(P(=O)(O)O)"" can act as a hydrogen bond donor.
- From SMILES 2: The phenolic OH in ""C2=CC(=C(C=C2)O)"" can act as a hydrogen bond donor or acceptor, and the ether oxygen in ""CCCCO"" and ""CO"" groups can accept hydrogen bonds.","Moderate - The presence of multiple functional groups capable of hydrogen bonding can influence the pharmacokinetics and solubility of the drugs, which might affect their bioavailability or metabolic pathways."
alendronic acid,Alprazolam,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,Hydrogen bonding,"The primary amine group (CN) in SMILES 1 can act as a hydrogen bond donor, while the nitrogen atoms in the triazine ring (N1 and N2) in SMILES 2 can act as hydrogen bond acceptors.",SMILES 1 contains the segment CN indicative of an amino group where nitrogen has a lone pair that can donate hydrogen. SMILES 2 contains several aromatic nitrogen atoms in the heterocyclic rings which can accept hydrogen bonds.,"Moderate - Potential hydrogen bonding can influence the binding affinity between the two molecules under physiological conditions, affecting pharmacokinetic and pharmacodynamic profiles."
Fentanyl,Nimodipine,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,π-π stacking,"This interaction occurs between aromatic rings present in both structures, allowing the electron clouds of the rings to overlap. This stacking can stabilize the interaction between two aromatic systems.","SMILES 1 contains two phenyl groups (C3=CC=CC=C3 and C2=CC=CC=C2), while SMILES 2 features an aromatic ring (C2=CC(=CC=C2)[N+](=O)[O-]). These structures are capable of participating in π-π stacking interactions.","Moderate - Such stacking interactions can influence how drugs interact at biochemical targets or with metabolic enzymes, potentially altering efficacy or metabolism."
Aciclovir,Citalopram,C1=NC2=C(N1COCCO)NC(=NC2=O)N,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor and a hydrogen bond acceptor. In physiological conditions, the presence of amine and amide groups in one SMILES and nitrile and fluorine in the other allows for potential hydrogen bond interactions.","- SMILES 1 contains amine (N) and hydroxyl (O) groups that can serve as hydrogen bond donors or acceptors.
- SMILES 2 includes a nitrile (C#N) and an aromatic fluorine (F) which can serve as hydrogen bond acceptors.",Moderate - Likely potential for hydrogen bonding under physiological conditions which could affect binding or solubility.
Lidocaine,Pamidronic acid,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen bonding,"The interaction occurs between a hydrogen bond donor in one molecule and a hydrogen bond acceptor in the other. In this case, the amide oxygen (=O) in the first SMILES can act as a hydrogen bond acceptor, while the hydroxyl group (O-H) in the second SMILES can act as a hydrogen bond donor.","The first SMILES contains an amide group with an oxygen (C(=O)N), which is capable of accepting hydrogen bonds. The second SMILES contains phosphoric acid groups with hydroxyls (P(=O)(O)O) that can donate hydrogen bonds.","Moderate - Hydrogen bonding can influence solubility and binding, affecting drug bioavailability and interaction, but the overall pharmacological impact depends on the context of these drugs in a biological system."
Triazolam,Exemestane,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,π-π Stacking,"π-π stacking interactions occur between aromatic rings due to the overlap of the pi electron clouds, which can lead to stabilization between the two molecules.","SMILES 1 contains two chlorophenyl groups (C3=C(C=C(C=C3)Cl) and C4=CC=CC=C4Cl) that are aromatic, and SMILES 2 contains an aromatic cyclohexene (C4=CC(=O)C=CC34C), indicating the potential for π-π interactions between these aromatic rings.","Moderate - π-π stacking can influence the binding orientation and affinity of drugs, potentially affecting pharmacodynamics and pharmacokinetics."
Efavirenz,oxybutynin,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Steric Clash,"A steric clash can occur due to the close proximity of bulky groups from both drug molecules, which could cause physical interference or spatial hindrance.","- SMILES 1 contains a cyclopropane ring (C1CC1) and a trifluoromethyl group (C(F)(F)F) attached to a carbon atom also linked to an aromatic ring.
- SMILES 2 contains a large, bulky group featuring a tert-butyl ester segment (C(C1CCCCC1)(C2=CC=CC=C2)O) and an aromatic ring.
- The presence of these bulky groups in close proximity might lead to spatial hindrance.","Moderate - Steric clashes could affect the conformation and possible interactions of each molecule with their respective targets, potentially altering pharmacological effects."
Amlodipine,Dexpramipexole,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CCCNC1CCC2=C(C1)SC(=N2)N,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor group, such as a primary or secondary amine, and an acceptor group like a carbonyl oxygen or amide nitrogen.","- SMILES 1 contains a carbonyl group (C(=O)) in the ester and another in the amide, which can act as hydrogen bond acceptors.
- SMILES 2 contains an amino group (N) in the guanidine-like moiety (NC1CCC2=C(C1)SC(=N2)N), which can act as a hydrogen bond donor.","Moderate - Depending on the proximity and orientation of the interacting groups, hydrogen bonding can significantly affect the drugs' binding properties and bioavailability."
Amlodipine,Thalidomide,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Hydrogen Bonding,"Hydrogen bonding can occur when a hydrogen atom, covalently bonded to an electronegative atom like nitrogen or oxygen, interacts with another electronegative atom with lone pairs located on the other molecule.","In SMILES 1, the amide nitrogen (NC) within the pyrrolidine ring has hydrogen atoms that could act as hydrogen bond donors. In SMILES 2, the carbonyl oxygens (C(=O) groups) in the lactam and in the isocoumarin structures could act as hydrogen bond acceptors, facilitating potential hydrogen bonding to the hydrogen on the nitrogen of SMILES 1.","Moderate - The presence of multiple carbonyl groups in close proximity may facilitate hydrogen bonding under physiological conditions, influencing the pharmacokinetic or pharmacodynamic properties of either compound."
Naproxen,Temazepam,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor group in one molecule and an acceptor group in another. In physiological conditions, polar groups with hydrogen atoms (often part of hydroxyl, amino, or carboxyl groups) can interact with electronegative atoms like nitrogen or oxygen that have lone pairs.","In SMILES 1, the carboxylic acid group 'C(=O)O' could act as a hydrogen bond donor and acceptor. In SMILES 2, the amide group 'C(=NC(C1=O)O)' can likewise function as a hydrogen bond donor and acceptor due to its electronegative oxygen and nitrogen.",Moderate - The ability of these molecules to form one or more hydrogen bonds could stabilize a complex or influence the molecules' bioavailability or binding to similar sites.
Diazepam,Formoterol,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Hydrogen Bonding,The hydroxyl group (-OH) in SMILES 2 can form a hydrogen bond with the carbonyl oxygen (=O) in SMILES 1.,"SMILES 1 contains a carbonyl group (C=O) from the structure ""C(=O)"" present in the lactam ring, which can act as a hydrogen bond acceptor. SMILES 2 includes a hydroxyl group in the structure ""C(C2=CC(=C(C=C2)O)"" which can act as a hydrogen bond donor.","Moderate - While hydrogen bonds can contribute to molecular interactions, the pharmacological impact is often contingent on the specific context of the interaction and concentration of the drugs."
Ranitidine,gadoversetamide,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],Hydrogen bonding,The presence of several carbonyl (C=O) groups in SMILES 2 could potentially form hydrogen bonds with the NH or OH groups or other polar regions in SMILES 1 under physiological conditions.,"SMILES 1 contains an OH group in the oxirane ring (C1=CC=C(O1)), which can act as a hydrogen bond donor. SMILES 2 has multiple C=O groups (carbonyl) which can act as hydrogen bond acceptors.",Moderate - Due to the potential multiple hydrogen bond interactions that could stabilize a drug-protein complex or modify bioavailability slightly.
Naproxen,Lamotrigine,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Hydrogen bonding,"The carboxyl group (-C(=O)O) in SMILES 1 can act as a hydrogen bond donor or acceptor, and the amino group (-NH2) in the triazole ring of SMILES 2 can act as a hydrogen bond donor. Under physiological conditions, these groups could form a hydrogen bond.","- SMILES 1 has a carboxyl group (C(=O)O) which can participate in hydrogen bonding.
- SMILES 2 has an amino group (N) in the triazole ring (C2=C(N=C(N=N2)N)), providing an H donor site for such interactions.","Moderate - Hydrogen bonds can significantly impact binding affinities and pharmacological interactions depending on the context, such as proximity and orientation of the molecules."
Carvedilol,Dexpramipexole,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CCCNC1CCC2=C(C1)SC(=N2)N,Hydrogen bonding,"Hydrogen bonds can form between a hydrogen donor and an acceptor. The first molecule contains an amino group (NCC), which can act as both a hydrogen bond donor and acceptor, engaging with the sulfur-containing heterocycle or nitrogen atoms in the second molecule.","- In SMILES 1, the amino group (NCC) can act as a hydrogen donor.
- In SMILES 2, the nitrogen in the thiazole ring and the nitrogen at the end of the chain (C(=N2)N) can act as hydrogen bond acceptors.","Moderate - Given the potential for hydrogen bonding, this interaction could impact the pharmacokinetic or pharmacodynamic properties of the involved drugs under physiological conditions."
phenytoin,Dapsone,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Hydrogen bonding,"A hydrogen bond can potentially form between a hydrogen donor in one molecule and an acceptor in the other molecule, stabilizing the interaction under physiological conditions.","- In SMILES 1, the structure includes an amide group represented by ""C(=O)N"", which contains both a possible hydrogen donor (the nitrogen of the amide group could have a hydrogen attached) and a hydrogen bond acceptor (the carbonyl oxygen).
- In SMILES 2, the sulfonamide group ""S(=O)(=O)"" is a strong hydrogen bond acceptor (due to the electronegative oxygen atoms), and the amine group ""C=C1N"" could act as a hydrogen donor if protonated under physiological conditions.",Moderate - Hydrogen bonds are common in drug interactions and can have moderate impacts depending on the overall pharmacokinetics and pharmacodynamics of the drugs involved.
Celecoxib,Propofol,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC(C)C1=C(C(=CC=C1)C(C)C)O,Hydrogen Bonding,"The phenolic hydroxyl group (-OH) from SMILES 2 can act as a hydrogen donor, while the sulfonamide group (S(=O)(=O)N) in SMILES 1 can act as a hydrogen acceptor.","In SMILES 1, the group S(=O)(=O)N suggests the presence of oxygen atoms in the sulfonamide that can accept hydrogen bonds. In SMILES 2, the presence of the -OH group can donate hydrogen to form hydrogen bonds.","Moderate - Hydrogen bonding is a common interaction that can modulate solubility and affect binding affinity, impacting pharmacological properties."
Gabapentin,Lamivudine,C1CCC(CC1)(CC(=O)O)CN,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Hydrogen Bonding,"The SMILES of the two molecules suggest potential hydrogen bonding due to the presence of carboxylic acid (-COOH) in SMILES 1 and an amide group (C=O and NH) in SMILES 2. The carboxylic acid group can act as a hydrogen bond donor through its hydroxyl hydrogen and acceptor through its carbonyl oxygen, while the amide group can act as a hydrogen bond donor through its NH group and acceptor through its carbonyl oxygen.","In SMILES 1, the carboxylic acid group ""CC(=O)O"" provides an -OH hydrogen donor and a C=O acceptor. In SMILES 2, the ""NC=O"" within the bicyclic structure provides an NH donor and a C=O acceptor for hydrogen bonding.","Moderate - Hydrogen bonding can significantly affect the pharmacokinetics and pharmacodynamics of drugs, influencing solubility, permeability, and binding affinity to other biological targets."
Norfloxacin,Sorafenib,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors (such as -NH or -OH groups) and acceptors (such as carbonyl oxygens or fluorine atoms). In SMILES 1, there is a carboxylic acid group (C(=O)O), which can act as both a hydrogen donor and acceptor. In SMILES 2, there are several carbonyl groups (C=O) which can act as hydrogen bond acceptors.","In SMILES 1, the presence of C(=O)O indicates a carboxylic acid group capable of donating or accepting hydrogen bonds. In SMILES 2, the groups CNC(=O) and NC(=O)NC indicate amide groups, which have carbonyl oxygens capable of accepting hydrogen bonds from the acidic hydrogen in the carboxylic acid of SMILES 1.","Moderate - Hydrogen bonding can significantly influence pharmacokinetics and the binding affinity of drugs to their target proteins or other molecules, potentially affecting efficacy or metabolism."
Candesartan,Famotidine,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor and an acceptor. In SMILES 1, the carboxylic acid group (C(=O)O) can potentially act as a hydrogen bond donor. In SMILES 2, the sulfonamide group (S(=O)(=O)N) contains oxygen atoms capable of acting as hydrogen bond acceptors.","SMILES 1 contains ""C(=O)O"" which indicates the presence of a carboxylic acid, while SMILES 2 contains ""S(=O)(=O)N"" which includes oxygens that are potential hydrogen bond acceptors.","Moderate - Hydrogen bonds are moderate strength interactions and could influence binding affinity or stability, though much depends on the spatial orientation which cannot be deduced from SMILES alone."
Rofecoxib,Zolpidem,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,π-π Stacking,Both SMILES strings contain aromatic rings capable of engaging in π-π stacking interactions. These interactions occur between the delocalized electrons of the overlapping π systems within the aromatic structures.,"SMILES 1 contains phenyl groups at C1=CC=C and C3=CC=CC=C. SMILES 2 contains aromatic rings C1=CC=C and C=C3, with potential alongside other aromatic systems in the heterocyclic component.",Moderate - π-π stacking can influence the pharmacokinetic and pharmacodynamic properties of drugs by affecting molecular orientation and complex formation.
Modafinil,Pamidronic acid,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,"The second SMILES string contains phosphoric acid groups (P(=O)(O)O), which have hydroxyl groups that can act as hydrogen bond donors or acceptors. The first SMILES string has an amide group (C(=O)N), where the oxygen can act as a hydrogen bond acceptor.","In the first SMILES, the presence of the amide group, particularly the carbonyl oxygen (C(=O)), can potentially form hydrogen bonds with the hydroxyl groups (O-H) present in the phosphoric acid groups in the second SMILES.","Moderate - This potential hydrogen bonding interaction could stabilize or alter the conformation and solubility of the drugs when in proximity, impacting their bioavailability and activity under physiological conditions."
Fluorouracil,Indapamide,C1=C(C(=O)NC(=O)N1)F,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,Hydrogen Bonding,"The carbonyl group (C=O) in SMILES 1 has a partially negative oxygen that can hydrogen bond with hydrogens attached to electronegative atoms in SMILES 2. Specifically, the amine group (-NH-) forming part of the five-membered ring in SMILES 2 can act as a hydrogen bond donor due to the presence of hydrogen bound to nitrogen.","SMILES 1 has an oxygen in the C=O group (C1=C(C(=O)NC(=O)N1)F), and SMILES 2 has a secondary amine group in the piperazine ring (CC1CC2=CC=CC=C2N1N) that can donate hydrogen.","Moderate - Hydrogen bonds can influence drug binding and solubility, potentially affecting pharmacokinetics."
Carvedilol,Pilocarpine,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CCC1C(COC1=O)CC2=CN=CN2C,Hydrogen bonding,A hydrogen bond may form between a hydrogen bond donor (N-H or O-H) from one molecule and a hydrogen bond acceptor (N or O) from the other molecule.,"In SMILES 1, ""COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O"" contains an -OH group (phenolic hydroxyl) and a secondary alcohol group. These hydroxyl groups can act as hydrogen bond donors. In SMILES 2, ""CCC1C(COC1=O)CC2=CN=CN2C"" contains an =O in the ester moiety and several nitrogen atoms in the imidazole group, which can act as hydrogen bond acceptors.",Moderate - The potential hydrogen bonding could impact the solubility or alter the pharmacokinetic behavior of these compounds when administered together.
Ondansetron,Telmisartan,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Pi-Pi Stacking,Pi-Pi stacking occurs between aromatic rings when the electron cloud of one aromatic ring aligns with that of another. This interaction is primarily driven by the quadrupole moment of the aromatic systems.,"Both SMILES 1 and SMILES 2 contain aromatic rings. SMILES 1 has an indole-like structure (specifically the phenyl and pyrrole fused rings) represented by ""C3=C(C2=O)C4=CC=CC=C4N3"". SMILES 2 contains a biphenyl system as well (""C3=CC=C(C=C3)C4=CC=CC=C4""). The proximity of these aromatic systems can facilitate this interaction through stacking.","Moderate - Pi-Pi stacking can have a noticeable impact on drug binding affinity and pharmacokinetics, but generally, it does not fundamentally alter the pharmacological effects unless critical to the active site binding or receptor alignment."
Celecoxib,Pirbuterol,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donor and acceptor groups present in the two molecules under physiological conditions, facilitating interactions between them.","- In SMILES 1: The sulfonamide group ""S(=O)(=O)N"" contains oxygens that can act as hydrogen bond acceptors.
- In SMILES 2: The hydroxyl groups ""C(C1=NC(=C(C=C1)O)CO)O"" provide hydrogen atoms capable of donating hydrogen bonds.","Moderate - Hydrogen bonding can influence drug solubility, bioavailability, and receptor interactions, potentially affecting pharmacological activity."
Furosemide,vincristine,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen Bonding,"SMILES 1 contains a carboxylic acid group (-C(=O)O) which can act as a hydrogen bond donor and acceptor. SMILES 2 contains multiple carbonyl groups (-C(=O)OC), which can act as hydrogen bond acceptors. The hydrogen from the carboxylic acid in SMILES 1 could potentially form a hydrogen bond with the carbonyl oxygen in SMILES 2, facilitating interaction.","SMILES 1 has a -C(=O)O group, indicating possible hydrogen bond formation. SMILES 2 includes -C(=O)OC groups, which can accept hydrogen bonds.","Moderate - Due to the potential stabilizing effect and proximity of these functional groups under physiological conditions, this interaction could influence the pharmacokinetic properties such as solubility or binding affinity."
Carvedilol,Famotidine,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Hydrogen bonding,The presence of an -OH group (hydroxyl) in SMILES 1 and the presence of amine groups (N and NH) in SMILES 2 allows for potential hydrogen bonding interactions. The hydrogen atom of the hydroxyl group can form a hydrogen bond with the lone pair of electrons on the nitrogen atoms.,"In SMILES 1, the hydroxyl group is present as ""O"" attached to the aromatic ring. In SMILES 2, the nitrogen-containing groups ""NC"", ""N=C"", and ""N"" can serve as hydrogen bond acceptors or donors due to the lone pairs on nitrogen atoms.","Moderate - Hydrogen bonding can significantly impact drug binding and solubility under physiological conditions, affecting pharmacokinetic or pharmacodynamic profiles. However, the actual impact depends on the spatial orientation and availability of these groups in vivo."
Candesartan,Thalidomide,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Hydrogen Bonding,Hydrogen bonding can occur between hydrogen donors (such as NH groups) and acceptors (such as carbonyl oxygen atoms). The SMILES structures indicate potential donor and acceptor pairs that could form hydrogen bonds under physiological conditions.,"In SMILES 2, the structure contains an amide group (-CONH-) with a hydrogen donor (NH) and carbonyl oxygen acceptor (C=O). SMILES 1 includes a carboxyl group (C(=O)O) which acts as a hydrogen bond acceptor and potentially as a donor from the hydroxyl group.","Moderate - This interaction could affect the relative binding affinities or solubility of the drugs, influencing absorption or distribution in the body."
Gabapentin,Ziprasidone,C1CCC(CC1)(CC(=O)O)CN,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Hydrogen Bonding,Hydrogen bonds can form between hydrogen donors like NH (from the amine group in SMILES 1) and hydrogen acceptors like the carbonyl oxygen (C=O) in SMILES 2.,"In SMILES 1, the NH group on CN is a potential hydrogen bond donor. In SMILES 2, the carbonyl oxygen in the indole-like structure (between C3 and N3) is a likely hydrogen bond acceptor.","Moderate - Hydrogen bonds can significantly affect molecular interaction, potentially influencing the biological activity and efficacy of drugs in combination."
Citalopram,Terazosin,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Potential Hydrogen Bonding,"Hydrogen bonds can occur between a hydrogen atom bound to an electronegative atom (like nitrogen or oxygen) and another electronegative atom with a lone pair capable of forming a bond. In physiological conditions, hydrogen bonds play a significant role in molecular interactions.","- In SMILES 1, there is a nitrile group (C#N) which includes a nitrogen capable of accepting hydrogen bonds.
- In SMILES 2, there are multiple nitrogen atoms in the heterocyclic structure and oxygen atoms in the methoxy groups, any of which may participate in hydrogen bonding as donors or acceptors.","Moderate - While hydrogen bonds are significant, they are one of the weaker non-covalent interactions in terms of stability. However, they can influence drug binding affinity and specificity in biological systems."
Zolpidem,solifenacin,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,Pi-Pi Stacking,Pi-pi stacking interactions occur when aromatic rings in two different molecules align in parallel or offset stacking arrangements. These interactions are non-covalent and involve the overlap of pi-electron clouds in aromatic systems.,"In SMILES 1, there is an indole moiety with an aromatic ring structure containing a pyrrole and a benzene ring. In SMILES 2, a phenyl ring is present. The presence of multiple aromatic rings in close proximity can lead to pi-pi stacking.",Moderate - This interaction could influence the pharmacokinetics or binding affinity of the molecules if they are capable of forming a stable complex through this interaction.
Rofecoxib,Torasemide,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen bonding,"A hydrogen bond can potentially form between a hydrogen donor group from SMILES 2 and an acceptor group from SMILES 1. Specifically, the N-H group in the sulfonamide segment of SMILES 2 can act as a hydrogen donor, and the sulfonyl oxygen (S=O) groups in SMILES 1 can act as hydrogen acceptors.","In SMILES 2, there is an ""S(=O)(=O)N"" segment indicating sulfonamide, typically with an N-H bond. In SMILES 1, there is an ""S(=O)(=O)"" segment indicating sulfonyl oxygens which can act as hydrogen bond acceptors.",Moderate - This type of interaction can affect molecular binding potency and pharmacokinetics.
Celecoxib,Desloratadine,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,Pi-Pi Stacking,"Pi-pi stacking occurs due to the overlapping of the pi-electron clouds from the aromatic rings present in both molecular structures, which can stabilize the interaction in a biological context.","The SMILES of Drug 1 contains two benzene rings and a triazole ring, while Drug 2 contains two benzene rings. These structures are indicative of aromatic systems capable of engaging in pi-pi stacking.","Moderate - While pi-pi interactions can affect the binding properties of compounds with protein targets, such interactions are generally subtle and contingent upon precise geometric alignment."
Methylphenidate,Salmeterol,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Hydrogen Bonding,"The hydroxyl group (-OH) present on aromatic rings or aliphatic chains can act as hydrogen bond donors or acceptors. In SMILES 2, multiple hydroxyl groups are evident, which can form hydrogen bonds with the carbonyl oxygen in SMILES 1.","In SMILES 1, the ester group has a carbonyl oxygen (C=O) that can serve as a hydrogen bond acceptor. In SMILES 2, there are hydroxyl groups (represented as -OH), particularly the ""O"" in the segments like ""OCC"" which can donate hydrogen to interact with the carbonyl oxygen in SMILES 1.","Moderate - Hydrogen bonds, while generally weak, can influence drug binding affinity depending on the context, but typically have a moderate impact on the pharmacological profile when intermolecular."
Metoprolol,Perphenazine,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,Hydrogen Bonding,"A hydrogen bond can occur between a hydrogen atom attached to a more electronegative atom (donor) and an electronegative atom with a lone pair of electrons (acceptor). In the first SMILES, an alcohol group (-OH) is present, potentially acting as a hydrogen bond donor. In the second SMILES, the oxygen in the ether group (CCO) can act as a hydrogen bond acceptor.","SMILES 1 contains the group ""...C(COC1=CC=C(C=C1)CCOC)O"" with an -OH group capable of donating a hydrogen bond. SMILES 2 contains the sequence ""N(CCO)"" where the oxygen could act as an acceptor.",Moderate - This interaction could influence the solvation and binding characteristics of the molecules when in proximity to each other within a biological environment.
Lamotrigine,oxybutynin,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor and an acceptor. In SMILES 1, the NH group in the hydrazine moiety (N=N) and the amine group (NH) can act as hydrogen bond donors. In SMILES 2, the carbonyl oxygen (C=O) can act as a hydrogen bond acceptor.","- SMILES 1 contains a hydrazine moiety ""N=N"" with an adjacent ""NH"" group capable of donating hydrogen bonds.
- SMILES 1 contains an amine group ""N"" that can donate hydrogen bonds.
- SMILES 2 contains a ""C(=O)"" group, where the oxygen can accept hydrogen bonds.",Moderate - Hydrogen bonding is a common interaction that can influence the pharmacokinetic properties of drugs without necessarily causing significant adverse effects.
acetazolamide,Celecoxib,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Hydrogen Bonding,"The interaction occurs due to the presence of hydrogen bond donors and acceptors in both molecules. Hydrogen bond donors (NH groups) in SMILES 1 can interact with acceptor atoms (N or O) in SMILES 2, or vice versa.","- SMILES 1 contains an NH group: ""S(=O)(=O)N"", where the NH can donate a hydrogen.
- SMILES 2 has sulfonamide ""S(=O)(=O)N"", where the sulfone oxygen can act as a hydrogen bond acceptor.","Moderate - The hydrogen bonds could affect the binding affinity or solubility of one or both drugs, impacting their pharmacological behavior."
Naproxen,Torasemide,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen Bonding,"A hydrogen bond can form between a hydrogen donor group in one molecule and an acceptor group in the other under physiological conditions, such as between a carbonyl oxygen or sulfonyl oxygen and an acidic hydrogen.","- In SMILES 1, there is a carboxylic acid group (C(=O)O) which can act as both a hydrogen bond donor and acceptor.
- In SMILES 2, there is a sulfonamide group (S(=O)(=O)N) where the sulfonyl oxygens can be hydrogen bond acceptors, and the adjacent NH group can be a hydrogen bond donor.","Moderate - This interaction could potentially affect the solubility or binding of these compounds if they are in proximity, influencing their pharmacological profiles."
Famotidine,Lamotrigine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Hydrogen bonding,"Hydrogen bonding occurs between a hydrogen atom attached to a nitrogen or oxygen atom in one molecule and an electronegative atom (such as nitrogen, oxygen, or sulfur) in the other molecule.","- SMILES 1 contains amino groups (-N=C(N)N and -NS(=O)(=O)N) which have hydrogen atoms capable of forming hydrogen bonds.
- SMILES 2 contains amino groups (-N) and azide (-N=N-) units that can also participate in hydrogen bonding either as donors or acceptors.
- The sulfur-containing group in SMILES 1 (N=CSCCC(=NS(=O)(=O)N)N) and the nitrogen-rich group in SMILES 2 (N=C(N=N)N) may interact through hydrogen bonding given the proximity of their hydrogen donor and acceptor groups.","Moderate - Hydrogen bonding can affect molecular recognition and binding, potentially influencing drug efficacy or interaction."
Cetirizine,desvenlafaxine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,Hydrogen Bonding,A hydrogen bond can potentially form between the hydroxyl group (–OH) of the second molecule and the carbonyl group (C=O) of the first molecule. Hydrogen bonds are typical between an electronegative atom with a lone pair (such as oxygen in –OH) and a hydrogen attached to an electronegative atom (such as oxygen in C=O).,"In SMILES 1, there is a carbonyl group (C=O) within the ester moiety, and in SMILES 2, there is a hydroxyl group (–OH) on the aromatic ring.","Moderate - Hydrogen bonding is a common and significant interaction in biological systems, influencing compound solubility and receptor binding affinity."
Duloxetine,desvenlafaxine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,Hydrogen Bonding,Hydrogen bonding can occur between the hydroxyl group (–OH) in SMILES 2 and the ether oxygen (–O–) in SMILES 1.,"SMILES 1 contains “OC2=...”, indicating the presence of an ether oxygen, while SMILES 2 has “C(C1=...O)C2”, indicating a hydroxyl group. These groups can potentially interact via hydrogen bonding.",Moderate - Hydrogen bonding can significantly influence binding and interaction in a biological context.
Celecoxib,Midodrine,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,Hydrogen Bonding,"The presence of hydrogen bond donors and acceptors within both molecules allows for potential hydrogen bonds to form between them. Specifically, an NH group in SMILES 1 could serve as a hydrogen bond donor, while an oxygen atom in the methoxy group of SMILES 2 could act as a hydrogen bond acceptor.","- In SMILES 1, the sulfonamide group (S(=O)(=O)N) contains oxygen atoms which can participate in hydrogen bond interactions either as acceptors or donors.
- In SMILES 2, methoxy groups (OC) consist of oxygen capable of accepting hydrogen bonds, and the presence of an alcohol group (C(C)O) along with amide group (NC(=O)) provide potential donor sites.","Moderate - The presence of these functional groups can influence the drugs' solubility and intermolecular interactions, pertinent in physiological environments."
Amlodipine,Furosemide,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Hydrogen Bonding,"The hydrogen bonding interaction could potentially occur between donor-acceptor groups present in each of the SMILES strings. In SMILES 1, the secondary amine nitrogen in the heterocyclic structure is capable of hydrogen bonding. In SMILES 2, the carboxyl group provides a hydrogen bond donor (OH) and an acceptor (C=O).","- SMILES 1: The amine nitrogen in the fragment `NC(=C...` suggests a lone pair that could act as a hydrogen bond acceptor.
- SMILES 2: The carboxyl group `C(=O)O` has an OH, which can donate a hydrogen for bonding.","Moderate - Hydrogen bonding can influence drug solubility and permeability, potentially affecting pharmacokinetic profiles."
oxybutynin,Zaleplon,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,Pi-Pi Stacking,"Aromatic pi-pi stacking occurs between aromatic rings in each molecule, which can stabilize the molecules when they are in proximity to each other.","Both SMILES contain phenyl rings. In SMILES 1, C2=CC=CC=C2 represents a phenyl ring, and in SMILES 2, C1=CC=CC(=C1) represents another phenyl ring. These rings have the potential to engage in a pi-pi stacking interaction.",Moderate - Pi-pi stacking could influence binding affinity or selectivity in a pharmacological context.
Celecoxib,tolcapone,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],π-π Stacking,"π-π stacking occurs when aromatic rings are involved in non-covalent interactions, due to their ability to share electron cloud regions. This interaction can occur between the aromatic rings in proximity.","Both SMILES contain aromatic benzene rings: SMILES 1 has multiple benzene rings (e.g., `C1=CC=C(C=C1)`) and SMILES 2 also contains a benzene ring (`C1=CC=C(C=C1)`). These aromatic systems can potentially align and participate in π-π stacking interactions.","Moderate - While π-π interactions are generally weak compared to covalent or ionic bonds, they are significant in drug design due to their influence on molecular conformation and binding properties."
Temozolomide,Thalidomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Hydrogen Bonding,"Hydrogen bonding can occur due to the presence of a hydrogen bond donor in one molecule and a corresponding hydrogen bond acceptor in another. In this case, the amide groups present in both molecules can participate in hydrogen bonding.","In SMILES 1, the amide group is represented by the ""C(=O)N"" sequence, and in SMILES 2, the lactam structure ""NC(=O)"" and the carbonyl group in the diketone structure ""C(=O)"" can act as hydrogen bond donors and acceptors.",Moderate - This interaction could influence the molecules’ binding orientations or their solubility but depends on the overall molecular conformation and surrounding environment.
Haloperidol,indometacin,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor group (e.g., hydroxyl or amine group) and an acceptor group (e.g., a carbonyl oxygen), leading to potential non-covalent interactions.","In SMILES 1, there is an -OH group in the structure (evident from ""CCC1(C2=CC=C(C=C2)Cl)O"" part), which can act as a hydrogen donor. In SMILES 2, there is a carbonyl group (evident from ""CC(=O)O"" part), which can act as a hydrogen bond acceptor.","Moderate – This interaction could potentially stabilize a complex if these groups are spatially aligned, affecting bioavailability or efficacy under certain conditions."
Amlodipine,Ziprasidone,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Hydrogen Bonding,Possible hydrogen bonding could occur between the tertiary amine nitrogen in SMILES 1 and the carbonyl oxygen in the lactam group of SMILES 2.,"- SMILES 1 contains the sequence ""COCCN"", indicating the presence of an ether-linked chain terminating in a tertiary amine, which can accept hydrogen bonds.
- SMILES 2 contains ""CC(=O)N"", indicating a lactam with a carbonyl group that can donate a hydrogen bond.","Moderate - This interaction could influence binding affinity if both drugs interact with a biological molecule simultaneously, affecting pharmacokinetics or dynamics."
Citalopram,Thalidomide,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen bond donors and acceptors. In drug molecules, common donors are -NH, -OH groups, and common acceptors include -C=O, nitrile, and aromatic nitrogen atoms.",The second SMILES structure has multiple carbonyl groups (C=O) which can act as hydrogen bond acceptors. The first SMILES structure has an amine group (N in CN(C)) that can act as a hydrogen bond donor.,Moderate - Hydrogen bonds can significantly affect drug binding and solubility.
Norfloxacin,Zolpidem,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Hydrogen Bonding,"The carboxylic acid group in the first molecule can act as a hydrogen bond donor (or acceptor), and the carbonyl oxygen in the amide group of the second molecule can act as a hydrogen bond acceptor (or donor). This interaction can form a hydrogen bond between the hydrogen of the carboxylic acid in SMILES 1 and the carbonyl oxygen in SMILES 2 or vice versa.","SMILES 1 contains a ""C(=O)O"" group indicative of a carboxylic acid, while SMILES 2 contains a ""C(=O)N"" group indicative of an amide, presenting a potential pair for hydrogen bonding.","Moderate - This interaction could stabilize the proximity of the compounds within a biological context, potentially altering pharmacokinetic or pharmacodynamic properties."
Naproxen,Furosemide,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen atom bonded to an electronegative atom (such as oxygen or nitrogen) and an electronegative atom with a lone pair of electrons, such as oxygen or nitrogen. In this case, potential hydrogen bond donors and acceptors are present.",SMILES 1 contains a carboxylic acid group (`C(=O)O`) that can act as both a hydrogen bond donor and acceptor. SMILES 2 has an amine nitrogen (`CNC`) that can act as a hydrogen bond donor and a sulfonamide group (`S(=O)(=O)N`) that can act as a hydrogen bond acceptor as well.,"Moderate - Hydrogen bonds can significantly impact the molecular interaction and binding affinity, leading to potential pharmacological effects."
Fentanyl,Labetalol,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Hydrogen Bonding,"Hydrogen bonds can form between the carbonyl oxygen of a ketone or amide and hydrogen donors such as -OH or -NH groups. In physiological conditions, this is a common form of molecular interaction.","- SMILES 1 contains multiple carbonyl groups (C=O), specifically at the 'CCC(=O)N' and 'C(=O)N' positions.
- SMILES 2 has both hydroxyl (-OH) and amine (-NH) groups, particularly at the 'NCC(C2=CC(=C(C=C2)O)' showing potential hydrogen bond donors.","Moderate - This interaction can influence the pharmacokinetic properties of drugs, such as altering solubility, permeability, or binding affinity."
Temazepam,Cinacalcet,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,π-π Stacking,π-π stacking occurs between aromatic rings when they align in a way that allows for interactions between the π-electron clouds. This interaction is possible between the phenyl ring in SMILES 1 and the biphenyl structure in SMILES 2.,"SMILES 1 contains a phenyl ring represented by ""C3=CC=CC=C3"" and SMILES 2 features a biphenyl system ""C1=CC=CC2=CC=CC=C21"", both of which are capable of π-π stacking interactions due to their planar aromatic structures.",Moderate - π-π interactions can influence molecular recognition and binding but are generally less critical than other interactions like hydrogen bonds or ionic bonds in terms of pharmacological impact.
Ranitidine,Dobutamine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,Hydrogen bonding,Potential hydrogen bonding can occur between the hydroxyl groups in SMILES 2 and electronegative atoms or potential hydrogen bond acceptors in SMILES 1.,"SMILES 2 contains phenolic hydroxyl groups (-OH) that are capable of donating hydrogen bonds. In SMILES 1, the nitro group (N(=O)[O-]) contains oxygen atoms that can act as hydrogen bond acceptors.","Moderate - The presence of hydrogen bonding could impact the pharmacokinetic or pharmacodynamic properties by influencing solubility, stability, or the binding profile of the drugs."
Ofloxacin,Imatinib,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,Hydrogen bonding could occur between the carboxylic acid group in SMILES 1 and the amine group in SMILES 2.,"SMILES 1 contains a ""C(=O)O"" group, suggesting the presence of a carboxylic acid, which can act as a hydrogen bond donor or acceptor. SMILES 2 contains an amine group ""NC(=O)"" which could potentially serve as a hydrogen bond acceptor.",Moderate - This hydrogen bonding could influence drug solubility or receptor binding but typically does not lead to significant pharmacological interactions without specific spatial alignment.
alendronic acid,Sumatriptan,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Hydrogen Bonding,The hydrogen bond could occur between the hydrogen atoms of the hydroxyl groups in the phosphate moieties of SMILES 1 and the sulfonamide oxygen in SMILES 2.,"SMILES 1 includes hydroxyl groups as part of the phosphonate groups (P(=O)(O)O), which are potential hydrogen donors. SMILES 2 contains a sulfonyl group (S(=O)(=O)) which includes oxygen that can act as hydrogen bond acceptors.",Moderate - Hydrogen bonds can increase the affinity or alter the solubility between these molecules in a biological system.
alendronic acid,Ibuprofen,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Hydrogen bonding,The phosphate groups in SMILES 1 contain oxygen atoms with lone pairs that can act as hydrogen bond acceptors. The carboxylic acid group in SMILES 2 has both a hydrogen atom capable of donating a hydrogen bond and an oxygen atom that can accept hydrogen bonds.,"SMILES 1 has the substructure P(=O)(O)O, indicating the presence of hydroxyl groups and phosphates with acceptor ability, whereas SMILES 2 contains the C(=O)O substructure, indicating a carboxylic acid group with both a donor (OH) and an acceptor (C=O).","Moderate - Hydrogen bonding can significantly influence the solubility and binding of molecules, but whether it impacts pharmacological action depends on specific binding site involvement."
Naproxen,Terazosin,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen Bonding,"A hydrogen bond can form between a hydrogen bond donor in one molecule and a hydrogen bond acceptor in the other. In SMILES 1, the carboxylic acid group contains an -OH which can act as a hydrogen bond donor. In SMILES 2, there are multiple nitrogen atoms in the triazine ring that can serve as hydrogen bond acceptors.","SMILES 1 has the carboxylic acid group ""C(=O)O"" which provides the hydroxyl group for hydrogen bonding. SMILES 2 has the triazine ring ""C(=N)N"" with nitrogen atoms capable of accepting hydrogen bonds.","Moderate - The hydrogen bonding could influence the solubility or binding affinity when these molecules are present in the same environment, potentially affecting pharmacokinetics or pharmacodynamics."
Furosemide,Oxaprozin,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors between the two molecules. SMILES 1 contains a carboxylic acid group (-C(=O)O) which can act as both a hydrogen bond donor and acceptor. SMILES 2 also contains a carboxylic acid group, which can participate similarly.","In SMILES 1, the carboxylic acid group is represented by `C(=O)O`. In SMILES 2, the carboxylic acid group is similarly represented by `C(=O)O`.",Moderate - Hydrogen bonding is a common and moderate interaction which can influence drug solubility and binding but does not typically lead to drastic changes in pharmacological behavior unless part of a larger pattern of interactions.
Naproxen,Amoxapine,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,Pi-Pi Stacking,Pi-Pi stacking is an interaction that occurs between aromatic rings where electron clouds overlap. This interaction can stabilize the orientation of the molecules relative to each other.,The first SMILES contains a benzene ring connected to an ester (C1=CC2=C(C=C1...) while the second SMILES also contains a planar aromatic system (C2=NC3=CC=CC=C3). These planar aromatic structures can participate in pi-pi stacking interactions due to the proximity of electron-rich pi orbitals.,Moderate - Pi-Pi stacking can affect binding affinity and orientation of drug molecules with potential impacts on drug activity and metabolism.
Etiracetam,Ziprasidone,CCC(C(=O)N)N1CCCC1=O,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Hydrogen Bonding,"A hydrogen bond can occur between a hydrogen atom bonded to a highly electronegative atom (like oxygen or nitrogen) and a lone pair of electrons on another electronegative atom. In this case, the carbonyl group oxygen in SMILES 1 can act as a hydrogen bond acceptor, and the secondary amine hydrogen in SMILES 2 can act as a hydrogen bond donor.",The carbonyl oxygen in SMILES 1 (C(=O)N) provides a lone pair that can accept a hydrogen bond. The nitrogen in the piperazine ring of SMILES 2 (N in CN(CCN1)) has hydrogens that can potentially donate.,"Moderate - Given the presence of hydrogen bond capability on both drugs, this interaction could potentially affect their binding or solubility, but the overall physiological impact would depend on the context of their use and concentration."
Celecoxib,Chloroquine,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,Pi-Pi stacking,"Pi-Pi stacking occurs when aromatic rings interact through their pi-electron clouds, providing a non-covalent interaction that can stabilize the complex between two molecules.",SMILES 1 contains two benzene rings [(C1=CC=C(C=C1)] and SMILES 2 also contains an aromatic ring system with two interconnected ring structures [C1=C2C=CC(=CC2=NC=C1)]. These aromatic rings can participate in pi-pi stacking interactions.,"Moderate - While pi-pi stacking can influence molecular binding and pharmacodynamics, its direct impact may vary depending on the larger three-dimensional context of a drug-receptor interaction."
Ranitidine,Rosiglitazone,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Hydrogen bonding,The nitro group (–[N+](=O)[O-]) in SMILES 1 can act as a hydrogen bond acceptor due to the presence of electronegative oxygen atoms. The NH group in the thioamide moiety (–NC(=O)S–) in SMILES 2 can act as a hydrogen bond donor because of the presence of the hydrogen atom bonded to nitrogen.,"In SMILES 1, the nitro group contains oxygen atoms capable of hydrogen bonding, and in SMILES 2, the NH group provides a hydrogen atom for potential interaction.","Moderate - While individually these interactions may not be strong, in the context of a complex biological environment, they could potentially stabilize interactions between the molecules, affecting drug activity or binding to a target."
acetazolamide,Famotidine,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Hydrogen Bonding,"A hydrogen bond can occur between a hydrogen donor and a hydrogen acceptor. In the given SMILES, there is a potential interaction where an NH group acts as a hydrogen donor, and an oxygen atom in a sulfonamide group acts as a hydrogen acceptor.","In SMILES 1, the NH group from the sulfonamide (-S(=O)(=O)N) can serve as a hydrogen donor. In SMILES 2, the oxygen atom in the sulfonamide group (-S(=O)(=O)N) can serve as a hydrogen acceptor for the NH group from the first SMILES.","Moderate - Hydrogen bonding could stabilize a complex under physiological conditions, possibly influencing binding affinity but not causing a steric clash or serious interaction on its own."
Ketorolac,Ticlopidine,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,π-π Stacking,π-π stacking occurs when aromatic rings interact due to their cloud of delocalized electrons. The planar nature of aromatic rings allows them to align parallel to one another and stabilize their interaction.,Both SMILES strings contain benzene rings (C3=CC=CC=C3 in SMILES 1 and C3=CC=CC=C3 in SMILES 2). These aromatic rings present in the structures of both drugs suggest the possibility of π-π stacking.,Moderate - π-π stacking can affect the pharmacokinetic properties such as absorption and distribution but typically does not result in strong pharmacodynamic interactions.
Famotidine,Fosphenytoin,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Hydrogen bonding,"Hydrogen bonds can form between hydrogen atom donors and acceptors such as nitrogen, oxygen, or sulfur atoms with lone pairs. In physiological conditions, these interactions are crucial in binding and stability.","The first SMILES contains amine groups (-NH2) and sulfonamide groups (-S(=O)(=O)N) which can act as hydrogen bond donors and acceptors. The second SMILES has carbonyl oxygens (=O), phosphate oxygens, and potentially the amide nitrogen, which can function as acceptors.",Moderate - This interaction is common in biological systems and could affect the binding affinity and pharmacokinetics of the drugs involved.
Ranitidine,Sibutramine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,Steric Clashes,"The presence of bulky groups within close proximity in both SMILES strings can lead to steric clashes, potentially affecting how these molecules might fit into binding sites or interact with other molecules.",The first SMILES contains a secondary amine (NCCSCC1) and a bulky group with aromatic rings (C1=CC=C(O1)CN(C)C). The second SMILES also has a bulky tert-butyl group (CC(C)C) and a cyclohexane ring (C1(CCC1)). These bulky groups can cause steric hindrance when in close proximity.,"Moderate - Depending on the binding environment, steric clashes might significantly affect binding affinity or pharmacokinetics, but the impact can vary based on spatial orientation and flexibility."
Furosemide,Salmeterol,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Hydrogen Bonding,A potential hydrogen bond may form between the carboxylic acid group in the first SMILES and the hydroxyl groups present in the second SMILES.,"- SMILES 1 contains a carboxylic acid group (C(=O)O) which can act as a hydrogen bond donor or acceptor.
- SMILES 2 contains hydroxyl groups (O) which can act as hydrogen bond donors.",Moderate - Hydrogen bonding is a common type of interaction that can impact pharmacokinetics or binding characteristics when present between drug molecules.
Metronidazole,Pimecrolimus,CC1=NC=C(N1CCO)[N+](=O)[O-],CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen atom attached to a more electronegative atom (such as oxygen or nitrogen) and another electronegative atom with a lone pair of electrons. In this case, potential donors or acceptors can be found in both SMILES.","- SMILES 1 contains the nitro group [N+](=O)[O-], which has the potential oxygen atom as hydrogen bond acceptors.
- SMILES 2 contains several carbonyl groups (C=O) and possibly hydroxyl groups (as suggested by the presence of 'O' atoms not directly involved in esters or ethers) which could donate hydrogen atoms for hydrogen bonding or further act as acceptors.","Moderate - While hydrogen bonds can significantly influence the interaction between molecules, the overall impact would depend on the specific physiological context (e.g., proximity and orientation of these groups within a biological environment). Given only the structures, it's a plausible but moderate interaction in isolation."
Rofecoxib,Triazolam,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,π-π Stacking Interaction,"π-π stacking occurs between aromatic rings when they are able to align in a parallel or edge-to-face manner. This interaction can result from van der Waals forces, with the presence of aromatic rings in both compounds facilitating this stacking.","In SMILES 1, the structure includes multiple phenyl rings (e.g., `C1=CC=C(C=C1)` and `C3=CC=CC=C3`). In SMILES 2, there are also phenyl rings (`C3=C(C=C(C=C3)Cl)` and `C4=CC=CC=C4Cl`). The presence of these aromatic systems can lead to stacking interactions under proximity.","Moderate - While π-π interactions may contribute to protein binding affinity and specificity, they generally have a moderate effect compared to other interactions like electrostatic or hydrogen bonding."
acetazolamide,Diazepam,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen bond donors (e.g., NH groups) and hydrogen bond acceptors (e.g., C=O, N, S=O groups).","SMILES 1 features an NH group adjacent to a sulfonamide (S(=O)(=O)N), which is both a hydrogen bond donor and acceptor. The SMILES 2 structure has C=O functionalities and aromatic nitrogen in the imidazole that can act as hydrogen bond acceptors.","Moderate - Hydrogen bonding can affect molecular recognition and binding affinity, influencing pharmacological activity (e.g., absorption, distribution, interaction with biological targets)."
Methylphenidate,Sorafenib,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Hydrogen bond donor-acceptor interaction,"The nitrogen atom in the amide group of SMILES 2 (CNC(=O)...) can act as a hydrogen bond donor, while the carbonyl oxygen in the ester group of SMILES 1 (COC(=O)...) can serve as a hydrogen bond acceptor. This can facilitate a hydrogen bonding interaction between these two sites.","- Donor: The amide NH (N) in SMILES 2 'CNC(=O)...'
- Acceptor: The carbonyl oxygen (O) in SMILES 1 'COC(=O)...'",Moderate - Hydrogen bonds can influence binding affinity and solubility but are usually weaker than covalent bonds.
Citalopram,Zolpidem,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Potential Pi-Pi Stacking,Pi-pi stacking interactions occur between aromatic rings due to electron cloud interactions. This can lead to stabilization between two molecules when they are within close proximity.,"From SMILES 1, the aromatic rings are represented by ""C2=C(CO1)C=C(C=C2)"" and ""C3=CC=C(C=C3)"". From SMILES 2, the aromatic rings are in ""CC1=CC=C(C=C1)"" and the heteroaromatic ring ""N3C=C(C=CC3=N2)"".","Moderate - The interaction may affect binding affinities or modulation of active sites under physiological conditions, given the presence of multiple aromatic systems in both structures."
Efavirenz,Perindopril,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"The interaction is likely due to hydrogen bonding between the carbonyl group in SMILES 2 (an amide group -C(=O)N-) and a hydrogen bond donor on SMILES 1, such as the carboxylic acid -C(=O)OH group, which can donate a proton to an acceptor.",SMILES 1 has a carboxylic acid moiety (NC(=O)O2) which can participate in hydrogen bonding. SMILES 2 has an amide linkage (C(=O)NC-) which can act as a hydrogen bond acceptor.,Moderate - Hydrogen bonding could influence how these molecules might interact at a biological target or influence solubility/bioavailability.
indometacin,oxybutynin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Hydrogen Bonding,A potential hydrogen bond can form between the hydroxyl group of one molecule and the carbonyl oxygen of the other due to hydrogen donor-acceptor interactions.,"- SMILES 1 contains a carbonyl group in the carboxylic acid moiety: CC(=O)O
- SMILES 2 contains a hydroxyl group: OC(=O)
- The oxygen in the carboxylic group (a good hydrogen bond acceptor) can interact with the hydrogen in the hydroxyl group (a good hydrogen bond donor).",Moderate - This interaction could potentially alter solubility or the pharmacokinetic profile but is not likely to cause significant pharmacodynamic changes without further context.
Celecoxib,Palonosetron,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,π-π Stacking,"Aromatic rings from the two molecules can interact through π-π stacking, a favorable non-covalent interaction between aromatic systems.","SMILES 1 contains two phenyl rings: one in the structure ""CC1=CC=C(C=C1)"" and another in ""C3=CC=C(C=C3)"", while SMILES 2 contains a phenyl ring in ""C3=CC=CC(=C23)"". These aromatic systems are structurally capable of engaging in π-π stacking interactions.","Moderate - While π-π interactions can stabilize drug-drug interactions, the pharmacological impact depends on how these interactions influence the drugs' biological targets or pathways."
Carvedilol,Ibuprofen,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Hydrogen Bonding,A potential hydrogen bond interaction could occur between the hydroxyl group in the first SMILES string and the carboxylic acid group in the second SMILES string.,"The first SMILES string contains an -OCCN-CH(OH)- group, where the hydroxyl group (OH) is capable of donating a hydrogen bond. The second SMILES string contains a carboxylic acid group -C(=O)O-, which can accept a hydrogen bond through its carbonyl oxygen.","Moderate - Hydrogen bonds can significantly affect solubility, binding affinity, and the pharmacokinetics of drugs, but the physiological impact depends on the overall drug environment and other competing interactions."
Candesartan,Perindopril,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"The presence of carbonyl groups and an amide proton in close proximity within these molecules suggests potential hydrogen bond formation. This occurs because the carbonyl oxygen can act as a hydrogen bond acceptor, while the amide proton can act as a hydrogen bond donor.","- SMILES 1 contains multiple carbonyl groups, such as C(=O)O.
- SMILES 2 also contains carbonyl groups, such as C(=O)O, alongside a secondary amine (NC(C)C(=O)N), which provides an N-H hydrogen bond donor.","Moderate - While hydrogen bonding can influence pharmacokinetics (e.g., solubility, permeability), the presence of such bonds between these drug molecules in a physiological setting is not uncommon and usually does not drastically alter pharmacological outcomes unless it significantly impacts drug absorption or metabolism."
Methylphenidate,Ofloxacin,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Hydrogen Bonding,Hydrogen bonding can occur between the carbonyl oxygen in SMILES 1 and the hydrogen donor present in the secondary amine of SMILES 2.,"- SMILES 1 contains a carbonyl group (C=O) within the ester functional group (COC(=O)).
- SMILES 2 contains a secondary amine within the piperazine ring (N4), which can serve as a hydrogen donor due to adjacent hydrogen atoms.",Moderate - Hydrogen bonding contributes to the affinity and specificity of interactions at molecular targets and can influence the pharmacokinetics and pharmacodynamics of the compounds.
Rofecoxib,Etiracetam,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,CCC(C(=O)N)N1CCCC1=O,Hydrogen Bonding,A hydrogen bond can occur between an electron-rich oxygen atom in the sulfonyl group from SMILES 1 and a hydrogen atom attached to the nitrogen atom in the amide group from SMILES 2.,SMILES 1 contains a sulfonyl group (`S(=O)(=O)`) that has oxygen atoms which can act as hydrogen-bond acceptors. SMILES 2 features an amide group (`C(=O)N`) with an NH group that can serve as a hydrogen-bond donor.,"Moderate - Hydrogen bonds moderately impact pharmacological activity, potentially affecting solubility or protein binding characteristics under physiological conditions."
Lidocaine,vincristine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen Bonding,The potential for hydrogen bonding interaction exists between the amine group in SMILES 1 and carbonyl groups or hydroxyl groups in SMILES 2.,"In SMILES 1, the structure ""C(=O)NC"" indicates the presence of an amide bond, where the nitrogen can act as a hydrogen bond donor. In SMILES 2, the structure includes several ester and hydroxyl groups, such as ""C(=O)OC"" and ""OC"", which can act as hydrogen bond acceptors.",Moderate - Such interactions can affect solubility and bioavailability.
Minoxidil,Perindopril,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"The carbonyl oxygen (C=O) in the aliphatic carboxylic group of SMILES 2 can act as a hydrogen bond acceptor with the hydrogen atoms attached to the nitrogen of the amide and amine groups in SMILES 1, which can donate hydrogen atoms.","In SMILES 1, the amine group (N-C) offers hydrogen donors, while in SMILES 2 the carbonyl (C=O) provides an acceptor site at the carboxylic acid.","Moderate - Hydrogen bonding can affect molecular interactions but depends on the spatial orientation, which can vary significantly in complex structures."
Amlodipine,Pyridostigmine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,Hydrogen Bonding,A hydrogen bond may form between the amine nitrogen (N) in the first SMILES and the carbonyl oxygen (O) in the second SMILES.,"In SMILES 1, ""COCCN"" includes an amine nitrogen that can potentially donate a hydrogen in hydrogen bonding. In SMILES 2, ""OC(=O)N(C)"" contains a carbonyl oxygen that can accept a hydrogen bond.","Moderate - Hydrogen bonds are a significant type of non-covalent interaction and can influence molecular binding and biological activity, though the actual impact depends on context."
Cetirizine,Imatinib,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors. In SMILES 2, there are amide groups (-NC(=O)-) that can act as hydrogen bond acceptors (the carbonyl oxygen) or donors (the NH group). In SMILES 1, there is a carboxylic acid group (-C(=O)O) that can act as both a hydrogen bond donor (through the OH) and acceptor (through the carbonyl and hydroxyl oxygens).","SMILES 1 contains a carboxylic acid group ""C(=O)O"" and SMILES 2 contains an amide group ""NC(=O)"".","Moderate - This type of interaction could enhance binding or alter the pharmacokinetic profile if both drugs are administered concurrently, potentially affecting drug efficacy or metabolism."
Famotidine,Fulvestrant,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,Hydrogen Bonding,"A primary interaction possibility arises from the hydrogen bond donors and acceptors present within both molecules. The first SMILES string contains several nitrogen and sulfur atoms within functional groups capable of acting as hydrogen bond donors or acceptors (e.g., amines, thiol groups). The second SMILES string contains hydroxy groups which can also serve as effective hydrogen bond donors or acceptors.","- SMILES 1: The group within the first structure, involving N atoms (e.g., the -N=C(N)N group), can act as both hydrogen bond donors (via hydrogen on nitrogen) and acceptors (via the lone pair on nitrogen sulfur as an acceptor).
- SMILES 2: The presence of hydroxy groups (-OH) in the second structure, specifically allows for hydrogen donation and accepting capabilities.","Moderate - While hydrogen bonding is generally not as strong as covalent or ionic bonds, these interactions can significantly influence docking processes and, therefore, pharmacological activity. Their presence across various functional groups could potentially moderate the drugs' pharmacokinetics and pharmacodynamics."
Risedronic acid,mercaptopurine,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,C1=NC2=C(N1)C(=S)N=CN2,Hydrogen Bonding,The hydrogen bond interaction can occur between the hydrogen atom of the hydroxyl group in SMILES 1 and the nitrogen in the pyrimidine ring in SMILES 2.,"SMILES 1 contains the hydroxyl group -O (within CC(O)(P(=O)(O)O)), which can act as a hydrogen bond donor. SMILES 2 contains a pyrimidine nitrogen (N in C1=NC2), which can act as a hydrogen bond acceptor.",Moderate - Hydrogen bonding is a common and moderate interaction affecting the pharmacokinetics and dynamics of drug molecules.
Dofetilide,Bimatoprost,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Hydrogen Bonding,Hydrogen bonds can form between hydrogen bond donors (such as -OH or -NH groups) of one molecule and hydrogen bond acceptors (like carbonyl groups or sulfonamide oxygen atoms) of another molecule.,"- SMILES 1 contains sulfonamide groups (NS(=O)(=O)C) which have two oxygens capable of acting as hydrogen bond acceptors.
- SMILES 2 contains hydroxyl groups (O in CC1C(CC(C1C=CC)O)O) which can act as hydrogen bond donors.",Moderate - The presence of multiple hydrogen bonding sites could lead to noticeable alterations in the pharmacokinetic properties if these drugs were administrated together.
Ziprasidone,Acamprosate,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,CC(=O)NCCCS(=O)(=O)O,Hydrogen Bonding,A hydrogen bonding interaction is possible between the carbonyl oxygen (C=O) of the sulfonamide group in SMILES 2 and the hydrogen atoms attached to the nitrogen in the piperazine or amide groups in SMILES 1.,"SMILES 1 has nitrogen atoms capable of donating hydrogen (e.g., N-H groups in the amide linkage), which can form hydrogen bonds with the sulfonyl oxygen in SMILES 2. The relevant groups are:
- SMILES 1: N-H (from the amide group)
- SMILES 2: S(=O)(=O)O (the sulfonamide oxygen atoms, particularly the =O oxygen)","Moderate - Hydrogen bonding can affect molecular recognition and binding when both molecules are in physiological conditions, potentially impacting the pharmacokinetics or dynamics of the drugs."
Capecitabine,Erlotinib,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor and an acceptor. In these SMILES strings, there are potential hydrogen bond donors and acceptors within and between the molecules.","In SMILES 1, the presence of several hydroxyl groups (-OH) on the sugar moiety (C2C(C(C(O2)C)O)O) and the amide group (OC(=O)N-) provides hydrogen bond donors and acceptors. SMILES 2 contains nitrogen atoms in the triazine ring (C=NC=N) that can serve as hydrogen bond acceptors.","Moderate - Hydrogen bonding is a common and significant interaction that can affect the pharmacokinetic profiles of drugs, such as absorption and distribution. However, its impact will depend on the context, such as the presence of these groups on accessible surfaces when the molecules are in a physiological environment."
indometacin,Terazosin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Pi-Pi Stacking,Pi-pi stacking is a non-covalent interaction that occurs between aromatic rings. It involves the attraction between the electron clouds of the two aromatic systems.,"Both SMILES contain aromatic rings. SMILES 1 has a chlorophenyl ring, as seen in the ""C3=CC=C(C=C3)Cl"" portion. SMILES 2 contains an aromatic phenyl ring in ""COC1=C(C=C2...C(=C1)...C(=N2)...)"" section. The presence of these aromatic rings suggests the possibility of pi-pi stacking interactions when these molecules are in close proximity.","Moderate - Pi-pi stacking can affect the binding affinity and stability of molecular interactions under physiological conditions, potentially influencing pharmacokinetic properties."
Fenofibrate,Modafinil,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,Aromatic π-π Stacking,"The interaction occurs due to the presence of aromatic rings in both SMILES strings. Aromatic π-π stacking interactions are driven by π-electron cloud overlap between the aromatic rings, which can stabilize the molecular complex under certain geometries.","- SMILES 1 contains two phenyl groups: OC1=CC=C(C=C1) and C2=CC=C(C=C2).
- SMILES 2 contains two phenyl groups: C1=CC=C(C=C1) and C2=CC=CC=C2.
- The presence of these aromatic groups in close proximity in a molecular complex can favor π-π stacking.",Moderate - π-π interactions can have a significant impact on molecular recognition and binding but generally do not lead to strong pharmacological consequences on their own unless other interactions are present or structural specificities are involved.
Cetirizine,hydroxychloroquine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Hydrogen bonding,"The presence of possible hydrogen bond donors and acceptors in proximity between the two molecules can facilitate hydrogen bonding. Specifically, the carboxylate group (-C(=O)O) can act as a hydrogen bond acceptor, and the secondary amines (NHR) in both SMILES can act as hydrogen bond donors.","In SMILES 1, the carboxylate group C(=O)O (acting as acceptor), and in SMILES 2, the secondary amine N(CCCC(C)NC) (acting as donor).","Moderate - The interaction can affect the binding and activity of the molecules, influencing bioavailability or pharmacokinetics by altering solubility or protein binding."
Temazepam,mitomycin C,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,Hydrogen Bond Donor-Acceptor,Hydrogen bond interactions can occur between hydrogen bond donors such as NH groups and hydrogen bond acceptors such as carbonyl (C=O) groups and oxygen atoms.,"In SMILES 1, the amide group (`NC1=O`) contains a carbonyl oxygen, which acts as a hydrogen bond acceptor. In SMILES 2, the lactam group (`C1(C2=O)N3`) contains a carbonyl group that can act as a hydrogen bond acceptor, and potentially other hydrogens in its ring structure can act as donors for forming hydrogen bonds with carbonyl oxygens.","Moderate - These interactions can potentially influence binding affinity and drug activity, especially if the hydrogen bonds affect the structural conformation or receptor binding interfaces under physiological conditions."
Tramadol,Trimethoprim,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Hydrogen Bond Donor-Acceptor,"The hydroxyl group (-OH) on SMILES 1 can act as a hydrogen bond donor, while the nitrogen atoms in the triazole ring (N=C-N) of SMILES 2 can act as hydrogen bond acceptors.","SMILES 1 has an -OH group: ""O"" and SMILES 2 has a triazole ring with nitrogen: ""N=C(N=C2N)"".",Moderate - Hydrogen bonding can influence drug binding and solubility but is less likely to result in high-impact changes unless strategically positioned in a binding site.
Gabapentin,Moexipril,C1CCC(CC1)(CC(=O)O)CN,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donors and acceptors when they are in close proximity. In these SMILES strings, an interaction can form between the carboxylic acid group in SMILES 1 and the amide or ether groups in SMILES 2.","- SMILES 1 contains the group ""CC(=O)O"", showing a carboxylic acid which has the capacity to donate a hydrogen.
- SMILES 2 has multiple potential hydrogen bond acceptors: the carbonyl groups in ""C(=O)"" and the ether oxygens in ""OC"" of the methyl and methoxy groups.","Moderate - Such interaction can potentially stabilize a complex formation, affecting solubility or absorption characteristics but may not drastically alter pharmacokinetics without further context."
Lamivudine,Metoprolol,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Hydrogen Bonding,A hydrogen bond can occur between a hydrogen atom attached to a nitrogen or oxygen (donor) and an electronegative atom like nitrogen or oxygen (acceptor) from the other molecule.,"In SMILES 1, the hydroxyl group `CO` connected to the cyclic ether (C1C(OC(S1)CO)N2C=CC(=NC2=O)N) can act as a hydrogen bond donor. In SMILES 2, the ether oxygen `COC1=CC=C(C=C1)CCOC` provides a potential acceptor site for hydrogen bonding.","Moderate - Hydrogen bonds can influence solubility and binding site interactions, impacting pharmacokinetics and pharmacodynamics significantly."
Methylphenidate,Pirbuterol,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,Hydrogen Bonding,"Hydrogen bonds can form between proton donors and acceptors when they come into proximity under physiological conditions. In this case, the presence of hydroxyl groups and nitrogen atoms in the structures allows for potential hydrogen bonding.","SMILES 1 includes a nitrogen atom in the piperidine ring (N1), which can act as a hydrogen bond acceptor. SMILES 2 contains hydroxyl groups (O) attached to the benzene ring and the aliphatic carbon (CO), both of which can donate hydrogen for bonding.","Moderate - Hydrogen bonds can significantly influence the binding affinity and interaction strength between molecules, potentially affecting their pharmacological activities."
Alfuzosin,Gemfibrozil,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Hydrogen Bonding,"The nitrogen atom in the amide group of SMILES 1 can act as a hydrogen bond acceptor, while the hydroxyl (O-H) group in SMILES 2 can act as a hydrogen bond donor.","In SMILES 1, the amide group represented by ""NC(=O)"" contains a nitrogen that can accept hydrogen bonds. In SMILES 2, the part ""C1=CC(=C(C=C1)C)O"" contains a hydroxyl group that can donate a hydrogen bond.",Moderate - Hydrogen bonds can significantly affect drug interactions and binding affinities under physiological conditions.
Candesartan,Cinacalcet,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,π-π Stacking,"π-π stacking interactions can occur between aromatic rings, which stabilize the interaction through overlapping π-orbitals. This interaction is not due to a single bond but rather the spatial alignment and orientation of the aromatic systems.","Both SMILES strings feature multiple aromatic rings. Specifically:
- SMILES 1 has phenyl groups in the structure like C3=CC=C(C=C3) and C4=CC=CC=C4.
- SMILES 2 starts with an aromatic phenylene group: C1=CC=CC2=CC=CC=C21.
These rings have the potential to come into proximity and align in a stacked formation through π-π interactions.","Moderate - π-π stacking can influence solubility and binding in a pharmacological context, impacting the drugs' bioavailability or mechanism of action."
Naproxen,hydroxychloroquine,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Hydrogen bonding,A hydrogen bond could form between the hydroxyl group (O-H) of the carboxylic acid in SMILES 1 and the nitrogen atom in the secondary amine group in SMILES 2. This is possible under physiological conditions where such groups can participate in hydrogen bonding with each other.,"SMILES 1 has the carboxylic acid group ""C(=O)O"" supporting a possible hydrogen bond donor (the hydroxyl hydrogen), and SMILES 2 contains ""NC"" in ""CCCC(C)NC"" indicating an amine which can act as a hydrogen bond acceptor.","Moderate - Hydrogen bonding can significantly influence molecular interaction and binding affinities, especially in drug-receptor interactions."
Citalopram,Riluzole,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,π-π Stacking,"Both molecules contain aromatic rings which can interact via π-π stacking. This type of interaction occurs when the aromatic rings are parallel and close enough for their π-electron clouds to overlap, providing stabilization.","SMILES 1 contains several aromatic rings, one being part of a fluorobenzene group (C3=CC=C(C=C3)F). SMILES 2 has a benzene ring directly connected to a heterocyclic structure (C1=CC2=C(C=C1OC(F)(F)F)). The presence of these aromatic moieties suggests potential for π-π interactions.","Moderate - π-π stacking can influence the binding affinity and stability of molecular complexes, which may moderately impact pharmacological properties such as receptor interaction or bioavailability."
folinic acid,Perindopril,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors, such as hydroxyl (-OH) or amine (-NH) groups, and acceptors like carbonyl (C=O) or amide (C=O) groups. In physiological environments, especially aqueous, hydrogen bonds are significant for interactions between molecules.","- In SMILES 1, the presence of multiple amide groups (N-H) in sections such as `NC(=O)` and carboxylic acids `(C(=O)O)` could serve as donors, and the carbonyl groups `(C=O)` could serve as acceptors.
- In SMILES 2, the carboxylic acid `(C(=O)O)` and additional amide groups `(NC(=O))` provide further sites where they could participate as acceptors to hydrogen bonds.","Moderate - Hydrogen bonding, while not overly strong compared to covalent interactions, can affect drug binding and interactions, potentially altering pharmacokinetics or pharmacodynamics."
Famotidine,hydroxychloroquine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor and an acceptor. In SMILES 1, the sulfonamide group (S(=O)(=O)N) and thiosemicarbazide moiety (N=C(N)N) provide potential hydrogen bond donors (NH groups) and acceptors (O and N atoms). Similarly, in SMILES 2, the ether group (CCO) contains an oxygen atom that can act as a hydrogen bond acceptor.","In SMILES 1, the sulfonamide (S(=O)(=O)N) acts as a hydrogen bond donor with its NH group, and in SMILES 2, the oxygen in the ethanol moiety (CCO) acts as a hydrogen bond acceptor.","Moderate - Hydrogen bonding can affect drug binding affinities and distributions, potentially influencing pharmacokinetics and pharmacodynamics."
Ibuprofen,Modafinil,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,Hydrogen Bonding,Hydrogen bonding can occur between the carbonyl oxygen of the carboxylic acid group in SMILES 1 and both the sulfone oxygen and the amide oxygen present in SMILES 2.,"SMILES 1 contains a carboxylic acid group (C(=O)O), suggesting the potential to donate a hydrogen bond from the hydroxyl (-OH) group. SMILES 2 contains a sulfone group (S(=O)) which could accept hydrogen bonds due to its oxygen atoms. Additionally, SMILES 2 features an amide group (C(=O)N), where the carbonyl oxygen could also serve as a hydrogen bond acceptor.",Moderate - The interaction may affect the solubility or binding properties of the molecules in physiological environments.
Fentanyl,Metolazone,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Hydrogen Bonding,"Hydrogen bonding may occur due to the presence of a carbonyl oxygen in SMILES 1, which can act as a hydrogen bond acceptor, and an amide hydrogen attached to nitrogen in SMILES 2, which can serve as a hydrogen bond donor.","The SMILES 1 contains a ""C(=O)"" group which features a carbonyl oxygen capable of accepting hydrogen bonds. SMILES 2 contains an ""NC"" sequence in the lactam ring, indicating the presence of a hydrogen attached to nitrogen capable of donating hydrogen bonds.",Moderate - This interaction could impact the binding affinity or solubility but is unlikely to cause substantial pharmacological changes on its own.
Lamotrigine,Sildenafil,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,"Hydrogen bonds may form between hydrogen donors and acceptors within the molecules under physiological conditions. A primary amine group (-NH2) in the first molecule can serve as a hydrogen donor, and carbonyl oxygens (=O) in the second molecule can act as acceptors.",SMILES 1 contains an -NH2 group (N at the end of the triazene moiety). SMILES 2 has a carbonyl group (=O) in the benzoxazole structure.,Moderate - This potential hydrogen bonding could influence the pharmacokinetics and/or pharmacodynamics by altering solubility or binding affinities if the drugs are co-administered.
Citalopram,Propofol,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CC(C)C1=C(C(=CC=C1)C(C)C)O,Hydrogen Bonding,A hydrogen bond could potentially form between the phenolic OH group in the second SMILES (CC(C)C1=C(C(=CC=C1)C(C)C)O) and the nitrogen atom in the cyano group (C#N) of the first SMILES (CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F).,"The second SMILES has a hydroxyl group (-OH) attached directly to the aromatic ring, which can act as a hydrogen bond donor. The first SMILES contains a cyano group (C#N), where the nitrogen can act as a hydrogen bond acceptor.","Moderate - Depending on the proximity of the groups in an actual biological context or conformation, such an interaction could affect binding or reactivity."
Diazepam,Gemfibrozil,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Hydrogen Bonding,"The carbonyl oxygen in SMILES 1 can potentially act as a hydrogen bond acceptor. In SMILES 2, the hydroxyl group (-OH) can donate a hydrogen to form a hydrogen bond with the carbonyl oxygen.","- SMILES 1 contains a carbonyl group (C=O) on the imide position within the isoindole-1-one moiety.
- SMILES 2 has a hydroxyl group (-OH) which can act as a hydrogen bond donor.",Moderate - This type of interaction can affect the solubility and binding properties of the molecules.
Naproxen,Capecitabine,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,Hydrogen Bonding,A hydrogen bond can potentially form between the hydrogen on the carboxylic acid group of SMILES 1 and either the carbonyl oxygen or the nitrogen in the amide group of SMILES 2.,"SMILES 1 has a carboxylic acid group represented by C(=O)O, which can donate a hydrogen. SMILES 2 has an amide group represented by OC(=O)NC, and the carbonyl oxygen in this group can act as a hydrogen bond acceptor.",Moderate - This interaction could potentially influence solubility or binding affinity in a pharmacological context.
Gabapentin,Sildenafil,C1CCC(CC1)(CC(=O)O)CN,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,"Hydrogen bonding can occur between the carboxylic acid group in SMILES 1 and the sulfonamide group in SMILES 2. The OH group from the carboxylic acid can act as a hydrogen bond donor, while the oxygen atoms in the sulfonamide group can act as hydrogen bond acceptors.","SMILES 1 contains a carboxylic acid group represented by ""CC(=O)O"", and SMILES 2 contains a sulfonamide group represented by ""S(=O)(=O)N4"".","Moderate - Hydrogen bonds are significant in physiological conditions, affecting drug solubility, permeability, and binding."
alendronic acid,Moexipril,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors. In SMILES 1, there are phosphate groups that can serve as hydrogen bond donors (OH groups) and acceptors (P=O groups). In SMILES 2, the carboxylic acid group (C(=O)O) contains both hydrogen donors and acceptors, as well as other carbonyl oxygens and ether oxygens which can act as hydrogen bond acceptors.","- From SMILES 1: The presence of phosphate groups with OH (P(=O)(O)O) provides potential for hydrogen bonding.
- From SMILES 2: The presence of a carboxylic acid group (C(=O)O) provides both a hydrogen bond donor and acceptor.","Moderate - This interaction is likely to affect the pharmacokinetic properties by altering the solubility or local distribution of the compounds, but not profoundly affect bioactivity unless critcally positioned."
Risedronic acid,Terazosin,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen Bonding,"This interaction occurs when a hydrogen atom, shared between two electronegative atoms, forms a bridge between them. In physiological conditions, polar groups with hydrogen can potentially engage in hydrogen bonding with electronegative atoms.","In SMILES 1, the phosphoric acid groups ('P(=O)(O)O') offer multiple -OH groups that can act as hydrogen bond donors and acceptors. In SMILES 2, the aromatic heterocycle contains nitrogen atoms ('=N') that can act as hydrogen bond acceptors.","Moderate - The formation of hydrogen bonds can influence the binding affinity and solubility of a drug, impacting its pharmacological profile."
Temazepam,Trimipramine,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,π-π Stacking Interaction,"π-π stacking occurs between aromatic rings within molecules that align parallel to each other, allowing interactions between π-electron clouds.","SMILES 1 contains a phenyl ring (C3=CC=CC=C3), and SMILES 2 contains multiple phenyl rings (C2=CC=CC=C2 and C3=CC=CC=C3). The presence of these aromatic systems in close proximity suggests potential π-π interactions.","Moderate - π-π stacking can influence molecular binding and stability, impacting pharmacological activity, but typically does not cause severe effects on its own."
Ofloxacin,Darunavir,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen atom, which is bonded to an electronegative atom (like oxygen or nitrogen), and another electronegative atom with a lone pair of electrons.","In SMILES 1, the carboxylic acid group `C(=O)O` contains both a hydrogen donor (OH) and an acceptor (C=O). In SMILES 2, the secondary amine group `NC(=O)` has a nitrogen atom that could act as a hydrogen bond donor or acceptor. The carbonyl group `C(=O)` attached to the nitrogen further contributes to hydrogen bonding potential.","Moderate - Hydrogen bonds can influence the binding affinity when present in drug interactions, potentially modifying activity or selectivity without necessarily leading to substantial adverse effects."
Ketorolac,Ondansetron,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor, such as the -NH group, and an acceptor, such as a carbonyl oxygen.","In SMILES 1, the structure includes a carbonyl oxygen in the carboxylic acid group (C(=O)O), which can act as a hydrogen bond acceptor. In SMILES 2, the -NH group in the indole structure (C4=CC=CC=C4N3) can act as a hydrogen bond donor.","Moderate - This interaction could influence the orientation and positioning of the drugs relative to each other, impacting pharmacodynamics or pharmacokinetics."
Amlodipine,Isoniazid,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C1=CN=CC=C1C(=O)NN,Hydrogen Bonding,The hydrogen atom(s) in SMILES 2's hydrazine group (NN) can form hydrogen bonds with carbonyl oxygen(s) in SMILES 1.,"SMILES 1 contains a carbonyl group (C(=O)) at various positions, and SMILES 2 has a hydrazine group (NN), which provides hydrogen donors capable of forming hydrogen bonds with the carbonyl oxygen(s) acting as hydrogen bond acceptors.",Moderate - This type of interaction can influence drug solubility and binding properties under physiological conditions.
Furosemide,Fulvestrant,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,Hydrogen Bonding,Hydrogen bonds can form between hydrogen donors and acceptors. The first SMILES contains a carboxylic acid group (-C(=O)O) which can act as both a hydrogen bond donor and acceptor. The second SMILES contains a phenolic hydroxyl group (-C=CC(=C)O) that can also participate in hydrogen bonding.,"- SMILES 1 contains a -C(=O)O group, where the oxygen can act as a hydrogen bond acceptor.
- SMILES 2 contains a phenol -C=C(O) group, where the oxygen can act as a hydrogen bond acceptor and the hydrogen can act as a donor.","Moderate - While hydrogen bonds are relatively common, their pharmacological impact depends on the specific context and binding sites involved in drug interactions."
Diazepam,Desloratadine,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,π-π Stacking Interaction,π-π stacking interactions occur between aromatic rings when the electron clouds overlap. Such interactions are common when two aromatic systems align parallel or close to each other.,"Both structures contain chlorinated phenyl rings:  
- SMILES 1 has a chlorinated benzene ring, visible in the section `C2=C1C=CC(=C2)Cl`.  
- SMILES 2 also contains a chlorinated benzene, shown in the section `2=C(C=CC(=C2)Cl)`.  
These similar aromatic systems could potentially result in π-π stacking.",Moderate - π-π stacking may influence drug binding and overall pharmacodynamics but usually doesn't lead to severe pharmacological consequences by itself unless it's highly critical to binding orientation.
Metoprolol,Pirbuterol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors present in the molecules. In SMILES strings, -OH groups can act as both donors and acceptors, while lone pairs present on electronegative atoms (like oxygen or nitrogen) are typical acceptors.","In both SMILES, there are hydroxyl groups (-OH) present in the structures. In SMILES 1, the group is represented by 'C(COC1=CC=C(C=C1)CCOC)O' and in SMILES 2, it is 'C(C1=NC(=C(C=C1)O)CO)O'. The OH in SMILES 2 could interact with an O atom in the ether linkage 'CCOC' or the aromatic methoxy in SMILES 1.","Moderate - Hydrogen bonds are relatively common in physiological conditions, influencing solubility and the overall three-dimensional interaction between drugs, which can impact pharmacodynamics or pharmacokinetics."
Risedronic acid,vincristine,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Hydrogen Bonding,"A hydrogen bond can form between a hydrogen donor and an acceptor. In SMILES 1, the phosphoric acid groups (P(=O)(O)O) have hydroxyl oxygens that can serve as hydrogen bond acceptors. In SMILES 2, there are multiple NH groups within aromatic structures (e.g., tertiary amines) that could act as potential hydrogen bond donors.","The SMILES 1 contains O=P(O)(O)O groups indicating potential acceptors, and SMILES 2 contains N atoms within the ring structure indicating potential donors.",Moderate - Hydrogen bonding can significantly impact the pharmacokinetics and pharmacodynamics of drug compounds.
Brimonidine,hydroxychloroquine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen atom donors, such as amine (N-H) groups, and hydrogen acceptors, like nitrogen atoms in aromatic rings or halogens.","- SMILES 1 contains an amine group (N-H) within the imidazole-like ring.
- SMILES 2 has multiple nitrogen atoms in aromatic systems that can act as hydrogen bond acceptors.","Moderate - Hydrogen bonds can influence binding affinity and specificity, potentially affecting pharmacological activity."
Amlodipine,Erlotinib,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,Hydrogen Bonding,Hydrogen bonds can form between a hydrogen donor (such as a nitrogen with an available hydrogen) and an acceptor (such as an oxygen or nitrogen with a lone pair).,SMILES 1 has an amine group (NC) that could potentially donate a hydrogen for hydrogen bonding. SMILES 2 features ether groups (COC) which contain oxygen atoms that can act as hydrogen bond acceptors.,Moderate - Hydrogen bonding between drugs can influence solubility and bioavailability but is less likely to cause significant pharmacological interactions compared to ionic or covalent bonding.
Naproxen,Norfloxacin,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors. The carboxylic acid group (-C(=O)O) in SMILES 1 can act as both a hydrogen bond donor and acceptor. In SMILES 2, the carbonyl groups associated with acidic and potentially hydrogen bond accepting features can facilitate this interaction.","- SMILES 1: Contains a carboxylic acid group (-C(=O)O), which can act as a hydrogen bond donor and acceptor.
- SMILES 2: Contains a carbonyl group (=O) within the cyclic structure that may participate in hydrogen bonding.","Moderate - Hydrogen bonding can influence drug interactions and pharmaceutical behavior, particularly affecting solubility and binding affinities."
Candesartan,Ofloxacin,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,π-π Stacking Interaction,"π-π stacking interactions occur when aromatic rings align parallel to each other, allowing overlap of their π-electron clouds, which can stabilize the interaction between molecules.","- SMILES 1 contains several aromatic rings: an indazole ring (C2=CC=CC(=C2N), phenyl rings (C3=CC=C(C=C3) and C4=CC=CC=C4).
- SMILES 2 contains aromatic rings as well, particularly the benzene-like structure around the indole (C2=C3N) system.
- These aromatic rings can align parallel to each other, allowing π-π interactions under physiological conditions.",Moderate - The potential interaction might impact binding affinities if they were both targeting similar biological sites but would be less significant in solution without target protein mediation.
Ondansetron,Telithromycin,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Hydrogen Bonding,A potential hydrogen bonding interaction can occur between the carbonyl group (C=O) in SMILES 1 and the hydroxyl group (O) in SMILES 2.,"The structure of SMILES 1 contains a carbonyl group (C=O) in a keto function, which can act as a hydrogen bond acceptor. Meanwhile, SMILES 2 contains a hydroxyl group (O), which can act as a hydrogen bond donor.","Moderate - This interaction is plausible under physiological conditions and can reasonably contribute to the binding affinity between the two molecules. However, its impact would depend on the specific orientation and proximity of the groups in a real biological system."
Carvedilol,melphalan,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor and a hydrogen bond acceptor. The amine group in the second molecule (SMILES 2) can act as a hydrogen bond donor, given the presence of hydrogens bound to nitrogen. The ether oxygen or hydroxyl oxygen in the first molecule (SMILES 1) can act as a hydrogen bond acceptor.","- SMILES 1 contains an ether oxygen in the -OCC- group and a hydroxyl group (-OH) attached to a benzene ring, which can act as hydrogen bond acceptors.
- SMILES 2 contains a primary amine group (N) attached to the aliphatic chain, capable of donating hydrogens for hydrogen bonding.","Moderate - This interaction can moderately affect how these molecules behave in proximity, potentially influencing solubility or binding properties."
alendronic acid,Perindopril,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen bonding,"The two molecules can interact through hydrogen bonding between their hydrogen bond donors and acceptors. Specifically, the oxygen atoms from phosphate (P=O) groups in the first molecule can form hydrogen bonds with hydrogen bond donors (such as NH groups) in the second molecule.","In SMILES 1, the phosphate groups contain oxygen atoms (P=O) that can act as hydrogen bond acceptors. In SMILES 2, there are NH groups (e.g., NC(C)C(=O)N) that can donate hydrogen atoms for bonding.","Moderate - While hydrogen bonds are typically weaker than covalent bonds, they can significantly influence binding affinity and molecular interactions under physiological conditions."
Paracetamol,Disopyramide,CC(=O)NC1=CC=C(C=C1)O,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,Hydrogen Bonding,Hydrogen bonding can occur between the N-H group in the amide structure of the first molecule and the carbonyl oxygen in the amide structure of the second molecule.,"The first SMILES has an amide group ""-NC(=O)-"" where the nitrogen can donate a hydrogen bond by the hydrogen attached to it, and the second SMILES contains a carbonyl group ""C(=O)N"" where the oxygen can accept a hydrogen bond.",Moderate - Such hydrogen bonding interactions could potentially affect the pharmacokinetics by altering solubility or binding efficiency.
Famotidine,Formoterol,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,Hydrogen Bonding,"The presence of potential hydrogen bond donors and acceptors in close proximity can lead to hydrogen bonding. In SMILES 1, there are amino (NH2) groups that can act as hydrogen bond donors, and sulfones (S(=O)=O) that can act as hydrogen bond acceptors. In SMILES 2, there is a hydroxyl group (OH) that can both donate and accept hydrogen bonds.","- SMILES 1: The amino group (N=C(N)N) and the sulfone group (=S(=O)(=O)).
- SMILES 2: The hydroxyl group (C(C2=CC(=C(C=C2)O)).","Moderate - The presence of these groups suggests a strong likelihood of hydrogen bonding, which can affect the pharmacokinetics by changing solubility and absorption characteristics."
Repaglinide,Perindopril,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bond Formation,Hydrogen bonds can form between hydrogen bond donors and acceptors such as amide groups and carboxylic acids present in both molecules.,"- SMILES 1 contains an amide group (NC(=O)) and a carboxylic acid (C(=O)O) which can act as a hydrogen bond donor and acceptor.
- SMILES 2 also contains both an amide group (NC(=O)) and a carboxylic acid (C(=O)O).
- These groups can potentially interact via hydrogen bonding under physiological conditions.",Moderate - Hydrogen bond interactions can influence molecular recognition and binding but usually do not by themselves cause significant pharmacological impacts without other contributing factors.
Zolpidem,vincristine,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Steric Clashes,"Steric clashes occur when bulky groups are in close proximity, potentially hindering molecular interactions or proper binding to a target site. The presence of multiple cyclic and bulky groups in close proximity on large molecules can result in steric interference.","- SMILES 1 contains a bicyclic aromatic system with an additional bulky N-methylamide group.
- SMILES 2 is heavily substituted, including multiple cyclic structures and ester side chains, contributing to its large and complex steric footprint.",High - Steric clashes can significantly impact binding efficacy and alter pharmacological outcomes by preventing optimal alignment or interaction of the drug molecules with their target.
Dexpramipexole,Ticlopidine,CCCNC1CCC2=C(C1)SC(=N2)N,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor and an acceptor. In this case, the secondary amine group (NH) in SMILES 1 can act as a hydrogen bond donor, and the nitrogen atom in the heterocyclic thiazole portion of SMILES 2 can act as an acceptor.","In SMILES 1, the group ""NC1CCC2"" contains an NH group, which is a potential hydrogen bond donor. In SMILES 2, the ""S"" and ""NC=C2"" implies there could be a nitrogen available for hydrogen bonding interaction within cyclic structures.","Moderate - This level suggests a likely pharmacological impact if the interaction leads to changes in absorption, distribution, or receptor binding properties."
Fentanyl,Zaleplon,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,π-π Stacking,"The phenyl rings in both structures can align parallel to each other, allowing for overlap of their π-electron clouds, which stabilizes the interaction under physiological conditions.","- SMILES 1 contains a phenyl ring in the structure represented as `C3=CC=CC=C3`.
- SMILES 2 contains a phenyl ring in the structure represented as `C1=CC=CC(=C1)`.","Moderate - While π-π stacking can affect the orientation and behavior of molecules, the impact on pharmacological activity depends on the context of drug interactions and binding environments."
Carvedilol,solifenacin,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,π-π Stacking,"The interaction occurs between aromatic rings in close proximity, where the electron clouds of the rings align and create non-covalent stacking interactions.","SMILES 1 contains two phenyl rings: one in ""COC1=CC=CC=C1"" and another in ""C2=CC=CC3=C2..."". SMILES 2 contains several phenyl rings in ""C4=CC=CC=C4"" and ""C5=CC=CC=C5"". These aromatic rings could physically stack due to π-π interactions when the drugs are near each other.","Moderate, as π-π stacking can influence drug binding to proteins or other macromolecules, potentially affecting pharmacokinetic or pharmacodynamic properties."
Cimetidine,Sumatriptan,CC1=C(N=CN1)CSCCNC(=NC)NC#N,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,Hydrogen Bond Donor-Acceptor,The first molecule has a secondary amine group (N-H) that's capable of donating a hydrogen bond. The second molecule has several sulfonamide oxygens that can act as hydrogen bond acceptors.,"In SMILES 1, the 'NC(=NC)' segment indicates the presence of a secondary amine. In SMILES 2, the 'S(=O)(=O)' indicates sulfonamide oxygens, which are known to be good hydrogen bond acceptors.","Moderate - While hydrogen bonding can influence pharmacokinetics and pharmacodynamics, the severity will depend on the specific context of these interactions in a biological system."
Amlodipine,Metolazone,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Hydrogen Bond,Hydrogen bond interactions can occur when a hydrogen atom covalently bonded to a highly electronegative atom (such as nitrogen or oxygen) is in close proximity to another electronegative atom with a lone pair.,"In SMILES 1, there is an amine group (COCCN), and in SMILES 2, there is a sulfonamide group (S(=O)(=O)N) as well as carbonyl groups (C=O). The nitrogen in the amine group of SMILES 1 could potentially form a hydrogen bond with the oxygen atoms in the sulfonyl group or carbonyl groups of SMILES 2.","Moderate - Depending on the molecular orientation, this interaction could affect how these compounds influence their respective targets, especially in drug binding and pharmacokinetics."
Ketorolac,Duloxetine,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,π-π Stacking,"π-π stacking interactions occur when aromatic rings are in proximity, allowing for parallel overlap of their π-electron clouds, which can stabilize the interaction. These are non-covalent interactions particularly relevant between aromatic-containing compounds.",SMILES 1 contains two aromatic systems: a phenyl group (C3=CC=CC=C3) and a conjugated pyridine system within the fused structure. SMILES 2 contains an aromatic thiophene ring (C1=CC=CS1) as well as a naphthalene system (C2=CC=CC3=CC=CC=C32). The presence of these aromatic rings in both structures suggests the potential for π-π stacking.,"Moderate - π-π interactions can influence molecular interactions in binding pockets or active sites, potentially affecting pharmacokinetics or drug binding affinities but without direct covalent change."
Doxazosin,Metoprolol,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donors and acceptors, such as hydrogen atoms bonded to nitrogen or oxygen (donors) with oxygen or nitrogen atoms with lone pairs (acceptors) in the other structure.","- SMILES 1 contains several nitrogen atoms within amine groups (e.g., N3CCN) and an ether oxygen (COC5).
- SMILES 2 includes a hydroxyl group (O) attached to an alkyl chain (CC(C)O) which can act as both a hydrogen bond donor (due to the hydroxyl hydrogen) and acceptor.
- Additionally, SMILES 2 has ether oxygens (COC1=CC and CCOC) which can serve as hydrogen bond acceptors.",Moderate - The existence of multiple potential hydrogen bond donors and acceptors within physiological conditions could significantly affect the pharmacological interactions and the solubility/availability of the compounds.
Haloperidol,oxybutynin,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor, such as an -OH group, and a hydrogen acceptor like an electronegative atom with lone pairs, such as oxygen.","- In SMILES 1, there is an -OH group next to a cyclohexane (C1CN(CCC1(C2=CC=C(C=C2)Cl)O)).
- In SMILES 2, the COC(=O) group contains an oxygen atom with lone pairs that can accept hydrogen bonds.","Moderate - The potential hydrogen bonding might influence binding affinity or solubility of the compounds when co-administered, but may not significantly affect pharmacological action unless in sensitive environments or formulations."
Furosemide,Rosiglitazone,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Hydrogen bonding,A hydrogen bond may form between the hydrogen of the carboxylic acid group (–COOH) on SMILES 1 and the carbonyl oxygen (C=O) of the lactam group on SMILES 2.,"- SMILES 1 contains a carboxylic acid group denoted by ""C(=O)O"".
- SMILES 2 includes a carbonyl group within the ""C(=O)NC(=O)S"" motif.","Moderate - Hydrogen bonds can influence the positional or conformational interaction of compounds, potentially impacting their pharmacological behavior, especially binding affinities or solubility."
Fentanyl,Ondansetron,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,π-π Stacking,"π-π stacking occurs when aromatic rings are in close proximity, allowing for overlap of their π orbitals, which can stabilize the interaction through non-covalent interactions.","In SMILES 1, there are two phenyl rings: `C3=CC=CC=C3`. In SMILES 2, there is also a phenyl ring: `C4=CC=CC=C4`. These aromatic groups can potentially align parallel to each other under physiological conditions, facilitating π-π interactions.","Moderate - While π-π stacking is often a stabilizing interaction, its pharmacological impact depends on the context within a physiological environment, which is not provided here."
Methylphenidate,Modafinil,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,π-π Stacking,"Aromatic rings from both molecules can engage in a π-π stacking interaction, a non-covalent bond formed between aromatic structures through interaction of their electron clouds.","Both SMILES strings have benzene rings present. SMILES 1 has a benzene ring represented by `C2=CC=CC=C2`, and SMILES 2 has two benzene rings represented by `C1=CC=C(C=C1)` and `C2=CC=CC=C2`.","Moderate - π-π stacking can influence the binding affinity of drugs to protein targets or each other, which may affect pharmacokinetics and dynamics."
Gabapentin,Bimatoprost,C1CCC(CC1)(CC(=O)O)CN,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Hydrogen Bonding,The presence of hydrogen bond donors and acceptors in close proximity could allow for hydrogen bonding between the two molecules.,"- In SMILES 1, the CN group at the end provides a -NH group that can act as a hydrogen bond donor.
- In SMILES 2, the several -OH groups present, such as in the segment ""C(C1C=CC(CCC2=CC=CC=C2)O)O"", can act as hydrogen bond acceptors.","Moderate - This interaction could influence the relative positioning or affinity of the molecules when in close proximity, potentially affecting their pharmacological activity."
Lidocaine,Metoprolol,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor and an acceptor, often involving a hydroxyl (OH) group as the donor and a carbonyl (C=O) group as the acceptor.","SMILES 1 contains a carbonyl group (CC(=O)NC1), which can act as a hydrogen bond acceptor. SMILES 2 has a hydroxyl group (CC(C)NCC(COC1)O), which can act as a hydrogen bond donor.",Moderate - This hydrogen bond could impact the solubility or binding affinity of these molecules under physiological conditions.
Furosemide,Gemfibrozil,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Hydrogen Bonding,The phenolic hydroxyl group (-OH) in SMILES 2 can donate a hydrogen bond to the carboxylate group (-C(=O)O) in SMILES 1.,"In SMILES 1, the carboxylic acid group is represented by C(=O)O, which can participate as a hydrogen bond acceptor. In SMILES 2, the phenol group is represented by C=C(C=C1)O, where the hydroxyl (-OH) can act as a hydrogen bond donor.","Moderate - Hydrogen bonding can enhance binding affinity and solubility of drugs, potentially impacting their pharmacodynamics or pharmacokinetics."
Famotidine,Lamivudine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Hydrogen Bonding,Hydrogen bonding can occur between a hydrogen atom bound to a nitrogen (or oxygen) in one molecule and a nitrogen (or oxygen) atom in another molecule due to the presence of lone electron pairs.,"In SMILES 1, the group ""N=C(N)N"" includes nitrogen atoms that may act as hydrogen bond donors or acceptors. Similarly, in SMILES 2, groups like ""=NC2=O"" have oxygen atoms which can be hydrogen bond acceptors. Also, the hydroxyl group ""(OC(S1)CO)"" in SMILES 2 contains a hydrogen bound to oxygen, which could act as a donor to nitrogen atoms in SMILES 1.","Moderate - Depending on the orientation and proximity of these groups in their 3D conformations, these hydrogen bonds may significantly impact drug binding or solubility in a physiological environment."
Naproxen,Brimonidine,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Hydrogen Bonding,"The carboxylic acid group (C(=O)O) in SMILES 1 can act as a hydrogen bond donor or acceptor, and the nitrogen atoms in the triazine ring (NC=CN) of SMILES 2 can act as hydrogen bond acceptors.","SMILES 1 contains a carboxylic acid group (C(=O)O), and SMILES 2 contains nitrogen atoms in the triazine ring structure (NC=CN).",Moderate - Hydrogen bonding can influence solubility and bioavailability but may not strongly alter pharmacological activity on its own.
Haloperidol,Rosiglitazone,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors in one molecule and hydrogen acceptors in the other. In this case, the hydroxyl group (O-H) in SMILES 1 can serve as a hydrogen bond donor, interacting with the carbonyl oxygen (C=O) in SMILES 2, which can act as a hydrogen bond acceptor.","SMILES 1 contains an -OH group (`O`), indicating a potential hydrogen donor. SMILES 2 contains an amide carbonyl (`C(=O)N`), which can act as a hydrogen bond acceptor.",Moderate - This interaction could potentially influence the pharmacokinetics or pharmacodynamics of the drugs if they are co-administered.
Famotidine,Exemestane,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors present in the structures under physiological conditions. In SMILES 1, there are hydrogen bond donors and acceptors, while SMILES 2 also provides potential hydrogen bond acceptors.","SMILES 1 contains NH groups that can donate hydrogen bonds, specifically the ones in the thiadiazole ring (the nitrogen atoms adjacent to the sulfur, and the NH adjacent to the sulfonamide group). SMILES 2 contains carbonyl groups (=O) which can act as hydrogen bond acceptors.","Moderate - The presence of hydrogen bonding can influence drug binding and solubility, impacting pharmacokinetics and pharmacodynamics."
Ciclopirox,Imatinib,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,"The first molecule contains a hydroxyl group (O-H) capable of acting as a hydrogen bond donor. The second molecule contains several nitrogen atoms in aromatic heterocycles and an amide linkage, which can act as hydrogen bond acceptors.","SMILES 1 contains ""N(C(=C1)C2CCCCC2)O"", indicating the presence of a hydroxyl group (-OH) connected to a nitrogen atom. SMILES 2 contains ""NC(=O)"" and ""NC4=NC=CC(=N4)C5=CN=CC=C5"", indicating nitrogen atoms and an amide group that could accept hydrogen bonds.","Moderate - Hydrogen bonding interactions can influence binding affinity or alter pharmacokinetics, impacting the efficacy or potency of the drugs."
Ketoprofen,Sufentanil,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,Hydrogen Bonding,The interaction occurs between the hydrogen of the carboxylic acid group in SMILES 1 and the carbonyl oxygen of the amide group in SMILES 2.,"SMILES 1 contains a carboxylic acid group denoted by ""C(=O)O"", which can act as a hydrogen bond donor. SMILES 2 contains an amide group ""C(=O)N"", with the carbonyl oxygen capable of acting as a hydrogen bond acceptor.",Moderate - Hydrogen bonding can significantly influence drug-drug interactions by stabilizing a complex or altering solubility and bioavailability.
Naproxen,Cetirizine,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Hydrogen Bond,"Hydrogen bonding can occur between a hydrogen bond donor (such as an acidic hydrogen) and a hydrogen bond acceptor (such as a carbonyl oxygen). In this case, the carboxylic acid group (-C(=O)O) in SMILES 1 could potentially form a hydrogen bond with the nitrogen atom in the piperazine ring of SMILES 2.",The carboxylic acid group in SMILES 1 (C(=O)O) provides a potential hydrogen bond donor (the hydrogen from the -OH group) and the piperazine nitrogen in SMILES 2 can act as a hydrogen bond acceptor.,"Moderate - This interaction is likely to have a moderate pharmacological impact as hydrogen bonds can stabilize drug-drug complexes, influencing bioavailability or metabolic stability."
vincristine,Torasemide,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donors (e.g., -NH groups) and acceptors (e.g., carbonyl oxygen atoms or sulfonyl oxygen atoms). In these SMILES strings, such groups are present.","- The first SMILES has esters denoted by ""C(=O)OC"" and tertiary amide groups, which provide carbonyl oxygens as potential acceptors for hydrogen bonds.
- The second SMILES contains an -NH group in ""NC2"" (aniline derivative) and also sulfonamide (S(=O)(=O)N) and amide groups, both providing nitrogen-hydrogen donors and carbonyl/sulfonyl oxygen acceptors.","Moderate - Hydrogen bonds often contribute significantly to molecular interactions affecting solubility, permeability, or binding in biological systems, thus potentially affecting pharmacokinetics or pharmacodynamics."
Lamotrigine,Dexpramipexole,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,CCCNC1CCC2=C(C1)SC(=N2)N,Hydrogen Bonding,"Hydrogen bonds may form between a hydrogen donor atom with a partial positive charge (such as an -NH or -OH group) and an electronegative hydrogen acceptor atom with a lone pair of electrons (such as -N, =O, or -Cl). In these SMILES, the NH group can act as a hydrogen donor, and the nitrogen atoms attached to unsaturated systems can act as hydrogen acceptors.","In SMILES 1, the group ""N=C(N=N2)"" includes nitrogen atoms that could act as hydrogen bond acceptors, while in SMILES 2, the primary amine group ""CCCNC1"" contains hydrogen that can act as hydrogen bond donors.",Moderate - The interaction occurs under physiological conditions and may affect drug binding or recognition but isn't as strong as ionic interactions.
Candesartan,Dexpramipexole,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CCCNC1CCC2=C(C1)SC(=N2)N,Hydrogen Bonding,"This interaction can occur between hydrogen bond donors and acceptors. In SMILES 1, the carboxylic acid group (C(=O)O) can act as both a hydrogen bond donor and acceptor. In SMILES 2, the thiazole nitrogen (SC(=N2)N) can act as a hydrogen bond acceptor, allowing for potential hydrogen bonding.",SMILES 1 – The group C(=O)O has both hydrogen bond donating and accepting capabilities due to the carbonyl oxygen and hydroxyl group. SMILES 2 – The nitrogen involved in the C(=N2) within the thiazole ring can function as a hydrogen bond acceptor.,"Moderate – This interaction is specific and could influence the binding affinity or conformation when these molecules are proximal, potentially affecting pharmacokinetic or pharmacodynamic properties."
Temazepam,Zafirlukast,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,Hydrogen Bonding,A hydrogen bond may occur between a hydrogen atom connected to a nitrogen in one molecule and a carbonyl oxygen in the other molecule.,"In SMILES 1, there is an N-H group in the structure of the amide linkage (C(=NC(C1=O)O)). In SMILES 2, there are carbonyl groups present (NC(=O) and OC(=O)). The N-H hydrogen from SMILES 1 can potentially form a hydrogen bond with one of the carbonyl oxygens in SMILES 2.","Moderate - Hydrogen bonds can influence drug binding affinity and specificity, which may alter pharmacological efficacy or interactions."
indometacin,Isoniazid,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,C1=CN=CC=C1C(=O)NN,Hydrogen Bonding,"Hydrogen bonding can occur between an electronegative atom bearing a hydrogen (donor) and another electronegative atom with a lone pair of electrons (acceptor). In these SMILES, the carboxylic acid group in the first structure can participate in hydrogen bonding with the amide group in the second structure.","In SMILES 1, the carboxylic acid group -CC(=O)O contains a hydroxyl (OH) which can donate a hydrogen. In SMILES 2, the amide group (=C(=O)NN) provides nitrogen or oxygen atoms that can accept hydrogen bonds.","Moderate - Hydrogen bonding can influence drug solubility and binding affinity, affecting pharmacokinetics and pharmacodynamics."
Aciclovir,Azelastine,C1=NC2=C(N1COCCO)NC(=NC2=O)N,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor group, such as an N-H group, and an acceptor group such as a carbonyl oxygen or a tertiary amine nitrogen, when properly oriented.","In SMILES 1, an N-H group is present in the pyrimidinone ring (NC(=NC2=O)N). In SMILES 2, a carbonyl oxygen (C=O) is part of the heterocyclic structure (N2C(=O)C3=CC=CC=C3).","Moderate - This hydrogen bond could stabilize co-binding at a target site, impacting the pharmacokinetic properties of both molecules if they are co-administered."
Ketorolac,Trazodone,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Hydrogen Bond,"A hydrogen bond can occur between a hydrogen donor and acceptor. In this case, the carboxylic acid group (-C(=O)O) in SMILES 1 can act as a hydrogen donor or acceptor, and the carbonyl group (C=O) within the urea moiety in SMILES 2 can act as a hydrogen acceptor.","In SMILES 1, the group C(=O)O indicates a carboxylic acid, which can form hydrogen bonds. In SMILES 2, the segment C(=O)N indicates a potential hydrogen-bond acceptor due to the presence of the carbonyl oxygen.","Moderate - This hydrogen bonding interaction can influence how the molecules orient themselves relative to each other, possibly affecting binding profiles or pharmacokinetics, but is not necessarily expected to dramatically alter pharmacological effects by itself without further context."
Metolazone,Metoprolol,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,Hydrogen Bonding,A hydrogen bond could possibly form between the hydrogen atom of the hydroxyl (–OH) group in SMILES 2 and the carbonyl oxygen (C=O) in SMILES 1.,"SMILES 1 contains a carbonyl group (C=O) within the structure, which can act as a hydrogen bond acceptor. SMILES 2 contains an alcohol group (–OH), where the hydrogen can act as a hydrogen bond donor.","Moderate - Hydrogen bonds are significant in molecular recognition processes and can impact drug interactions and binding affinity, affecting pharmacological activity."
Carvedilol,Metolazone,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Hydrogen Bonding,Hydrogen bonds can form between a hydrogen donor (such as an -OH group) and an acceptor (such as a carbonyl group C=O or -N in sulfonamide).,"The first SMILES contains an -OH group (""OCCNCC(COC2=CC=..."") while the second SMILES features a carbonyl group (""C(=O)N1C3=..."") and a sulfonamide group (""S(=O)(=O)N"").","Moderate - Hydrogen bonding can influence the binding affinity and solubility of molecules, affecting pharmacokinetics and potential interactions between drugs."
Zafirlukast,Duloxetine,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen atom, which is covalently bound to an electronegative atom (such as nitrogen or oxygen), creating a donor group, and an electronegative atom with a lone pair of electrons (such as nitrogen or oxygen) that can act as an acceptor. This kind of interaction is important for the affinity and specificity of molecular interactions, particularly in drug design.","In SMILES 1, the group S(=O)(=O)N represents a sulfonamide group, where the nitrogen can be a hydrogen bond donor. Additionally, the oxygen atoms in the sulfonamide group can act as hydrogen bond acceptors. In SMILES 2, the nitrogen in the CNCCC chain can act as a hydrogen bond donor.","Moderate - Hydrogen bonding can significantly influence molecular interactions, affecting drug efficacy and selectivity."
Diazepam,melphalan,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,Hydrogen Bonding,Hydrogen bonding can occur between the carbonyl oxygen (C=O) in SMILES 1 and the amine hydrogen (-NH-) in SMILES 2.,"SMILES 1 contains a carbonyl group (C=O), and SMILES 2 contains a primary amine (-NH-) in the side chain connected to the aromatic ring, which can act as a hydrogen bond donor.",Moderate - This interaction can influence binding affinity or solubility under physiological conditions.
Celecoxib,Lamotrigine,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Hydrogen Bonding,"Hydrogen bond donors and acceptors are present in both molecules, potentially facilitating hydrogen bonding. SMILES 1 contains sulfonamide (S(=O)(=O)N) groups which are potential hydrogen bond acceptors. SMILES 2 has a primary amine (N) that can act as a hydrogen bond donor.","In SMILES 1, the sulfonamide group has oxygen atoms capable of accepting hydrogen bonds. In SMILES 2, the primary amine group is a hydrogen bond donor.","Moderate - Hydrogen bonding can affect binding affinity and solubility, influencing drug interaction potential."
Furosemide,Indapamide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,Hydrogen Bonding,Hydrogen bonding can occur between the carboxylic acid group in SMILES 1 and the sulfonamide group in SMILES 2.,"In SMILES 1, the carboxylic acid group (C(=O)O) can act as a hydrogen bond donor or acceptor. In SMILES 2, the sulfonamide group (S(=O)(=O)N) contains oxygen atoms that can serve as hydrogen bond acceptors.","Moderate - Such interactions could influence the solubility or binding affinity under physiological conditions, affecting pharmacokinetics or dynamics."
Citalopram,Dapsone,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,Hydrogen Bonding,The nitrogen atom from the amine group in SMILES 2 can act as a hydrogen bond donor. The nitrile group (C#N) in SMILES 1 has a nitrogen that can potentially act as a hydrogen bond acceptor.,SMILES 1 contains the nitrile group (C#N) which includes a nitrogen that could act as a hydrogen bond acceptor. SMILES 2 contains an amine group (N) which can provide a hydrogen atom for bonding.,Moderate - Such interactions can affect the binding properties or solubility of the drugs.
Gabapentin,Minoxidil,C1CCC(CC1)(CC(=O)O)CN,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen bond donors and acceptors. The second molecule contains oxygen in a hydroxyl group and a nitrogen in an amine group, which can act as a hydrogen bond acceptor and donor, respectively. The first molecule contains an amine group that can act as a hydrogen bond donor.","- SMILES 1: Presence of an amine group (CN), where nitrogen can donate a hydrogen.
- SMILES 2: Presence of a hydroxyl group (N(C2)O) and an amine group in (N=C) that can accept or donate hydrogens for hydrogen bonding.",Moderate - This type of interaction could lead to a slight alteration in drug binding or solubility properties but is not likely major without additional specific binding context.
Orphenadrine,Trazodone,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Hydrogen Bonding,"A hydrogen bond can form when a hydrogen atom is covalently bonded to an electronegative atom (such as oxygen or nitrogen) and comes into proximity with another electronegative atom with a lone pair of electrons. In the given SMILES strings, molecule 1 has an -OH group that can act as a hydrogen bond donor, and molecule 2 contains several nitrogen atoms with lone pairs that can act as hydrogen bond acceptors.","The -OH group in SMILES 1 is part of the fragment ""C(C2=CC=CC=C2)O"", while the nitrogen atoms in SMILES 2, such as ""N2C(=O)N"", could interact as acceptors.","Moderate - Hydrogen bonds can influence drug affinity and specificity, potentially impacting pharmacokinetics or dynamics under physiological conditions."
Ketorolac,Moexipril,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors. In the provided SMILES, the carboxylic acid group from SMILES 1 can act as a hydrogen donor, and the carbonyl groups or oxygen atoms in ether linkages from SMILES 2 can act as hydrogen acceptors.","- SMILES 1 contains ""C(=O)O"" which is a carboxylic acid group that can donate hydrogen.
- SMILES 2 contains multiple carbonyl groups ""C(=O)"" and ether linkages ""OC"", which can accept hydrogen.","Moderate - Hydrogen bonding can influence binding affinity and drug interactions under physiological conditions, potentially affecting the pharmacokinetic or pharmacodynamic properties."
Naproxen,Exemestane,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,Pi-Pi Stacking,"Pi-Pi interactions occur between aromatic rings; when aromatic systems come into close proximity, they can stack, leading to stabilizing interactions.","SMILES 1 contains an aromatic phenyl-ether group indicated by ""C1=CC2=..."" and SMILES 2 contains another aromatic ring system indicated by ""C4=CC(=O)C=CC34C."" These groups could engage in face-to-face or edge-to-face stacking interactions.","Moderate - While pi-pi stacking can influence drug behavior, the overall pharmacological impact would depend on the context in which these molecules interact, which is unknown from SMILES alone."
Fentanyl,Loxapine,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,Aromatic stacking (π-π interaction),Aromatic stacking occurs when planar aromatic rings interact with each other through π-π interactions due to overlapping of π-electron clouds.,"Both SMILES contain aromatic rings. SMILES 1 has phenyl groups ""C2=CC=CC=C2"" and ""C3=CC=CC=C3"" which are classical aromatic systems. SMILES 2 contains aromatic rings as part of the quinoline moiety ""C2=NC3=CC=CC=C3OC4=C2"".","Moderate - Aromatic stacking can affect the relative orientation of the molecules, potentially influencing receptor binding or altering overall drug efficacy."
Tolbutamide,Perindopril,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor and an acceptor. In the given SMILES, SMILES 1 contains a sulfonamide group (N-S(=O)(=O)) that can act as a hydrogen bond acceptor due to the oxygen atoms bonded to sulfur. SMILES 2 has an amide group (C(=O)N) which shows a potential for hydrogen donating from the NH moiety as well as accepting through the carbonyl oxygen.","In SMILES 1, the sulfonamide group's oxygens have lone pairs that can accept hydrogen bonds. In SMILES 2, the NH in the amide group can donate a hydrogen, forming a potential hydrogen bond between SMILES 1 and SMILES 2.","Moderate - The potential hydrogen bonding can influence docking and activity, possibly affecting the pharmacokinetics/dynamics but is unlikely to be the sole determinant of interaction without other complementary interactions."
Efavirenz,Lamivudine,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Hydrogen Bonding,The presence of a hydrogen bond donor (hydroxyl group) in SMILES 2 and potential hydrogen bond acceptors (carbonyl groups) in SMILES 1 indicates the possibility of hydrogen bonding.,"SMILES 1 contains an ""NC(=O)O"" moiety, where the carbonyl oxygen can act as a hydrogen bond acceptor. SMILES 2 has a ""CO"" that denotes a hydroxyl group (-OH), which is a hydrogen bond donor.",Moderate - Hydrogen bonds can significantly influence the pharmacokinetics or binding properties but often do not lead to high-impact interactions without additional context.
Dapsone,Perindopril,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors in both molecules. In SMILES 1, the sulfonamide group (S(=O)(=O)) contains oxygen atoms that can serve as hydrogen bond acceptors. In SMILES 2, the amide group (NC(C)C(=O)) has a nitrogen and hydrogen that can act as hydrogen bond donors and acceptors.","In SMILES 1, the substructure ""S(=O)(=O)"" indicates the presence of sulfone oxygen atoms, which are capable of accepting hydrogen bonds. In SMILES 2, the amide portion ""NC(C)C(=O)"" of the molecule features an NH group capable of donating hydrogen bonds.","Moderate - Given the nature of the interaction and its potential influence on the pharmacological behavior of the drugs, moderate severity is assumed without further context."
Candesartan,Desloratadine,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,π-π Stacking,"π-π stacking interaction occurs between aromatic rings in the two molecules. This interaction originates from the overlap of the π-electron clouds of the adjacent aromatic rings, which can create a stabilizing interaction.","The first SMILES contains multiple aromatic rings, such as benzene (CC1=CC=C1), naphthyl (C4=CC=CC=C4), and triazole (C5=NNN=N5). The second SMILES includes a chlorophenyl group (C2=CC=CC(Cl)=C2) and a pyridine ring (C4=C1C=CC=N4). These groups are capable of engaging in π-π stacking.",Moderate - π-π stacking can moderately influence molecular aggregation and binding affinity but typically does not have an extreme pharmacological impact alone.
Furosemide,Sorafenib,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Hydrogen Bonding,"Hydrogen bonding can occur between the carboxylic acid group (-C(=O)O) from SMILES 1 and an amine or amide group from SMILES 2. The hydrogen on the nitrogen of an amine or amide can serve as an H-bond donor, and the oxygen on the carboxylic acid can be an H-bond acceptor.","SMILES 1 contains a carboxylic acid group (C(=O)O), which can act as a hydrogen bond acceptor. SMILES 2 contains several nitrogen atoms in the amine (CNC(=O)) and amide (NC(=O)NC) groups that can potentially serve as hydrogen bond donors.","Moderate - This interaction could stabilize a specific conformation or binding, potentially altering pharmacokinetic or pharmacodynamic properties."
Megestrol,Desloratadine,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,Steric Clashes,The bulkiest segments within the structures may limit the conformational flexibility or the appropriate positioning of each molecule upon close contact.,"- SMILES 1 contains multiple fused and substituted cyclohexane rings which form a very bulky structure. Specific features like the presence of two quaternary carbons (C3 and C4 in SMILES 1) highlight the bulky nature.
- SMILES 2 has fused aromatic rings (namely, a bicyclic indole-like system) that add rigidity and significant bulk to its structure.","Moderate - Steric clashes could influence binding affinities and the overall pharmacological effect, leading to possible competitive inhibition or reduced efficacy if both compounds target similar sites or environments within the body."
Metronidazole,Repaglinide,CC1=NC=C(N1CCO)[N+](=O)[O-],CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,Hydrogen bonding,"Hydrogen bonding is likely between the nitro group of SMILES 1 and the carboxylic acid group of SMILES 2. The nitro group contains oxygen atoms with partial negative charges, which can interact with the hydrogen of the hydroxyl group in the carboxylic acid.","- SMILES 1 contains a nitro group: [N+](=O)[O-]
- SMILES 2 contains a carboxylic acid group: C(=O)O","Moderate - The existence of hydrogen bonding could affect pharmacological properties such as solubility, absorption, or binding to biological targets depending on the concentration and presence of other interactions."
Naproxen,Orphenadrine,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,Pi-Pi Stacking,"Pi-pi stacking occurs when aromatic rings interact with each other through overlapping p-orbitals, which results in a stabilizing non-covalent interaction.","Both SMILES strings feature aromatic rings: SMILES 1 has a benzene ring within the methoxy-substituted phenyl group, and SMILES 2 contains two phenyl rings.","Moderate - Pi stacking can significantly influence molecular recognition and stability of drug complexes, affecting pharmacokinetics and pharmacodynamics."
Triazolam,Zaleplon,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,π-π Stacking,"π-π stacking occurs when the electron clouds of aromatic rings in proximity to each other overlap, leading to attractive interactions. This is common between planar aromatic structures.","SMILES 1 has aromatic rings connected to chlorine atoms and nitrogen atoms (potential ring structures: benzene rings). SMILES 2 has pyridine and benzene rings, which are also aromatic.","Moderate - π-π stacking is a fairly common interaction and can influence binding affinity and drug activity in a biological setting, but its impact can vary depending on the context."
Naproxen,Carvedilol,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,Hydrogen Bonding,The hydroxyl group present in SMILES 2 (C-O-H) can act as a hydrogen bond donor and may interact with the carbonyl oxygen of the carboxylic acid group in SMILES 1 (C(=O)O) acting as a hydrogen bond acceptor.,"In SMILES 1, the group C(=O)O represents a carboxylic acid, specifically highlighting the carbonyl oxygen which can accept hydrogen bonds. In SMILES 2, the group -C(COC2=CC=CC3=C2C4=CC=CC=C4N3)O represents a secondary alcohol where the C-OH portion contains a hydrogen that can be donated for hydrogen bonding.",Moderate - Hydrogen bonds can influence the pharmacokinetics and binding interactions in a biological environment.
Alprazolam,Sorafenib,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,π-π Stacking,"π-π stacking is a non-covalent interaction between aromatic rings. It occurs due to the attractive forces between the electron cloud of the aromatic systems, stabilizing the interaction.","Both SMILES strings contain aromatic rings. SMILES 1 has a phenyl ring (C4=CC=CC=C4), and SMILES 2 has multiple aromatic rings, including pyridine (C1=NC=CC(=C1)) and phenoxy groups (OC2=CC=C(C=C2)). The presence of multiple conjugated systems increases the likelihood of π-π stacking.","Moderate - π-π stacking can influence binding efficiency and specificity of drugs, potentially impacting pharmacodynamics and pharmacokinetics."
Cimetidine,Ibuprofen,CC1=C(N=CN1)CSCCNC(=NC)NC#N,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Hydrogen bonding,"The SMILES 1 contains a secondary amine group (N-H) which can serve as a hydrogen bond donor. The SMILES 2 contains a carboxylic acid group (C(=O)O) that can act as both a hydrogen bond donor and acceptor. Therefore, this amine group could potentially form a hydrogen bond with the carbonyl oxygen of the carboxylic acid.","- From SMILES 1: Presence of secondary amine group (CSCCN), specifically the NH part.
- From SMILES 2: Carboxylic acid group (-C(=O)O), specifically the C=O component.",Moderate - Hydrogen bonds can influence molecular solubility and interaction but generally have moderate impact compared to covalent bonds in the context of pharmacological effects.
Famotidine,Imatinib,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Hydrogen Bonding,"Hydrogen bonding can occur between donor and acceptor sites in these molecules. In SMILES 1, there are several NH groups that can act as hydrogen bond donors, and in SMILES 2, there are nitrogens in aromatic rings and amide groups that can act as hydrogen bond acceptors.","- SMILES 1: NH groups in the thiohydantoin and sulfonamide regions (N=C(N)N, and NS(=O)(=O)N) can donate hydrogen bonds.
- SMILES 2: Nitrogen atoms in the heterocyclic pyridine and other aromatic rings (e.g., NC4=NC=CC(=N4)C5=CN=CC=C5) and the amide carbonyl (NC(=O)C) can accept hydrogen bonds.",Moderate - This might affect binding profiles or solubility but depends on concentration and context.
Aciclovir,Efavirenz,C1=NC2=C(N1COCCO)NC(=NC2=O)N,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Hydrogen Bonding,Hydrogen bonding can occur between hydrogen bond donors (such as NH groups) and hydrogen bond acceptors (such as carbonyl oxygen atoms or other electronegative atoms).,The first SMILES contains an amide group (NC=O in NC(=NC2=O)N) that acts as both a hydrogen bond donor (NH) and acceptor (C=O). The second SMILES contains a carbonyl group (NC(=O)O2) that can act as a hydrogen bond acceptor.,"Moderate - If the hydrogen bonding sites of these molecules are suitably aligned when in close proximity, they can enhance binding affinity or modify the orientation within a biological target."
Ondansetron,Zolpidem,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Hydrogen Bonding,"A potential hydrogen bond can form between a hydrogen bond donor and a hydrogen bond acceptor. In these SMILES, the protonated nitrogen in one structure can interact with a carbonyl oxygen in the other.","- SMILES 1 contains a carbonyl group (C2=O) which can act as a hydrogen bond acceptor.
- SMILES 2 contains a secondary amine group (N(C)C) and an aromatic nitrogen (in the imidazole ring N3=C), either of which can donate a hydrogen for bonding.","Moderate - This type of interaction can influence the binding affinity and solubility of the drugs, but it may not drastically alter their pharmacokinetic profiles unless the interaction is particularly strong or prevalent under physiological conditions."
Amlodipine,melphalan,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,Hydrogen Bonding,Hydrogen bonding can occur when there is an interaction between a hydrogen donor (such as an -OH or -NH group) and an acceptor (such as a carbonyl oxygen).,"In SMILES 1, there is an amide group denoted by ""NC(=C(...)"", which includes an -NH that can act as a hydrogen donor. In SMILES 2, there is a carboxylic acid group, ""C(=O)O"", with a carbonyl oxygen that can act as a hydrogen acceptor.",Moderate - Hydrogen bonding can affect binding affinity and solubility but typically has less impact compared to ionic interactions or covalent bonds.
Naproxen,Efavirenz,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Aromatic π-π stacking,"π-π stacking interactions can occur between aromatic rings due to the parallel orientation of the π-orbitals, allowing for mild electrophilic and nucleophilic character interactions.","SMILES 1 contains two aromatic rings in the structure ""C1=CC2=C(C=C1)C=C(C=C2)OC"" which indicates overlapping aromatic rings. SMILES 2 has an aromatic ring in the portion ""C3=C(C=CC(=C3)Cl)"", suggesting potential for face-to-face interactions with the aromatic rings in SMILES 1.","Moderate - while π-π stacking is common and can influence binding and stabilization in a biological context, the overall pharmacological impact tends to be moderate without additional specific binding context."
Capecitabine,Desloratadine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,Potential Pi-Pi Stacking,"Pi-Pi stacking interactions occur when aromatic rings, such as phenyl rings or heterocycles, overlap and stabilize each other through pi-electron cloud interactions.","SMILES 1 contains an aromatic heterocycle ""NC1=NC"" and SMILES 2 has multiple aromatic rings, such as ""C1CC2"" and ""C4=C1"". These aromatic systems could potentially align themselves in a face-to-face orientation under physiological conditions, leading to pi-pi stacking.","Moderate - While pi-pi stacking can influence binding affinities in certain biological contexts, its pharmacological impact depends on the context of drug action, which is not specified here."
Famotidine,Darunavir,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Hydrogen Bonding,A hydrogen bond can form between a hydrogen donor (such as an amine) and an acceptor (such as a carbonyl oxygen or sulfonamide oxygen).,"- SMILES 1 contains N-H groups from the amine and thioamide: ""N=C(N)N"" and ""C(=NS(=O)(=O)N)"".
- SMILES 2 contains carbonyl oxygen from an ester: ""NC(=O)OC"".","Moderate - Hydrogen bonding can affect the binding affinity and solubility, impacting pharmacokinetics and pharmacodynamics."
Ofloxacin,Oxaprozin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,Hydrogen Bonding,Interaction between potential hydrogen bond donors and acceptors present in the two molecules.,"In SMILES 1, the carboxylic acid group `C(=O)O` at the end of the chain can serve as a hydrogen bond donor via its hydroxyl `O-H`, as well as an acceptor via its carbonyl `C=O`. In SMILES 2, the carbonyl group `C=O` within the carboxylic acid group also presents an opportunity for hydrogen bonding as an acceptor.",Moderate - Hydrogen bonds can significantly influence drug solubility and intermolecular interactions that affect binding affinity and specificity.
Citalopram,Salmeterol,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen donor (such as an -OH group) and a hydrogen acceptor (such as a nitrile or an ether oxygen), facilitating interaction between the two molecules.","SMILES 1 contains a nitrile group (C#N), which can act as a hydrogen bond acceptor. SMILES 2 contains multiple alcohol groups (-OH) that can serve as hydrogen bond donors. This structural alignment enables hydrogen bonding.","Moderate - Hydrogen bonding can influence binding affinity or solubility, potentially affecting pharmacodynamics/pharmacokinetics."
Orphenadrine,Temazepam,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,Hydrogen Bonding,A potential hydrogen bonding interaction can occur between the hydrogen of the hydroxyl group in SMILES 1 and the carbonyl oxygen in SMILES 2. The hydroxyl group (O-H) can donate a hydrogen bond to the acceptor carbonyl oxygen.,"SMILES 1 contains an -OCCN functional group, where the oxygen can participate in hydrogen bonding. SMILES 2 includes a carbonyl group (C1=O), which can act as a hydrogen bond acceptor.",Moderate - This interaction can affect the solubility or binding affinity of the drugs but is unlikely to be the sole driving force in their pharmacological activity.
acetazolamide,Lamotrigine,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Hydrogen Bonding,"The presence of hydrogen bond donors and acceptors in both molecules facilitates hydrogen bonding. The sulfonamide group in the first SMILES (CC(=O)NC1=NN=C(S1)S(=O)(=O)N), specifically the sulfonamide nitrogen, and the secondary amine in the second SMILES (C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N) have hydrogen-donating and hydrogen-accepting capabilities that promote hydrogen bond formation.","In SMILES 1, the sulfonamide group ""S(=O)(=O)N"" provides an oxygen that can accept a hydrogen bond. In SMILES 2, the amine group ""N"" can serve as a hydrogen bond donor.","Moderate - The hydrogen bond interaction can impact the drugs' solubility and biological availability, therefore having moderate pharmacological relevance."
Telmisartan,solifenacin,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,π-π Stacking,"This occurs when two aromatic rings interact in a face-to-face or edge-to-face manner, allowing electron cloud interactions between the π systems of the benzene rings to stabilize the interaction.","SMILES 1 contains aromatic rings at ""CC3=CC=C(C=C3)"" and ""C4=CC=CC=C4"", and SMILES 2 contains aromatic rings at ""C4=CC=CC=C4"" and ""C5=CC=CC=C5"". These aromatic systems are capable of undergoing π-π stacking interactions.","Moderate - π-π stacking interactions can influence the binding modes of drugs to proteins or other macromolecules, affecting pharmacological activity."
Temazepam,Emtricitabine,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,Hydrogen Bonding,"Hydrogen bonding can occur when a hydrogen atom covalently bonded to an electronegative atom (such as oxygen or nitrogen) forms an electrostatic interaction with another electronegative atom. In SMILES 1, there is an oxygen atom as part of the carboxylic acid group, which can act as a hydrogen bond acceptor. In SMILES 2, the secondary amine (N) has a potential hydrogen atom that can form a hydrogen bond with an electronegative atom.","SMILES 1 contains a carboxy group ""-C(=O)O"" which provides an electronegative oxygen that can accept hydrogen bonds. SMILES 2 includes an amide ""-C(=O)N"" and auxiliary ""-N"" sites that can donate hydrogen bonds via available hydrogen atoms connected to nitrogen.","Moderate - This interaction could potentially stabilize a complex between the two molecules, affecting pharmacokinetic properties such as absorption or distribution if both drugs are present in the system."
Metoprolol,Acitretin,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,π-π Stacking,"π-π stacking interactions can occur between aromatic rings in close proximity, facilitated by overlapping π-orbitals in the rings.","Both SMILES strings contain phenyl groups: 
- SMILES 1 has a phenyl group in the fragment `C1=CC=C(C=C1)`.
- SMILES 2 has multiple aromatic rings, for instance, `CC1=CC(=C(C(=C1...)...)OC` denotes a phenyl ring and its conjugated systems.","Moderate - These interactions can stabilize the drug complex, potentially affecting bioavailability or receptor binding affinity."
Candesartan,Lamivudine,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Hydrogen Bonding,"Hydrogen bonding is likely to occur between the carbonyl oxygen in SMILES 1 (ester group) and the hydroxy group in SMILES 2. These groups can serve as hydrogen bond acceptor and donor, respectively, facilitating interaction.","- SMILES 1 contains a carbonyl group as part of an ester, denoted by ""C(=O)O"".
- SMILES 2 contains a hydroxyl group, denoted by ""CO"" right after the cyclic ether ""OC(S1)"".","Moderate - The interaction involves functional groups typically engaging in hydrogen bonding, which can influence pharmacokinetics and the binding affinity towards biological targets if both molecules are present in close proximity."
Gabapentin,Amiloride,C1CCC(CC1)(CC(=O)O)CN,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,Hydrogen Bond,"A hydrogen bond can occur between a hydrogen donor and a hydrogen acceptor. In this case, the amine group from SMILES 1 can act as a hydrogen donor, and the carbonyl oxygen or amine nitrogen atoms in SMILES 2 can act as hydrogen acceptors.","- SMILES 1 contains an ""CN"" group at the end, where the nitrogen can donate a hydrogen in physiological conditions.
- SMILES 2 contains multiple potential acceptors: the carbonyl oxygen (""C(=O)N"") and the nitrogen atoms within the ring and side chains (e.g., ""=N"" and ""(=N)"").","Moderate - This type of interaction can influence the binding between molecules, potentially affecting pharmacological behavior, but the impact would depend on the broader context of biological systems and concentrations."
Carvedilol,Pirbuterol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O,Hydrogen Bonding,"The hydrogen bonding interaction can occur due to the presence of hydroxyl (OH) groups in both molecules, which can serve as hydrogen bond donors or acceptors.","- SMILES 1 contains an -OH group on the aromatic ring (represented as COC1=CC=CC=C1O), and another -OH group attached to the alkyl chain (represented as NCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O).
- SMILES 2 contains an -OH group on the alkyl chain (represented as CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O) and an -OH group bonded to a different aromatic ring (represented as NC(=C(C=C1)O)CO).","Moderate - Hydrogen bonding can influence solubility and binding affinities, impacting pharmacokinetic and pharmacodynamic profiles."
Dexpramipexole,Trimethoprim,CCCNC1CCC2=C(C1)SC(=N2)N,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Hydrogen Bonding,The second SMILES contains amino groups (N) that could act as hydrogen bond donors. The first SMILES also has nitrogen atoms capable of receiving hydrogen bonds.,"In SMILES 1, the amino group (NC in the imidazothiazole ring) can act as a hydrogen bond donor or acceptor. In SMILES 2, the guanidine (N) at the end (N=C(N)N) can act as a hydrogen bond donor.",Moderate - Hydrogen bonding can potentially influence the binding and pharmacological profile of drugs in a biological setting.
Metolazone,Dexpramipexole,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,CCCNC1CCC2=C(C1)SC(=N2)N,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen bond donors and acceptors. SMILES 1 contains a sulfonamide group (S(=O)(=O)N), which has oxygen atoms that can act as hydrogen bond acceptors. SMILES 2 contains a primary amine group (N) and potentially other secondary nitrogen atoms capable of donating hydrogen bonds.","SMILES 1 includes S(=O)(=O)N, which provides two oxygen atoms as possible hydrogen bond acceptors. SMILES 2 features a primary amine (NH) which can serve as a hydrogen bond donor.","Moderate - Hydrogen bonds can influence molecular interactions moderately, affecting solubility and binding affinity."
Amlodipine,Ketoprofen,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Hydrogen Bonding,"SMILES 2 contains a carboxylic acid group (-C(=O)O), which can engage in hydrogen bonding. SMILES 1 contains a secondary amine group (-NC) that could potentially act as a hydrogen bond acceptor. Under physiological conditions, the hydrogen of the carboxylic acid can form a hydrogen bond with the nitrogen in the secondary amine.","- SMILES 1: Presence of secondary amine: NC(=C...
- SMILES 2: Presence of carboxylic acid: C(=O)O","Moderate - Hydrogen bonding can significantly affect the drugs' interactions, potentially altering their pharmacokinetics or pharmacodynamics under certain conditions."
Gabapentin,Darunavir,C1CCC(CC1)(CC(=O)O)CN,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Hydrogen Bonding,"Hydrogen bonding can occur between the amine group (NH2) of SMILES 1 and the sulfonamide group (S(=O)(=O)N) of SMILES 2. The nitrogen in the amine can act as a hydrogen bond donor, and the oxygen atoms in the sulfonamide can act as hydrogen bond acceptors.","SMILES 1 contains an amine group (CN), and SMILES 2 contains a sulfonamide group (S(=O)(=O)C=N).",Moderate - Hydrogen bonding is a common interaction that can affect the binding affinity and pharmacological activity when both drugs interact within the same physiological environment.
Naproxen,Zolpidem,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,π-π Stacking Interaction,"π-π stacking occurs when two aromatic rings align parallel to each other, allowing π-electron cloud interactions. This is possible between aromatic rings present in both structures.",Both SMILES strings contain planar aromatic rings: the methoxyphenyl group (`C1=CC2=C(C=C1)C=C(C=C2)OC`) in SMILES 1 and the aromatic `CC1=CC=C(C=C1)` group in SMILES 2.,Moderate - π-π interactions can stabilize complexes and affect binding affinity but generally not as strongly as more polar interactions like hydrogen bonds.
acetazolamide,Haloperidol,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Hydrogen Bonding,The carbonyl oxygen (C=O) in SMILES 1 can form a hydrogen bond with the hydroxyl group (-OH) present in SMILES 2.,"SMILES 1 contains ""C(=O)"" indicating a carbonyl group capable of accepting a hydrogen bond. SMILES 2 contains ""(C1...O)"" indicating a hydroxyl group capable of donating a hydrogen bond.",Moderate - Hydrogen bonding can increase the affinity and alter the pharmacokinetics of compounds within physiological environments.
indometacin,Sildenafil,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor and an acceptor. In the provided SMILES, the carboxyl group (COOH) in the first compound can donate a hydrogen, while the sulfonamide group (SO2NH) in the second compound may accept a hydrogen through one of its oxygen atoms.","- SMILES 1 contains ""CC(=O)O"", indicating a carboxylic acid group where the oxygen is likely to act as a hydrogen bond acceptor.
- SMILES 2 features ""S(=O)(=O)N"", indicating a sulfonamide group; the oxygen atoms within the sulfonamide function can serve as hydrogen bond acceptors.","Moderate - This hydrogen bonding could potentially affect the solubility and bioavailability of the drugs if they are co-administered, but without knowing the full context of their pharmacokinetics, the impact may not be extensive."
Zolpidem,Perindopril,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"A potential hydrogen bond could occur between the carbonyl oxygen (C=O) in SMILES 1, which is part of the amide group, and an amine hydrogen (N-H) associated with the amide in SMILES 2.","In SMILES 1, the carbonyl oxygen is indicated by ""C(=O)N"", and in SMILES 2, the amide nitrogen bound to hydrogen is indicated by ""NC"".","Moderate - Hydrogen bonding is a common interaction that can influence binding affinity in biological systems, impacting drug effectiveness or interaction with biological targets."
Ondansetron,Trazodone,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,Hydrogen Bonding,Hydrogen bonding can occur between potential hydrogen bond donors and acceptors present within the two structures.,"- SMILES 1 contains a pyridine ring with a nitrogen atom that can act as a hydrogen bond acceptor in the pyridine (NC=CN).
- SMILES 2 contains several amine groups (e.g., CCN(CCN). These secondary amines can serve as hydrogen bond donors.","Moderate - Hydrogen bonding can affect the solubility and binding affinity of drugs, potentially altering their pharmacological profiles."
Naproxen,Doxazosin,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,Hydrogen Bonding,"Hydrogen bonds are likely to form between the carboxylic acid group of SMILES 1 and the secondary amine group in the imidazole ring of SMILES 2. The carboxylic acid (COOH) can act as a hydrogen bond donor, and the nitrogen atom in the imidazole can act as a hydrogen bond acceptor in SMILES 2.","- SMILES 1 contains a carboxylic acid group represented as C(=O)O.
- SMILES 2 contains an imidazole ring with nitrogen atoms capable of acting as hydrogen bond acceptors, represented by the NC(=N)N group.","Moderate - Hydrogen bonds can moderately influence pharmacological interactions, potentially affecting the binding affinity or bioavailability of the drugs."
Ketoprofen,Perindopril,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"A carboxylic acid group in both SMILES 1 and SMILES 2 can participate in hydrogen bonding interactions. The hydroxyl (-OH) group of the acid can act as a hydrogen donor, and the carbonyl oxygen (=O) can act as a hydrogen acceptor. Given their comparable acidic functionalities, hydrogen bonding is possible.","SMILES 1 contains the ""C(=O)O"" indicating a carboxylic acid group. SMILES 2 contains the ""C(=O)OCC"" also indicating the presence of a carboxylic ester linked to another acidic group capable of similar hydrogen bonding properties.","Moderate - Hydrogen bonds can significantly influence the pharmacokinetics of drug interactions, especially if they are present at a binding site or are involved in transportation processes within cells."
Dipyridamole,oxybutynin,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Hydrogen bonding,Hydrogen bonds can form between hydrogen donor groups (often NH or OH) and acceptor groups (such as carbonyl oxygens or nitrogen heteroatoms) under physiological conditions.,"- In SMILES 1, multiple ethoxy groups (-CCO) attached to tertiary amines could potentially serve as hydrogen bond acceptors toward hydrogen bond donors. 
- In SMILES 2, the carbonyl oxygen in the ester group (COC(=O)) could serve as a hydrogen bond acceptor.","Moderate - The presence of potential hydrogen bonding interactions may influence the solubility or binding characteristics of the compounds, affecting pharmacological properties if both molecules are present concurrently."
Lamotrigine,Amiloride,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,Hydrogen bonding,A hydrogen bond can form between the amine group (–NH2) of the first compound and the carbonyl oxygen (=O) of the second compound.,"In SMILES 1, there is an amine group linked to the triazole ring, represented as N (potential hydrogen bond donor). In SMILES 2, there is a carbonyl group C(=O), also represented as C=O, which can serve as a hydrogen bond acceptor.","Moderate - Hydrogen bonding can have a significant influence on the stability and solubility of the drug complex, hence possibly affecting pharmacokinetics or pharmacodynamics."
Sumatriptan,Balsalazide,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,C1=CC(=CC=C1C(=O)NCCC(=O)O)NN=C2C=CC(=O)C(=C2)C(=O)O,Hydrogen Bonding,"The hydrogen bonding interaction can occur between a hydrogen bond donor and an acceptor within the drug molecules. In SMILES 1, sulfur dioxide (SO2) functional groups may potentially participate as weak hydrogen bond acceptors, and in SMILES 2, there are several carbonyl groups (C=O) and carboxylic acid groups (-COOH) that can serve as hydrogen bond donors or acceptors.","In SMILES 1, the SO2 group is a potential hydrogen bond acceptor. In SMILES 2, the carboxylic acid group (-COOH) serves as a hydrogen bond donor/acceptor, and the adjacent carbonyl groups (C=O) can act as hydrogen bond acceptors.","Moderate - The presence of multiple hydrogen bond donors and acceptors suggests a reasonable probability of intermolecular interactions, although the impact on pharmacological activity would depend on the context of the interaction and the environment of the molecules."
Temazepam,Bimatoprost,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Hydrogen bonding,Hydrogen bonds can form between a hydrogen donor (like -OH or -NH groups) and an acceptor (such as C=O groups) in the drug structures.,"In SMILES 1, the C1=O group is capable of acting as a hydrogen bond acceptor. In SMILES 2, the -NH group (from the CCNC=O moiety) can act as a hydrogen bond donor.",Moderate - This interaction could influence the pharmacokinetics or solubility characteristics of the drugs without necessarily being critical for their function.
Doxazosin,Dexpramipexole,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,CCCNC1CCC2=C(C1)SC(=N2)N,Hydrogen bonding,"A hydrogen bond can form between a hydrogen donor in one structure and a hydrogen acceptor in the other. Specifically, the nitrogen atom in the pyrimidine ring of SMILES 1 can act as a hydrogen bond acceptor due to its lone pair of electrons. The primary amine group (-NH2) in SMILES 2 can act as a hydrogen bond donor.","- SMILES 1 contains ""C(=NC(=N...)"", indicating nitrogen atoms that can accept hydrogen bonds.
- SMILES 2 contains ""CCCNC..."" indicating a primary amine group capable of donating hydrogen.","Moderate - Given the potential for hydrogen bond formation, this could influence the pharmacodynamics or pharmacokinetics of a drug when administered together."
Telmisartan,Bimatoprost,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Hydrogen Bonding,Hydrogen bonds can form between a hydrogen bond donor (such as an -OH or -NH group) and a hydrogen bond acceptor (such as a carbonyl oxygen or a nitrogen atom with a lone pair of electrons).,"In SMILES 1, there is a carboxylic acid group (-C(=O)O) which can act as a hydrogen bond acceptor. SMILES 2 contains hydroxyl groups (-OH) which can act as hydrogen bond donors.","Moderate - The interaction could potentially influence the solubility or conformation of the drugs when in close proximity, but would not necessarily lead to a drug-drug interaction with significant pharmacological impact without knowing more about the context in which they are used."
Amlodipine,Sufentanil,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,Hydrogen Bonding,"The first SMILES contains an amide group (NC(=O)) and a secondary amine (N-H) which can act as hydrogen bond donors. The second SMILES contains a carbonyl group (C=O) from an amide, which can act as a hydrogen bond acceptor.","- From SMILES 1: The amide group NC(=O) and secondary amine hydrogen.
- From SMILES 2: The carbonyl C=O from the amide group.","Moderate - Hydrogen bonds can influence the pharmacokinetics and dynamics by altering solubility, binding affinity, etc., but usually do not cause strong adverse effects themselves."
Ibuprofen,Perindopril,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,Hydrogen Bonding,"Hydrogen bonds can form between hydrogen donors and acceptors, such as between hydroxyl (-OH) or amine (-NH2) groups and carbonyls (C=O).","- SMILES 1 contains a carboxylic acid group (C(=O)O) which can act as both a hydrogen donor (OH) and an acceptor (C=O).
- SMILES 2 contains a secondary amine (NC(C)), where the NH could serve as a hydrogen donor. Additionally, the ester group (C(=O)OCC) has a carbonyl that could also act as a hydrogen bond acceptor.","Moderate - Hydrogen bonding can influence the solubility, stability, and pharmacokinetics of drugs, but it is just one of many factors that determine drug-drug interactions."
Zafirlukast,Zolpidem,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Hydrogen Bonding,"Hydrogen bonding occurs when a hydrogen atom covalently bonded to an electronegative atom, such as oxygen or nitrogen, forms an interaction with another electronegative atom. In the given SMILES strings, there are potential donor and acceptor pairs.","- SMILES 1: The amide group `NC(=O)C` provides a hydrogen bond donor (NH) and an acceptor (C=O). 
- SMILES 2: The carbonyl group `C(=O)N` provides a carbonyl oxygen that can act as a hydrogen bond acceptor.","Moderate - Hydrogen bonds can significantly influence the binding affinity and pharmacological interactions of drugs, especially in aqueous environments like the human body."
Amlodipine,Metronidazole,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CC1=NC=C(N1CCO)[N+](=O)[O-],Hydrogen Bonding,Hydrogen bond interactions can occur between the nitrogen atom in the nitro group ([N+](=O)[O-]) from SMILES 2 and the carbonyl oxygen (C=O) from the ester group in SMILES 1.,"In SMILES 1, the carbonyl oxygen in the ester group C(=O)OC can act as a hydrogen bond acceptor. In SMILES 2, the oxygen atoms of the nitro group [N+](=O)[O-] can act as hydrogen bond donors or acceptors.","Moderate - This interaction has the potential to influence solubility, molecular recognition, or bioavailability, depending on the context in which these molecules are used together."
Naproxen,Risedronic acid,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,Hydrogen Bonding,A hydrogen bond is likely to occur between the carboxylic acid group (-C(=O)O) of SMILES 1 and the hydroxyl group (O) attached to the phosphorus atom (P) in SMILES 2.,"SMILES 1 contains a carboxylic acid group ""C(=O)O"", which features both a hydrogen bond donor (hydroxyl hydrogen) and a hydrogen bond acceptor (carbonyl oxygen). SMILES 2 features the hydroxyl group bonded to phosphorus ""P(=O)(O)O"", where the oxygen is capable of accepting a hydrogen bond.","Moderate - Depending on the spatial orientation and availability of these groups, this interaction might influence the pharmacokinetics or pharmacodynamics of these molecules under physiological conditions."
Metronidazole,Fosphenytoin,CC1=NC=C(N1CCO)[N+](=O)[O-],C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Hydrogen Bonding,"The interaction can occur between hydrogen bond donors and acceptors present within the structures. In SMILES 1, the nitro group ([N+](=O)[O-]) can accept hydrogen bonds. In SMILES 2, there are several amide groups (C(=O)N) which can serve as hydrogen bond donors.","SMILES 1 contains a nitro group which is a potential hydrogen bond acceptor: [N+](=O)[O-]. SMILES 2 has amide groups: C(=O)N, capable of donating hydrogen bonds.",Moderate - Hydrogen bonding can stabilize complexes but is typically weaker than some other types of interactions and depends on structural orientation.
Temazepam,Bosentan,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,Hydrogen Bonding,"Hydrogen bonding can occur between hydrogen donors and hydrogen acceptors. In these two structures, there is potential for such an interaction due to the presence of suitable functional groups.","- SMILES 1 contains an N-C=O group, specifically the C1=O (carbonyl group) is a hydrogen bond acceptor.
- SMILES 2 contains multiple amine groups, particularly the NC(=N)NCC, where the NH acts as a hydrogen bond donor.","Moderate - The interaction between these groups might affect binding affinities or the orientation of the molecules in a biological context, but would not be the sole determinant of overall molecular interaction strength."
Pyridostigmine,Telithromycin,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Hydrogen Bonding,A potential hydrogen bond interaction occurs when a hydrogen bond donor (such as an N-H or O-H group) interacts with a hydrogen bond acceptor (such as an O or N atom with a lone pair).,"In SMILES 1, the methoxy ester group contains an oxygen atom (C(=O)OC) that can act as a hydrogen bond acceptor. In SMILES 2, the system contains several hydroxyl (-OH) groups (e.g., C(C(CO3)O)), which can act as hydrogen bond donors.","Moderate - This type of interaction can influence solubility and the pharmacokinetic profile, potentially affecting how the drugs are absorbed and distributed in the body."
Lamotrigine,Zolpidem,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Hydrogen Bond (Potential donor-acceptor pair),"The first molecule contains an amine group (NH2) that can act as a hydrogen bond donor, while the second molecule has a carbonyl group (C=O) and aromatic nitrogen (N), which can potentially act as hydrogen bond acceptors.","In SMILES 1, the fragment ""N"" in ""C2=C(N=C(N=N2)"" represents a possible donor NH group. In SMILES 2, the fragment ""C(=O)N"" indicates a carbonyl oxygen, which is a strong hydrogen bond acceptor.",Moderate - Such interactions could have implications in binding affinity or solubility but are context-dependent on their pharmacokinetics and environment.
Lamotrigine,Fosphenytoin,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,Hydrogen Bonding,A potential hydrogen bond could form between the amino group (-NH2) in the triazene ring of SMILES 1 and the phosphate group (-OPO3H2) in SMILES 2.,"SMILES 1 includes a -NH2 group from the triazene moiety (represented by N), and SMILES 2 includes phosphate (-OPO(=O)(O)O), which can serve as a hydrogen bond acceptor due to the oxygen atoms carrying partial negative charges.","Moderate - While hydrogen bonding can significantly affect molecular interactions, the impact on pharmacological behavior would depend on the context of these interactions within the full biochemical environment."
Brimonidine,Terazosin,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,Hydrogen Bonding,Hydrogen bonds can form between a hydrogen atom attached to a more electronegative atom (such as nitrogen or oxygen) and a lone pair of electrons on another electronegative atom.,"In SMILES 1, the structure contains a nitrogen atom in the triazole ring, N=C(N1), which can act as a hydrogen bond acceptor. In SMILES 2, multiple nitrogen atoms are present in the pyrimidine ring, such as N1CCN(CC3), and an oxygen atom in the methoxy group (OC), which can serve as hydrogen bond acceptors or donors depending on their context.","Moderate - While hydrogen bonding can significantly affect the binding affinity and specificity of molecular interactions, in a physiological setting with many competing interactions, its impact may vary."
Fluorouracil,Fulvestrant,C1=C(C(=O)NC(=O)N1)F,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,Hydrogen Bonding,"A hydrogen bond can form between a hydrogen bond donor in one molecule and a hydrogen bond acceptor in the other. In this case, the secondary amide group (-NC(=O)-) in SMILES 1 can serve as a hydrogen bond donor and acceptor. The hydroxyl group (-OH) in SMILES 2 is a known hydrogen bond donor and acceptor.",SMILES 1 contains an amide group with a carbonyl oxygen (C(=O)N) that can act as a hydrogen bond acceptor. SMILES 2 contains a phenolic hydroxyl group (-C6H4-OH) that can act as a hydrogen bond donor.,"Moderate - While hydrogen bonds can significantly affect the interaction between molecules, the impact will vary depending on the context, such as concentration and the presence of other functional groups that may influence binding affinity or solubility. In a physiological setting, this interaction could influence the solubility or binding affinity of the molecules but is not likely to result in a strong, direct pharmacological effect without additional supporting interactions."
Naproxen,Gabapentin,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,C1CCC(CC1)(CC(=O)O)CN,Hydrogen bonding,A hydrogen bond can occur between a donor hydrogen atom attached to a nitrogen in one molecule and an oxygen atom present in the carboxylic acid group of the other molecule.,SMILES 2 contains a nitrogen atom in the secondary amine group (CN) which can serve as a hydrogen bond donor. SMILES 1 contains a carboxylic acid group (C(=O)O) which includes both an electronegative oxygen atom and a proton that can participate in hydrogen bonding.,"Moderate - Such hydrogen bonds can affect binding affinity and molecular stability, potentially influencing pharmacokinetics and dynamics."
alendronic acid,Efavirenz,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Hydrogen Bonding,"The amino group (NH2) from the first compound can form a hydrogen bond with the carbonyl oxygen (C=O) of the second compound, which is part of the lactone ring structure.","In SMILES 1, 'CN' indicates the presence of an amino group capable of donating a hydrogen for bonding. In SMILES 2, 'C(=O)O' within the lactone structure provides an oxygen atom with lone pairs that can accept a hydrogen bond.","Moderate - This interaction can influence the binding affinity or solubility of these compounds when in close proximity, potentially affecting pharmacological behavior."
Carvedilol,Darunavir,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Hydrogen Bonding,"The presence of hydroxyl (-OH) groups in both molecules allows them to act as hydrogen bond donors and/or acceptors, potentially engaging in hydrogen bonding interactions.","In SMILES 1, the hydroxyl group is part of the -OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O chain. In SMILES 2, the -NC(=O)OC2COC3C2CCO3 structure contains carbonyl oxygen that can act as a hydrogen bond acceptor, while the -OH attached to the secondary amine group can donate a hydrogen bond.",Moderate - These interactions can increase affinity or alter the binding dynamics if both molecules can access each other's hydroxyl or carbonyl groups. Their clinical significance would depend on concentration and proximity in physiological conditions.
Triazolam,solifenacin,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,π-π Stacking,"π-π stacking occurs due to the face-to-face interaction between aromatic rings, which can stabilize the interaction through attractive forces between the π-electron clouds.","SMILES 1 contains two chlorophenyl rings, ""C3=C(C=C(C=C3)Cl)"" and ""C4=CC=CC=C4Cl"", while SMILES 2 includes multiple phenyl rings, particularly ""C4=CC=CC=C4"" and ""C5=CC=CC=C5"", providing the aromatic systems necessary for potential stacking interactions.","Moderate - The π-π stacking interaction might influence the relative orientation of these molecules, potentially affecting their binding affinities and pharmacokinetics in metabolic pathways."
Furosemide,Zolpidem,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,Hydrogen Bonding,"Hydrogen bonding can occur between a hydrogen bond donor (e.g., -OH, -NH) and a hydrogen bond acceptor (e.g., carbonyl oxygen, -SO2-). In this case, the sulfonamide N-H group from SMILES 1 can donate a hydrogen bond to the carbonyl oxygen in the amide group of SMILES 2.","SMILES 1 has a sulfonamide group S(=O)(=O)N which contains an -NH group, and SMILES 2 contains a carbonyl group in its amide structure (C=O).","Moderate - while this type of interaction can influence binding affinity and specificity, its overall impact will depend on the concentration and context in a physiological setting."
Famotidine,Pilocarpine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,CCC1C(COC1=O)CC2=CN=CN2C,Hydrogen Bonding,"Hydrogen bonds can form between a hydrogen donor group in one molecule and an acceptor group in the other molecule. Here, the thiazole nitrogen in SMILES 1 and the carbonyl oxygen in SMILES 2 can participate in hydrogen bonding.","In SMILES 1, the thiazole ring contains a nitrogen atom that can act as a hydrogen bond acceptor. In SMILES 2, the carbonyl group (C=O) in the oxolane ring can act as a hydrogen bond acceptor.","Moderate - Such hydrogen bonds could potentially stabilize a complex formation, affecting the pharmacokinetics and binding profiles of the drugs in a biological system."
Theophylline,Bumetanide,CN1C2=C(C(=O)N(C1=O)C)NC=N2,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Hydrogen Bonding,"The NH group in the sulfonamide moiety of the second molecule is a potential hydrogen bond donor, and the carbonyl oxygen in the lactam ring of the first molecule can act as a hydrogen bond acceptor.","In SMILES 2, the segment 'S(=O)(=O)N' contains an NH group capable of donating a hydrogen. In SMILES 1, the segment 'C(=O)N' from the lactam contains a carbonyl (C=O) oxygen which can accept a hydrogen bond.","Moderate - Hydrogen bonding can stabilize or modulate the interaction between the molecules, potentially affecting pharmacological activity."
Celecoxib,Labetalol,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,Hydrogen Bonding,A hydrogen bond can occur between a hydrogen donor (such as an -OH or -NH group) and an acceptor (such as a carbonyl oxygen or sulfonamide oxygen).,"- SMILES 1 contains a sulfonamide group ""S(=O)(=O)"" which has two oxygen atoms that can act as hydrogen bond acceptors.
- SMILES 2 contains an -OH group ""CC(C2=CC(=C(C=C2)O)"" which can act as a hydrogen bond donor.",Moderate - This interaction can influence the binding affinity or solubility under physiological conditions.
Risedronic acid,Torasemide,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Hydrogen Bonding,"The presence of hydrogen bond donors and acceptors in both molecules can lead to potential hydrogen bonding between them. Specifically, the hydroxyl group (OH) and phosphate groups in SMILES 1 can act as hydrogen bond donors or acceptors, while the sulfonamide group (S(=O)2) and the amide group (NC=O) in SMILES 2 can act as hydrogen bond acceptors, creating opportunities for hydrogen bonding.","- SMILES 1 contains hydroxyl (O) and phosphate (P(=O)(O)O) groups that can engage in hydrogen interactions.
- SMILES 2 includes sulfonamide (S(=O)(=O)) and amide (NC=O) groups capable of accepting hydrogen bonds.","Moderate - The ability for these molecules to hydrogen bond could affect their pharmacokinetics and pharmacodynamics by altering solubility, binding affinity, or distribution."
Amlodipine,Desloratadine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,π-π Stacking Interaction,"π-π stacking interactions occur between aromatic rings when they are in proximity, and the stabilizing interactions arise from the overlap of π-electron clouds.",Both SMILES strings contain aromatic rings. SMILES 1 contains an aromatic phenyl ring (C2=CC=CC=C2Cl) adjacent to a chlorinated phenyl ring. SMILES 2 contains multiple aromatic rings including a chlorinated phenyl ring (C2=C(C=CC=C2)Cl) and another aromatic ring (C4=C1C=CC=N4). These structures provide the potential for π-π stacking interactions when the molecules come into proximity.,"Moderate - While π-π interactions can influence binding affinities and stability of drug-drug or drug-target complexes, the overall pharmacological impact may vary depending on the context in which these molecules interact."
